EurekaMag PDF full texts Chapter 72,902

Cong, Q.; Jia, H.; Li, P.; Qiu, S.; Yeh, J.; Wang, Y.; Zhang, Z-Lin.; Ao, J.; Li, B.; Liu, H. 2017: P38α MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging-dependent manner. Scientific Reports 7: 45964

Schultze, S.M.; Mairhofer, A.; Li, D.; Cen, J.; Beug, H.; Wagner, E.F.; Hui, L. 2012: P38α controls erythroblast enucleation and Rb signaling in stress erythropoiesis. Cell Research 22(3): 539-550

Rius-Pérez, S.; Tormos, A.M.; Pérez, S.; Finamor, I.; Rada, P.; Valverde, Ángela.M.; Nebreda, A.R.; Sastre, J.; Taléns-Visconti, R. 2019: P38α deficiency restrains liver regeneration after partial hepatectomy triggering oxidative stress and liver injury. Scientific Reports 9(1): 3775

Zhang, M.; Gao, J.; Zhao, X.; Zhao, M.; Ma, D.; Zhang, X.; Tian, D.; Pan, B.; Yan, X.; Wu, J.; Meng, X.; Yin, H.; Zheng, L. 2021: P38α in macrophages aggravates arterial endothelium injury by releasing IL-6 through phosphorylating megakaryocytic leukemia 1. Redox Biology 38: 101775

Guijarro, M.V.; Vergel, M.; Marin, J.J.; Muñoz-Galván, S.; Ferrer, I.; Ramon y Cajal, S.; Roncador, G.; Blanco-Aparicio, C.; Carnero, A. 2012: P38α limits the contribution of MAP17 to cancer progression in breast tumors. Oncogene 31(41): 4447-4459

Sorimachi, Y.; Karigane, D.; Ootomo, Y.; Kobayashi, H.; Morikawa, T.; Otsu, K.; Kubota, Y.; Okamoto, S.; Goda, N.; Takubo, K. 2021: P38α plays differential roles in hematopoietic stem cell activity dependent on aging contexts. Journal of Biological Chemistry 296: 100563

Salvador-Bernáldez, Mía.; Mateus, S.B.; Del Barco Barrantes, Ián.; Arthur, S.C.; Martínez-A, C.; Nebreda, A.R.; Salvador, Jús.M. 2017: P38α regulates cytokine-induced IFNγ secretion via the Mnk1/eIF4E pathway in Th1 cells. Immunology and Cell Biology 95(9): 814-823

Gianni, M.; Peviani, M.; Bruck, N.; Rambaldi, A.; Borleri, G.; Terao, M.; Kurosaki, M.; Paroni, G.; Rochette-Egly, C.; Garattini, E. 2012: P38αMAPK interacts with and inhibits RARα: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells. Leukemia 26(8): 1850-1861

Pascual-Serra, R.; Fernández-Aroca, D.M.; Sabater, S.; Roche, O.; Andrés, I.; Ortega-Muelas, M.; Arconada-Luque, E.; Garcia-Flores, N.; Bossi, G.; Belandia, B.; Ruiz-Hidalgo, M.J.; Sánchez-Prieto, R. 2021: P38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 156: 136-144

Katopodis, P.; Kerslake, R.; Zikopoulos, A.; Beri, N.; Anikin, V. 2021: P38β - MAPK11 and its role in female cancers. Journal of Ovarian Research 14(1): 84

Wang, F.; Qi, X.-M.; Wertz, R.; Mortensen, M.; Hagen, C.; Evans, J.; Sheinin, Y.; James, M.; Liu, P.; Tsai, S.; Thomas, J.; Mackinnon, A.; Dwinell, M.; Myers, C.R.; Bartrons Bach, R.; Fu, L.; Chen, G. 2020: P38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis. Cancer Research 80(16): 3251-3264

Yin, N.; Qi, X.; Tsai, S.; Lu, Y.; Basir, Z.; Oshima, K.; Thomas, J.P.; Myers, C.R.; Stoner, G.; Chen, G. 2016: P38γ MAPK is required for inflammation-associated colon tumorigenesis. Oncogene 35(8): 1039-1048

González-Terán, Bárbara.; López, J.Antonio.; Rodríguez, E.; Leiva, L.; Martínez-Martínez, S.; Bernal, J.Antonio.; Jiménez-Borreguero, L.Jesús.; Redondo, J.Miguel.; Vazquez, Jús.; Sabio, G. 2016: P38γ and δ promote heart hypertrophy by targeting the mTOR-inhibitory protein DEPTOR for degradation. Nature Communications 7: 10477

Tomás-Loba, A.; Manieri, E.; González-Terán, Bárbara.; Mora, A.; Leiva-Vega, L.; Santamans, Aén.M.; Romero-Becerra, R.; Rodríguez, E.; Pintor-Chocano, Aánzazu.; Feixas, F.; López, J.Antonio.; Caballero, B.; Trakala, M.; Blanco, Óscar.; Torres, J.L.; Hernández-Cosido, L.; Montalvo-Romeral, V.; Matesanz, N.; Roche-Molina, M.; Bernal, J.Antonio.; Mischo, H.; León, M.; Caballero, A.; Miranda-Saavedra, D.; Ruiz-Cabello, Jús.; Nevzorova, Y.A.; Cubero, F.Javier.; Bravo, Jónimo.; Vázquez, Jús.; Malumbres, M.; Marcos, M.; Osuna, Sílvia.; Sabio, G. 2019: P38γ is essential for cell cycle progression and liver tumorigenesis. Nature 568(7753): 557-560

Yang, K.; Liu, Y.; Liu, Z.; Liu, J.; Liu, X.; Chen, X.; Li, C.; Zeng, Y. 2013: P38γ overexpression in gliomas and its role in proliferation and apoptosis. Scientific Reports 3: 2089

Shi, C.; Cheng, W.-N.; Wang, Y.; Li, D.-Z.; Zhou, L.-N.; Zhu, Y.-C.; Zhou, X.-Z. 2020: P38γ overexpression promotes osteosarcoma cell progression. Aging 12(18): 18384-18395

George, S.A.; Kiss, A.; Obaid, S.N.; Venegas, A.; Talapatra, T.; Wei, C.; Efimova, T.; Efimov, I.R. 2020: P38δ genetic ablation protects female mice from anthracycline cardiotoxicity. American Journal of Physiology. Heart and Circulatory Physiology 319(4): H775-H786

Ouyang, L.; Chen, Y.; Wang, Y.; Chen, Y.; Fu, A.K.Y.; Fu, W-Yu.; Ip, N.Y. 2020: P39-associated Cdk5 activity regulates dendritic morphogenesis. Scientific Reports 10(1): 18746

Bishop, J.A.; Teruya-Feldstein, J.; Westra, W.H.; Pelosi, G.; Travis, W.D.; Rekhtman, N. 2012: P40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 25(3): 405-415

Flinterman, M.B.; Mymryk, J.S.; Klanrit, P.; Yousef, A.F.; Lowe, S.W.; Caldas, C.; Gäken, J.; Farzaneh, F.; Tavassoli, M. 2007: P400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing. Oncogene 26(48): 6863-6874

Vadlamudi, R.K.; Li, F.; Barnes, C.J.; Bagheri-Yarmand, R.; Kumar, R. 2004: P41-Arc subunit of human Arp2/3 complex is a p21-activated kinase-1-interacting substrate. Embo Reports 5(2): 154-160

Knockaert, M.; Lenormand, P.; Gray, N.; Schultz, P.; Pouysségur, J.; Meijer, L. 2002: P42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol. Oncogene 21(42): 6413-6424

Zhu, Z.; Mukhina, S.; Zhu, T.; Mertani, H.C.; Lee, K-Onn.; Lobie, P.E. 2005: P44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis. Oncogene 24(23): 3774-3785

Sutterlüty, H.; Chatelain, E.; Marti, A.; Wirbelauer, C.; Senften, M.; Müller, U.; Krek, W. 1999: P45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nature Cell Biology 1(4): 207-214

Taylor, G.A.; Feng, C.G.; Sher, A. 2004: P47 GTPases: regulators of immunity to intracellular pathogens. Nature Reviews. Immunology 4(2): 100-109

Kondo, H.; Rabouille, C.; Newman, R.; Levine, T.P.; Pappin, D.; Freemont, P.; Warren, G. 1997: P47 is a cofactor for p97-mediated membrane fusion. Nature 388(6637): 75-78

Shibata, Y.; Oyama, M.; Kozuka-Hata, H.; Han, X.; Tanaka, Y.; Gohda, J.; Inoue, J-ichiro. 2012: P47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO. Nature Communications 3: 1061

Gong, P.; Chen, Y.-Q.; Lin, A.-H.; Zhang, H.-B.; Zhang, Y.; Ye, R.D.; Yu, Y. 2020: P47phox deficiency improves cognitive impairment and attenuates tau hyperphosphorylation in mouse models of AD. Alzheimer's Research and Therapy 12(1): 146

Wang, X.; Zhang, S.; Ding, Y.; Tong, H.; Xu, X.; Wei, G.; Chen, Y.; Ju, W.; Fu, C.; Qi, K.; Li, Z.; Zeng, L.; Xu, K.; Qiao, J. 2020: P47phox deficiency impairs platelet function and protects mice against arterial and venous thrombosis. Redox Biology 34: 101569

Donaldson, M.; Antignani, A.; Milner, J.; Zhu, N.; Wood, A.; Cardwell-Miller, L.; Changpriroa, C.M.; Jackson, S.H. 2009: P47phox-deficient immune microenvironment signals dysregulate naive T-cell apoptosis. Cell Death and Differentiation 16(1): 125-138

Wu, L.; Crawley, C.D.; Garofalo, A.; Nichols, J.W.; Campbell, P-Ashley.; Khramtsova, G.F.; Olopade, O.I.; Weichselbaum, R.R.; Yamini, B. 2020: P50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability. Nature Communications 11(1): 5007

Ogawa, E.; Okuyama, R.; Ikawa, S.; Nagoshi, H.; Egawa, T.; Kurihara, A.; Yabuki, M.; Tagami, H.; Obinata, M.; Aiba, S. 2008: P51/p63 Inhibits ultraviolet B-induced apoptosis via Akt activation. Oncogene 27(6): 848-856

Katoh, I.; Aisaki, K.I.; Kurata, S.I.; Ikawa, S.; Ikawa, Y. 2000: P51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation. Oncogene 19(27): 3126-3130

Saxon, J.A.; Yu, H.; Polosukhin, V.V.; Stathopoulos, G.T.; Gleaves, L.A.; McLoed, A.G.; Massion, P.P.; Yull, F.E.; Zhao, Z.; Blackwell, T.S. 2018: P52 expression enhances lung cancer progression. Scientific Reports 8(1): 6078

Yoshizawa, R.; Umeki, N.; Yamamoto, A.; Okada, M.; Murata, M.; Sako, Y. 2021: P52Shc regulates the sustainability of ERK activation in a RAF-independent manner. Molecular Biology of the Cell 32(19): 1838-1848

Arena, A.; Stigliano, A.; Belcastro, E.; Giorda, E.; Rosado, M.M.; Grossi, A.; Assenza, M.R.; Moretti, F.; Fierabracci, A. 2021: P53 Activation Effect in the Balance of T Regulatory and Effector Cell Subsets in Patients with Thyroid Cancer and Autoimmunity. Frontiers in Immunology 12: 728381

Deng, X.; Li, Y.; Gu, S.; Chen, Y.; Yu, B.; Su, J.; Sun, L.; Liu, Y. 2020: P53 Affects PGC1α Stability Through AKT/GSK-3β to Enhance Cisplatin Sensitivity in Non-Small Cell Lung Cancer. Frontiers in Oncology 10: 1252

Al-Maghrabi, J.; Vorobyova, L.; Chapman, W.; Jewett, M.; Zielenska, M.; Squire, J.A. 2001: P53 Alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma: analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 14(12): 1252-1262

Epistolato, M.Carmela.; Disciglio, V.; Livide, G.; Berchialla, P.; Mencarelli, M.Antonietta.; Marozza, A.; Amenduni, M.; Hadjistilianou, T.; De Francesco, S.; Acquaviva, A.; Toti, P.; Cetta, F.; Ariani, F.; De Marchi, M.; Renieri, A.; Giachino, D. 2011: P53 Arg72Pro and MDM2 309 SNPs in hereditary retinoblastoma. Journal of Human Genetics 56(9): 685-686

Salomoni, P.; Pandolfi, P.Paolo. 2002: P53 De-ubiquitination: at the edge between life and death. Nature Cell Biology 4(6): E152-E153

Avallone, G.; Muscatello, L.V.; Leoni, A.; Roccabianca, P.; Lepri, E.; Crippa, L.; Bacci, B. 2020: P53 Expression in Canine Liposarcoma Correlates with Myxoid Variant and Higher Proliferative Activity. Veterinary Pathology 57(5): 620-622

Chandratre, G.A.; Wagh, V.; Badgujar, P.C.; Patil, V.; Nehte, R.S. 2020: P53 Gene Mutation in Blood of Zebu Cattle with Squamous Cell Carcinoma of the Horn. Journal of Comparative Pathology 181: 53-57

Kurup, S.P.; Moioffer, S.J.; Pewe, L.L.; Harty, J.T. 2020: P53 Hinders CRISPR/Cas9-Mediated Targeted Gene Disruption in Memory CD8 T Cells In Vivo. Journal of Immunology 205(8): 2222-2230

Thompson, E.F.; Chen, J.; Huvila, J.; Pors, J.; Ren, H.; Ho, J.; Chow, C.; Ta, M.; Proctor, L.; McAlpine, J.N.; Huntsman, D.; Gilks, C.Blake.; Hoang, L. 2020: P53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patterns. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 33(9): 1649-1659

Kim, J.; Nakasaki, M.; Todorova, D.; Lake, B.; Yuan, C-Y.; Jamora, C.; Xu, Y. 2014: P53 Induces skin aging by depleting Blimp1+ sebaceous gland cells. Cell Death and Disease 5: E1141

Liu, Y.; Wu, X.; Du, D.; Liu, J.; Zhang, W.; Gao, Y.; Zhang, H. 2021: P53 Inhibition Provides a Pivotal Protective Effect against Cerebral Ischemia-Reperfusion Injury via the Wnt Signaling Pathway. Cerebrovascular Diseases 50(6): 682-690

Funk, L.C.; Wan, J.; Ryan, S.D.; Kaur, C.; Sullivan, R.; Roopra, A.; Weaver, B.A. 2021: P53 Is not Required for High CIN to Induce Tumor Suppression. Molecular Cancer Research: Mcr 19(1): 112-123

Chen, T.; Wu, H.; Chen, X.; Xie, R.; Wang, F.; Sun, H.; Chen, L. 2020: P53 Mediates GnRH Secretion via Lin28/let-7 System in GT1-7 Cells. Diabetes Metabolic Syndrome and Obesity: Targets and Therapy 13: 4681-4688

Wang, H.; Chen, L.; Zhou, T.; Zhang, Z.; Zeng, C. 2021: P53 Mutation at Serine 249 and its Gain of Function Are Highly Related to Hepatocellular Carcinoma after Smoking Exposure. Public Health Genomics 24(3-4): 171-181

Zhang, Y.; Xia, M.; Zhou, Z.; Hu, X.; Wang, J.; Zhang, M.; Li, Y.; Sun, L.; Chen, F.; Yu, H. 2021: P53 Promoted Ferroptosis in Ovarian Cancer Cells Treated with Human Serum Incubated-Superparamagnetic Iron Oxides. International Journal of Nanomedicine 16: 283-296

Bock, F.J.; Tait, S.W.G. 2018: P53 REEPs to sow ER-mitochondrial contacts. Cell Research 28(9): 877-878

Ayuob, N.; Al-Shathly, M.R.; Bakhshwin, A.; Al-Abbas, N.S.; Shaer, N.A.; Al Jaouni, S.; Hamed, W.H.E. 2021: P53 Rather than β-Catenin Mediated the Combined Hypoglycemic Effect of Cinnamomum cassia (L.) and Zingiber officinale Roscoe in the Streptozotocin-Induced Diabetic Model. Frontiers in Pharmacology 12: 664248

Schubert, Jörg.; Brabletz, T. 2011: P53 Spreads out further: suppression of EMT and stemness by activating miR-200c expression. Cell Research 21(5): 705-707

Tan, Z.; Qu, W.; Tu, W.; Liu, W.; Baudry, M.; Schreiber, S.S. 2000: P53 accumulation due to down-regulation of ubiquitin: relevance for neuronal apoptosis. Cell Death and Differentiation 7(7): 675-681

Lim, Y.; De Bellis, D.; Dorstyn, L.; Kumar, S. 2018: P53 accumulation following cytokinesis failure in the absence of caspase-2. Cell Death and Differentiation 25(11): 2050-2052

Brockhaus, F.; Brüne, B. 1999: P53 accumulation in apoptotic macrophages is an energy demanding process that precedes cytochrome c release in response to nitric oxide. Oncogene 18(47): 6403-6410

Wales, M.M.; Biel, M.A.; el Deiry, W.; Nelkin, B.D.; Issa, J.P.; Cavenee, W.K.; Kuerbitz, S.J.; Baylin, S.B. 1995: P53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Medicine 1(6): 570-577

Chen, J.; Wang, J.; Li, H.; Wang, S.; Xiang, X.; Zhang, D. 2016: P53 activates miR-192-5p to mediate vancomycin induced AKI. Scientific Reports 6: 38868

Meyer, K.D.; Lin, S-Chieh.; Bernecky, C.; Gao, Y.; Taatjes, D.J. 2010: P53 activates transcription by directing structural shifts in Mediator. Nature Structural and Molecular Biology 17(6): 753-760

Sablina, A.A.; Chumakov, P.M.; Levine, A.J.; Kopnin, B.P. 2001: P53 activation in response to microtubule disruption is mediated by integrin-Erk signaling. Oncogene 20(8): 899-909

Kon, N.; Gu, W. 2021: P53 activation vs. stabilization: an acetylation tale from the C-terminal tail. Oncoscience 8: 58-60

Delia, D.; Mizutani, S.; Lamorte, G.; Goi, K.; Iwata, S.; Pierotti, M.A. 1996: P53 activity and chemotherapy. Nature Medicine 2(7): 724-725

Sheikh, T.; Sen, E. 2021: P53 affects epigenetic signature on SOCS1 promoter in response to TLR4 inhibition. Cytokine 140: 155418

Sauter, E.R.; Takemoto, R.; Litwin, S.; Herlyn, M. 2002: P53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma. Cancer Gene Therapy 9(10): 807-812

Buttitta, F.; Marchetti, A.; Gadducci, A.; Pellegrini, S.; Morganti, M.; Carnicelli, V.; Cosio, S.; Gagetti, O.; Genazzani, A.R.; Bevilacqua, G. 1997: P53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study. British Journal of Cancer 75(2): 230-235

Drexler, H.G.; Fombonne, S.; Matsuo, Y.; Hu, Z.B.; Hamaguchi, H.; Uphoff, C.C. 2000: P53 alterations in human leukemia-lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization?. Leukemia 14(1): 198-206

Ghosh, S.; Salot, S.; Sengupta, S.; Navalkar, A.; Ghosh, D.; Jacob, R.; Das, S.; Kumar, R.; Jha, N.Nath.; Sahay, S.; Mehra, S.; Mohite, G.M.; Ghosh, S.K.; Kombrabail, M.; Krishnamoorthy, G.; Chaudhari, P.; Maji, S.K. 2017: P53 amyloid formation leading to its loss of function: implications in cancer pathogenesis. Cell Death and Differentiation 24(10): 1784-1798

Lu, W-Jin.; Amatruda, J.F.; Abrams, J.M. 2009: P53 ancestry: gazing through an evolutionary lens. Nature Reviews. Cancer 9(10): 758-762

Liu, J.; Wang, H.; Zheng, M.; Deng, L.; Zhang, X.; Lin, B. 2020: P53 and ANXA4/NF‑κB p50 complexes regulate cell proliferation, apoptosis and tumor progression in ovarian clear cell carcinoma. International Journal of Molecular Medicine 46(6): 2102-2114

Fabi, A.; Mottolese, M.; Di Benedetto, A.; Sperati, F.; Ercolani, C.; Buglioni, S.; Nisticò, C.; Ferretti, G.; Vici, P.; Perracchio, L.; Malaguti, P.; Russillo, M.; Botti, C.; Pescarmona, E.; Cognetti, F.; Terrenato, I. 2020: P53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients with Long-Term Follow-up: An Observational Study. Clinical Breast Cancer 20(6): E761-E770

Jiang, P.; Du, W.; Wu, M. 2007: P53 and Bad: remote strangers become close friends. Cell Research 17(4): 283-285

Gannon, J.V.; Lane, D.P. 1987: P53 and DNA polymerase alpha compete for binding to SV40 T antigen. Nature 329(6138): 456-458

Schavolt, K.L.; Pietenpol, J.A. 2007: P53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis. Oncogene 26(42): 6125-6132

Polager, S.; Ginsberg, D. 2009: P53 and E2f: partners in life and death. Nature Reviews. Cancer 9(10): 738-748

de Belle, I.; Huang, R.P.; Fan, Y.; Liu, C.; Mercola, D.; Adamson, E.D. 1999: P53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene 18(24): 3633-3642

Santamaria, A.B.; Davis, D.W.; Nghiem, D.X.; McConkey, D.J.; Ullrich, S.E.; Kapoor, M.; Lozano, G.; Ananthaswamy, H.N. 2002: P53 and Fas ligand are required for psoralen and UVA-induced apoptosis in mouse epidermal cells. Cell Death and Differentiation 9(5): 549-560

Tergaonkar, V. 2009: P53 and NFkappaB: fresh breath in the cross talk. Cell Research 19(12): 1313-1315

Wickremasinghe, R.G.; Prentice, A.G.; Steele, A.J. 2011: P53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies. Leukemia 25(9): 1400-1407

Moll, U.M.; Marchenko, N.; Zhang, X-K. 2006: P53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction. Oncogene 25(34): 4725-4743

Linn, S.C.; Honkoop, A.H.; Hoekman, K.; van der Valk, P.; Pinedo, H.M.; Giaccone, G. 1996: P53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. British Journal of Cancer 74(1): 63-68

Zheng, H.; Ying, H.; Yan, H.; Kimmelman, A.C.; Hiller, D.J.; Chen, A-Jou.; Perry, S.R.; Tonon, G.; Chu, G.C.; Ding, Z.; Stommel, J.M.; Dunn, K.L.; Wiedemeyer, R.; You, M.J.; Brennan, C.; Wang, Y.Alan.; Ligon, K.L.; Wong, W.H.; Chin, L.; DePinho, R.A. 2008: P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 455(7216): 1129-1133

Cain, J.E.; Watkins, D.Neil. 2020: P53 and RB1 regulate Hedgehog responsiveness via autophagy-mediated ciliogenesis. Molecular and Cellular Oncology 7(6): 1805095

Poller, D.N.; Baxter, K.J.; Shepherd, N.A. 1997: P53 and Rb1 protein expression: are they prognostically useful in colorectal cancer?. British Journal of Cancer 75(1): 87-93

Minella, A.C.; Grim, J.E.; Welcker, M.; Clurman, B.E. 2007: P53 and SCFFbw7 cooperatively restrain cyclin E-associated genome instability. Oncogene 26(48): 6948-6953

Giatromanolaki, A.; Koukourakis, M.I. 1998: P53 and angiogenesis in non-small-cell lung cancer. British Journal of Cancer 77(5): 850-852

Piris, M.A.; Pezzella, F.; Martinez-Montero, J.C.; Orradre, J.L.; Villuendas, R.; Sanchez-Beato, M.; Cuena, R.; Cruz, M.A.; Martinez, B.; Pezella F [corrected to Pezzella, F.]. 1994: P53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time. British Journal of Cancer 69(2): 337-341

Wood, L.L. 1995: P53 and bladder cancer. New England Journal of Medicine 332(14): 958

Tan, P-Hoon.; Jayabaskar, T.; Yip, G.; Tan, Y.; Hilmy, M.; Selvarajan, S.; Bay, B-Huat. 2005: P53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 18(12): 1527-1534

Groves, M.J.; Johnson, C.E.; James, J.; Prescott, A.R.; Cunningham, J.; Haydock, S.; Pepper, C.; Fegan, C.; Pirrie, L.; Westwood, N.J.; Coates, P.J.; Ganley, I.G.; Tauro, S. 2013: P53 and cell cycle independent dysregulation of autophagy in chronic lymphocytic leukaemia. British Journal of Cancer 109(9): 2434-2444

Wu, G.S.; El-Diery, W.S. 1996: P53 and chemosensitivity. Nature Medicine 2(3): 255-256

Hiramoto, K.; Yamate, Y.; Sato, E.F. 2021: P53 and clock genes play an important role in memory and learning ability depression due to long-term ultraviolet A eye irradiation. Photochemical and Photobiological Sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology 2021

Bayer, F.E.; Zimmermann, M.; Fischer, P.; Gromoll, C.; Preiss, A.; Nagel, A.C. 2017: P53 and cyclin G cooperate in mediating genome stability in somatic cells of Drosophila. Scientific Reports 7(1): 17890

Royds, J.A.; Iacopetta, B. 2006: P53 and disease: when the guardian angel fails. Cell Death and Differentiation 13(6): 1017-1026

Jung, M.S.; Yun, J.; Chae, H.D.; Kim, J.M.; Kim, S.C.; Choi, T.S.; Shin, D.Y. 2001: P53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor. Oncogene 20(41): 5818-5825

Bourdon, J-C. 2007: P53 and its isoforms in cancer. British Journal of Cancer 97(3): 277-282

Knight, R.A. 1999: P53 and its younger siblings. Cell Death and Differentiation 6(12): 1143

Grover, R.; Candeias, M.M.; Fåhraeus, R.; Das, S. 2009: P53 and little brother p53/47: linking IRES activities with protein functions. Oncogene 28(30): 2766-2772

Vousden, K.H.; Ryan, K.M. 2009: P53 and metabolism. Nature Reviews. Cancer 9(10): 691-700

Prieur, A.; Besnard, E.; Babled, Aélie.; Lemaitre, J-Marc. 2011: P53 and p16(INK4A) independent induction of senescence by chromatin-dependent alteration of S-phase progression. Nature Communications 2: 473

Kwan, D.N.; Rocha, J.úl.T.Q.óz.; Niero-Melo, L.; Domingues, M.A.C.ód.; Oliveira, C.C. 2020: P53 and p21 expression in bone marrow clots of megaloblastic anemia patients. International Journal of Clinical and Experimental Pathology 13(7): 1829-1833

Soengas, M.S.; Lowe, S.W. 2000: P53 and p73: seeing double?. Nature Genetics 26(4): 391-392

Janz, C.; Süsse, S.; Wiesmüller, L. 2002: P53 and recombination intermediates: role of tetramerization at DNA junctions in complex formation and exonucleolytic degradation. Oncogene 21(14): 2130-2140

Rosenheimer-Goudsmid, N.; Haupt, Y.; Yefenof, E.; Zilberman, Y.; Guy, R. 2000: P53 and thymic 'death by neglect': thymic epithelial cell-induced apoptosis of CD4+8+ thymocytes is p53-independent. Cell Death and Differentiation 7(3): 241-249

Cote, R.J.; Esrig, D.; Groshen, S.; Jones, P.A.; Skinner, D.G. 1997: P53 and treatment of bladder cancer. Nature 385(6612): 123-125

Ambs, S.; Merriam, W.G.; Ogunfusika, M.O.; Bennett, W.P.; Ishibe, N.; Hussain, S.P.; Tzeng, E.E.; Geller, D.A.; Billiar, T.R.; Harris, C.C. 1998: P53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nature Medicine 4(12): 1371-1376

Bonnefoi, H.; Ducraux, A.; Movarekhi, S.; Pelte, M.F.; Bongard, S.; Lurati, E.; Iggo, R. 2002: P53 as a potential predictive factor of response to chemotherapy: feasibility of p53 assessment using a functional test in yeast from trucut biopsies in breast cancer patients. British Journal of Cancer 86(5): 750-755

Sun, J.; Wen, Y.; Zhou, Y.; Jiang, Y.; Chen, Y.; Zhang, H.; Guan, L.; Yao, X.; Huang, M.; Bi, H. 2018: P53 attenuates acetaminophen-induced hepatotoxicity by regulating drug-metabolizing enzymes and transporter expression. Cell Death and Disease 9(5): 536

Jiang, M.; Axe, T.; Holgate, R.; Rubbi, C.P.; Okorokov, A.L.; Mee, T.; Milner, J. 2001: P53 binds the nuclear matrix in normal cells: binding involves the proline-rich domain of p53 and increases following genotoxic stress. Oncogene 20(39): 5449-5458

Xiao, G.; White, D.; Bargonetti, J. 1998: P53 binds to a constitutively nucleosome free region of the mdm2 gene. Oncogene 16(9): 1171-1181

Marchetti, A.; Cecchinelli, B.; D'Angelo, M.; D'Orazi, G.; Crescenzi, M.; Sacchi, A.; Soddu, S. 2004: P53 can inhibit cell proliferation through caspase-mediated cleavage of ERK2/MAPK. Cell Death and Differentiation 11(6): 596-607

Godefroy, N.; Lemaire, C.; Renaud, F.; Rincheval, V.; Perez, S.; Parvu-Ferecatu, I.; Mignotte, B.; Vayssière, J-L. 2004: P53 can promote mitochondria- and caspase-independent apoptosis. Cell Death and Differentiation 11(7): 785-787

Pan, Y.; Oprysko, P.R.; Asham, A.M.; Koch, C.J.; Simon, M.Celeste. 2004: P53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment. Oncogene 23(29): 4975-4983

Quesnel, S.; Verselis, S.; Portwine, C.; Garber, J.; White, M.; Feunteun, J.; Malkin, D.; Li, F.P. 1999: P53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome. Oncogene 18(27): 3970-3978

Yamane, K.; Katayama, E.; Tsuruo, T. 2001: P53 contains a DNA break-binding motif similar to the functional part of BRCT-related region of Rb. Oncogene 20(23): 2859-2867

Wang, S-Ping.; Wang, W-Lung.; Chang, Y-Leong.; Wu, C-Tu.; Chao, Y-Chih.; Kao, S-Han.; Yuan, A.; Lin, C-Wu.; Yang, S-Chen.; Chan, W-Kai.; Li, K-Chau.; Hong, T-Ming.; Yang, P-Chyr. 2009: P53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nature Cell Biology 11(6): 694-704

Marin Navarro, A.; Pronk, R.Johan.; van der Geest, A.Tjitske.; Oliynyk, G.; Nordgren, A.; Arsenian-Henriksson, M.; Falk, A.; Wilhelm, M. 2020: P53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids. Cell Death and Disease 11(1): 52

Salah, Z.; Haupt, S.; Maoz, M.; Baraz, L.; Rotter, V.; Peretz, T.; Haupt, Y.; Bar-Shavit, R. 2008: P53 controls hPar1 function and expression. Oncogene 27(54): 6866-6874

Li, M.; Hou, T.; Gao, T.; Lu, X.; Yang, Q.; Zhu, Q.; Li, Z.; Liu, C.; Mu, G.; Liu, G.; Bao, Y.; Wen, H.; Wang, L.; Wang, H.; Zhao, Y.; Gu, W.; Yang, Y.; Zhu, W-Guo. 2018: P53 cooperates with SIRT6 to regulate cardiolipin de novo biosynthesis. Cell Death and Disease 9(10): 941

Franklin, D.A.; He, Y.; Leslie, P.L.; Tikunov, A.P.; Fenger, N.; Macdonald, J.M.; Zhang, Y. 2016: P53 coordinates DNA repair with nucleotide synthesis by suppressing PFKFB3 expression and promoting the pentose phosphate pathway. Scientific Reports 6: 38067

Zhu, G.; Ying, Y.; Ji, K.; Duan, X.; Mai, T.; Kim, J.; Li, Q.; Yu, L.; Xu, Y. 2020: P53 coordinates glucose and choline metabolism during the mesendoderm differentiation of human embryonic stem cells. Stem Cell Research 49: 102067

Landesman-Bollag, E.; Channavajhala, P.L.; Cardiff, R.D.; Seldin, D.C. 1998: P53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice. Oncogene 16(23): 2965-2974

Burr, K.L-A.; Smith, A.G.; Dubrova, Y.E. 2005: P53 deficiency does not affect mutation rate in the mouse germline. Oncogene 24(26): 4315-4318

Marxer, M.; Ma, H.T.; Man, W.Y.; Poon, R.Y.C. 2014: P53 deficiency enhances mitotic arrest and slippage induced by pharmacological inhibition of Aurora kinases. Oncogene 33(27): 3550-3560

Sphyris, N.; Harrison, D.J. 2005: P53 deficiency exacerbates pleiotropic mitotic defects, changes in nuclearity and polyploidy in transdifferentiating pancreatic acinar cells. Oncogene 24(13): 2184-2194

Chiche, A.; Moumen, M.; Romagnoli, M.; Petit, V.; Lasla, H.; Jézéquel, P.; de la Grange, P.; Jonkers, J.; Deugnier, M-A.; Glukhova, M.A.; Faraldo, M.M. 2017: P53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors. Oncogene 36(17): 2355-2365

Gao, J.; Huang, H-Ying.; Pak, J.; Cheng, J.; Zhang, Z-Ting.; Shapiro, E.; Pellicer, A.; Sun, T-Tien.; Wu, X-Ru. 2004: P53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis. Oncogene 23(3): 687-696

Plaster, N.; Sonntag, C.; Busse, C.E.; Hammerschmidt, M. 2006: P53 deficiency rescues apoptosis and differentiation of multiple cell types in zebrafish flathead mutants deficient for zygotic DNA polymerase delta1. Cell Death and Differentiation 13(2): 223-235

Begus-Nahrmann, Y.; Lechel, Aé.; Obenauf, A.C.; Nalapareddy, K.; Peit, E.; Hoffmann, E.; Schlaudraff, F.; Liss, B.; Schirmacher, P.; Kestler, H.; Danenberg, E.; Barker, N.; Clevers, H.; Speicher, M.R.; Rudolph, K.Lenhard. 2009: P53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice. Nature Genetics 41(10): 1138-1143

Feng, X.; Liu, X.; Zhang, W.; Xiao, W. 2011: P53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death. EMBO Journal 30(16): 3397-3415

Aoubala, M.; Murray-Zmijewski, F.; Khoury, M.P.; Fernandes, K.; Perrier, S.; Bernard, H.; Prats, A-C.; Lane, D.P.; Bourdon, J-C. 2011: P53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage. Cell Death and Differentiation 18(2): 248-258

Akdemir, F.; Christich, A.; Sogame, N.; Chapo, J.; Abrams, J.M. 2007: P53 directs focused genomic responses in Drosophila. Oncogene 26(36): 5184-5193

Wang, Y.; Zhu, S.; Cloughesy, T.F.; Liau, L.M.; Mischel, P.S. 2004: P53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition. Oncogene 23(6): 1283-1290

Zhang, Y.; Liao, J-Ming.; Zeng, S.X.; Lu, H. 2011: P53 downregulates Down syndrome-associated DYRK1A through miR-1246. Embo Reports 12(8): 811-817

Rother, K.; Kirschner, R.; Sänger, K.; Böhlig, L.; Mössner, J.; Engeland, K. 2007: P53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A. Oncogene 26(13): 1949-1953

Jaber, S.; Toufektchan, Eéonore.; Lejour, V.; Bardot, B.; Toledo, F. 2016: P53 downregulates the Fanconi anaemia DNA repair pathway. Nature Communications 7: 11091

Hsieh, P-C.; Chang, J-C.; Sun, W-T.; Hsieh, S-C.; Wang, M-C.; Wang, F-F. 2007: P53 downstream target DDA3 is a novel microtubule-associated protein that interacts with end-binding protein EB3 and activates beta-catenin pathway. Oncogene 26(34): 4928-4940

Rozan, L.M.; El-Deiry, W.S. 2007: P53 downstream target genes and tumor suppression: a classical view in evolution. Cell Death and Differentiation 14(1): 3-9

Sax, J.K.; El-Deiry, W.S. 2003: P53 downstream targets and chemosensitivity. Cell Death and Differentiation 10(4): 413-417

Jentsch, M.; Snyder, P.; Sheng, C.; Cristiano, E.; Loewer, A. 2020: P53 dynamics in single cells are temperature-sensitive. Scientific Reports 10(1): 1481

Wu, M.; Ye, H.; Tang, Z.; Shao, C.; Lu, G.; Chen, B.; Yang, Y.; Wang, G.; Hao, H. 2017: P53 dynamics orchestrates with binding affinity to target genes for cell fate decision. Cell Death and Disease 8(10): E3130

Terakawa, T.; Takada, S. 2015: P53 dynamics upon response element recognition explored by molecular simulations. Scientific Reports 5: 17107

Stewart-Ornstein, J.; Iwamoto, Y.; Miller, M.A.; Prytyskach, M.A.; Ferretti, S.; Holzer, P.; Kallen, J.; Furet, P.; Jambhekar, A.; Forrester, W.C.; Weissleder, R.; Lahav, G. 2021: P53 dynamics vary between tissues and are linked with radiation sensitivity. Nature Communications 12(1): 898

Bakhanashvili, M. 2001: P53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. Oncogene 20(52): 7635-7644

Vega, F.J.; Iniesta, P.; Caldés, T.; Sanchez, A.; López, J.A.; de Juan, C.; Diaz-Rubio, E.; Torres, A.; Balibrea, J.L.; Benito, M. 1997: P53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer. British Journal of Cancer 76(1): 44-51

Wadayama, B.; Toguchida, J.; Yamaguchi, T.; Sasaki, M.S.; Yamamuro, T. 1993: P53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. British Journal of Cancer 68(6): 1134-1139

Yang, C.M.; Kang, M.-K.; Jung, W.-J.; Joo, J.-S.; Kim, Y.-J.; Choi, Y.; Kim, H.-P. 2021: P53 expression confers sensitivity to 5-fluorouracil via distinct chromatin accessibility dynamics in human colorectal cancer. Oncology Letters 21(3): 226

Gupta, R.K.; Norton, A.J.; Thompson, I.W.; Lister, T.A.; Bodmer, J.G. 1992: P53 expression in Reed-Sternberg cells of Hodgkin's disease. British Journal of Cancer 66(4): 649-652

Hasebe, T.; Iwasaki, M.; Akashi-Tanaka, S.; Hojo, T.; Shibata, T.; Sasajima, Y.; Kinoshita, T.; Tsuda, H. 2010: P53 expression in tumor-stromal fibroblasts forming and not forming fibrotic foci in invasive ductal carcinoma of the breast. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 23(5): 662-672

Kagawa, S.; Fujiwara, T.; Hizuta, A.; Yasuda, T.; Zhang, W.W.; Roth, J.A.; Tanaka, N. 1997: P53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells. Oncogene 15(16): 1903-1909

Oh, H.Jeong.; Bae, J.Mo.; Wen, X.; Jung, S.; Kim, Y.; Kim, K.Ju.; Cho, N-Yun.; Kim, J.Ho.; Han, S-Won.; Kim, T-You.; Kang, G.Hoon. 2019: P53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy. British Journal of Cancer 120(8): 797-805

Tong, D.R.; Zhou, W.; Katz, C.; Regunath, K.; Venkatesh, D.; Ihuegbu, C.; Manfredi, J.J.; Laptenko, O.; Prives, C. 2021: P53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities. Molecular Cancer Research: Mcr 19(9): 1522-1533

Gui, S.; Xie, X.; O'Neill, W.Q.; Chatfield-Reed, K.; Yu, J-Ge.; Teknos, T.N.; Pan, Q. 2020: P53 functional states are associated with distinct aldehyde dehydrogenase transcriptomic signatures. Scientific Reports 10(1): 1097

de Souza-Pinto, N.C.; Harris, C.C.; Bohr, V.A. 2004: P53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria. Oncogene 23(39): 6559-6568

Song, H.; Hollstein, M.; Xu, Y. 2007: P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nature Cell Biology 9(5): 573-580

Quina, A.S.; Bastos-Silveira, C.; Miñarro, M.; Ventura, J.; Jiménez, R.; Paulo, O.S.; da Luz Mathias, M. 2015: P53 gene discriminates two ecologically divergent sister species of pine voles. Heredity 115(5): 444-451

Thompson, A.M.; Steel, C.M.; Chetty, U.; Hawkins, R.A.; Miller, W.R.; Carter, D.C.; Forrest, A.P.; Evans, H.J. 1990: P53 gene mRNA expression and chromosome 17p allele loss in breast cancer. British Journal of Cancer 61(1): 74-78

Bian, Y.S.; Osterheld, M.C.; Bosman, F.T.; Benhattar, J.; Fontolliet, C. 2001: P53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 14(5): 397-403

Rassidakis, G.Z.; Thomaides, A.; Wang, S.; Jiang, Y.; Fourtouna, A.; Lai, R.; Medeiros, L.J. 2005: P53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma. Leukemia 19(9): 1663-1669

Draus, J.M.; Elliott, M.J.; Atienza, C.; Stilwell, A.; Wong, S.L.; Dong, Y.; Yang, H.; McMasters, K.M. 2001: P53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells. Experimental and Molecular Medicine 33(4): 209-219

Gottlieb, E. 2011: P53 guards the metabolic pathway less travelled. Nature Cell Biology 13(3): 195-197

Teoh, P.J.; Chung, T.H.; Sebastian, S.; Choo, S.N.; Yan, J.; Ng, S.B.; Fonseca, R.; Chng, W.J. 2014: P53 haploinsufficiency and functional abnormalities in multiple myeloma. Leukemia 28(10): 2066-2074

Okuyama, R.; Ogawa, E.; Nagoshi, H.; Yabuki, M.; Kurihara, A.; Terui, T.; Aiba, S.; Obinata, M.; Tagami, H.; Ikawa, S. 2007: P53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity. Oncogene 26(31): 4478-4488

Piaton, E.; Faÿnel, J.; Ruffion, A.; Lopez, J.G.; Perrin, P.; Devonec, M. 2005: P53 immunodetection of liquid-based processed urinary samples helps to identify bladder tumours with a higher risk of progression. British Journal of Cancer 93(2): 242-247

Jacquemier, J.; Molès, J.P.; Penault-Llorca, F.; Adélaide, J.; Torrente, M.; Viens, P.; Birnbaum, D.; Theillet, C. 1994: P53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. British Journal of Cancer 69(5): 846-852

Serth, J.; Kuczyk, M.A.; Bokemeyer, C.; Hervatin, C.; Nafe, R.; Tan, H.K.; Jonas, U. 1995: P53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. British Journal of Cancer 71(1): 201-205

Soini, Y.; Turpeenniemi-Hujanen, T.; Kamel, D.; Autio-Harmainen, H.; Risteli, J.; Risteli, L.; Nuorva, K.; Pääkkö, P.; Vähäkangas, K. 1993: P53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression. British Journal of Cancer 68(5): 1029-1035

Yamaguchi, A.; Nakagawara, G.; Kurosaka, Y.; Nishimura, G.; Yonemura, Y.; Miyazaki, I. 1993: P53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance. British Journal of Cancer 68(2): 399-402

Schoop, I.; Maleki, S.S.; Behrens, H.-M.; Krüger, S.; Haag, J.; Röcken, C. 2020: P53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort. Human Pathology 105: 53-66

Nachmias, B.; Rund, D. 2021: P53 in Acute Myeloid Leukemia-Still a significant other. Leukemia and Lymphoma 2021: 1-3

Quiñones, M.; Al-Massadi, O.; Folgueira, C.; Bremser, S.; Gallego, Ría.; Torres-Leal, L.; Haddad-Tóvolli, R.; García-Caceres, C.; Hernandez-Bautista, R.; Lam, B.Y.H.; Beiroa, D.; Sanchez-Rebordelo, E.; Senra, A.; Malagon, J.A.; Valerio, P.; Fondevila, M.F.; Fernø, J.; Malagon, M.M.; Contreras, R.; Pfluger, P.; Brüning, J.C.; Yeo, G.; Tschöp, M.; Diéguez, C.; López, M.; Claret, M.; Kloppenburg, P.; Sabio, G.; Nogueiras, R. 2018: P53 in AgRP neurons is required for protection against diet-induced obesity via JNK1. Nature Communications 9(1): 3432

Scott, N.; Sagar, P.; Stewart, J.; Blair, G.E.; Dixon, M.F.; Quirke, P. 1991: P53 in colorectal cancer: clinicopathological correlation and prognostic significance. British Journal of Cancer 63(2): 317-319

Vousden, K.H.; Lane, D.P. 2007: P53 in health and disease. Nature Reviews. Molecular Cell Biology 8(4): 275-283

Curtin, J.C.; Spinella, M.J. 2005: P53 in human embryonal carcinoma: identification of a transferable, transcriptional repression domain in the N-terminal region of p53. Oncogene 24(9): 1481-1490

Bakhanashvili, M.; Grinberg, S.; Bonda, E.; Simon, A.J.; Moshitch-Moshkovitz, S.; Rahav, G. 2008: P53 in mitochondria enhances the accuracy of DNA synthesis. Cell Death and Differentiation 15(12): 1865-1874

Mor, O.; Read, M.; Fried, M. 1997: P53 in polyoma virus transformed REF52 cells. Oncogene 15(25): 3113-3119

Gatz, S.A.; Wiesmüller, L. 2006: P53 in recombination and repair. Cell Death and Differentiation 13(6): 1003-1016

Kruiswijk, F.; Labuschagne, C.F.; Vousden, K.H. 2015: P53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nature Reviews. Molecular Cell Biology 16(7): 393-405

Wang, B.; Niu, D.; Lai, L.; Ren, E.Chee. 2013: P53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1. Nature Communications 4: 2359

Ng, K.P.; Ebrahem, Q.; Negrotto, S.; Mahfouz, R.Z.; Link, K.A.; Hu, Z.; Gu, X.; Advani, A.; Kalaycio, M.; Sobecks, R.; Sekeres, M.; Copelan, E.; Radivoyevitch, T.; Maciejewski, J.; Mulloy, J.C.; Saunthararajah, Y. 2011: P53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia. Leukemia 25(11): 1739-1750

Yang, T.; Namba, H.; Hara, T.; Takmura, N.; Nagayama, Y.; Fukata, S.; Ishikawa, N.; Kuma, K.; Ito, K.; Yamashita, S. 1997: P53 induced by ionizing radiation mediates DNA end-jointing activity, but not apoptosis of thyroid cells. Oncogene 14(13): 1511-1519

Hao, Q.; Chen, J.; Liao, J.; Huang, Y.; Gan, Y.; Larisch, S.; Zeng, S.X.; Lu, H.; Zhou, X. 2021: P53 induces ARTS to promote mitochondrial apoptosis. Cell Death and Disease 12(2): 204

Zhu, K.; Wang, J.; Zhu, J.; Jiang, J.; Shou, J.; Chen, X. 1999: P53 induces TAP1 and enhances the transport of MHC class I peptides. Oncogene 18(54): 7740-7747

Liao, H.; Gaur, A.; Mauvais, C.; Denicourt, C. 2021: P53 induces a survival transcriptional response after nucleolar stress. Molecular Biology of the Cell 32(20): Ar3

Holmgren, L.; Jackson, G.; Arbiser, J. 1998: P53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma. Oncogene 17(7): 819-824

Lin, T.; Chao, C.; Saito, S'ichi.; Mazur, S.J.; Murphy, M.E.; Appella, E.; Xu, Y. 2005: P53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nature Cell Biology 7(2): 165-171

Adriaens, C.; Standaert, L.; Barra, J.; Latil, M.; Verfaillie, A.; Kalev, P.; Boeckx, B.; Wijnhoven, P.W.G.; Radaelli, E.; Vermi, W.; Leucci, E.; Lapouge, Gëlle.; Beck, B.; van den Oord, J.; Nakagawa, S.; Hirose, T.; Sablina, A.A.; Lambrechts, D.; Aerts, S.; Blanpain, Cédric.; Marine, J-Christophe. 2016: P53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nature Medicine 22(8): 861-868

Yang, R.; Xu, X.; Li, H.; Chen, J.; Xiang, X.; Dong, Z.; Zhang, D. 2017: P53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO. Scientific Reports 7: 43409

Yoon, M-Ho.; Kang, S-Mi.; Lee, S-Jin.; Woo, T-Gyun.; Oh, A-Young.; Park, S.; Ha, N-Chul.; Park, B-Joon. 2019: P53 induces senescence through Lamin A/C stabilization-mediated nuclear deformation. Cell Death and Disease 10(2): 107

Friborg, J.; Kong, W.; Hottiger, M.O.; Nabel, G.J. 1999: P53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402(6764): 889-894

Ihry, R.J.; Worringer, K.A.; Salick, M.R.; Frias, E.; Ho, D.; Theriault, K.; Kommineni, S.; Chen, J.; Sondey, M.; Ye, C.; Randhawa, R.; Kulkarni, T.; Yang, Z.; McAllister, G.; Russ, C.; Reece-Hoyes, J.; Forrester, W.; Hoffman, G.R.; Dolmetsch, R.; Kaykas, A. 2018: P53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nature Medicine 24(7): 939-946

Taylor, W.R.; Agarwal, M.L.; Agarwal, A.; Stacey, D.W.; Stark, G.R. 1999: P53 inhibits entry into mitosis when DNA synthesis is blocked. Oncogene 18(2): 283-295

Nazeer, F.I.; Devany, E.; Mohammed, S.; Fonseca, D.; Akukwe, B.; Taveras, C.; Kleiman, F.E. 2011: P53 inhibits mRNA 3' processing through its interaction with the CstF/BARD1 complex. Oncogene 30(27): 3073-3083

Pieles, O.; Reck, A.; Reichert, T.E.; Morsczeck, C. 2020: P53 inhibits the osteogenic differentiation but does not induce senescence in human dental follicle cells. Differentiation; Research in Biological Diversity 114: 20-26

Matas, D.; Milyavsky, M.; Shats, I.; Nissim, L.; Goldfinger, N.; Rotter, V. 2004: P53 is a regulator of macrophage differentiation. Cell Death and Differentiation 11(4): 458-467

Allende-Vega, N.; Dayal, S.; Agarwala, U.; Sparks, A.; Bourdon, J-C.; Saville, M.K. 2013: P53 is activated in response to disruption of the pre-mRNA splicing machinery. Oncogene 32(1): 1-14

Yan, H.; Solozobova, V.; Zhang, P.; Armant, O.; Kuehl, B.; Brenner-Weiss, G.; Blattner, C. 2015: P53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53. Cell Death and Disease 6: E1662

Giannakakou, P.; Sackett, D.L.; Ward, Y.; Webster, K.R.; Blagosklonny, M.V.; Fojo, T. 2000: P53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nature Cell Biology 2(10): 709-717

Grombacher, T.; Eichhorn, U.; Kaina, B. 1998: P53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents. Oncogene 17(7): 845-851

Cerone, M.A.; Marchetti, A.; Bossi, G.; Blandino, G.; Sacchi, A.; Soddu, S. 2000: P53 is involved in the differentiation but not in the differentiation-associated apoptosis of myoblasts. Cell Death and Differentiation 7(5): 506-508

Sandy, P.; Gostissa, M.; Fogal, V.; Cecco, L.D.; Szalay, K.; Rooney, R.J.; Schneider, C.; Del Sal, G. 2000: P53 is involved in the p120E4F-mediated growth arrest. Oncogene 19(2): 188-199

Rokhlin, O.W.; Gudkov, A.V.; Kwek, S.; Glover, R.A.; Gewies, A.S.; Cohen, M.B. 2000: P53 is involved in tumor necrosis factor-alpha-induced apoptosis in the human prostatic carcinoma cell line LNCaP. Oncogene 19(15): 1959-1968

Knippschild, U.; Milne, D.M.; Campbell, L.E.; DeMaggio, A.J.; Christenson, E.; Hoekstra, M.F.; Meek, D.W. 1997: P53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs. Oncogene 15(14): 1727-1736

Huang, J.; Sengupta, R.; Espejo, A.B.; Lee, M.Gyu.; Dorsey, J.A.; Richter, M.; Opravil, S.; Shiekhattar, R.; Bedford, M.T.; Jenuwein, T.; Berger, S.L. 2007: P53 is regulated by the lysine demethylase LSD1. Nature 449(7158): 105-108

Molchadsky, A.; Ezra, O.; Amendola, P.G.; Krantz, D.; Kogan-Sakin, I.; Buganim, Y.; Rivlin, N.; Goldfinger, N.; Folgiero, V.; Falcioni, R.; Sarig, R.; Rotter, V. 2013: P53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity. Cell Death and Differentiation 20(5): 774-783

Zhang, J.; Yan, W.; Chen, X. 2006: P53 is required for nerve growth factor-mediated differentiation of PC12 cells via regulation of TrkA levels. Cell Death and Differentiation 13(12): 2118-2128

Geden, M.J.; Romero, S.E.; Deshmukh, M. 2021: P53 is required for nuclear but not mitochondrial DNA damage-induced degeneration. Cell Death and Disease 12(1): 104

Lowe, S.W.; Schmitt, E.M.; Smith, S.W.; Osborne, B.A.; Jacks, T. 1993: P53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362(6423): 847-849

Takahashi, R.; Giannini, C.; Sarkaria, J.N.; Schroeder, M.; Rogers, J.; Mastroeni, D.; Scrable, H. 2013: P53 isoform profiling in glioblastoma and injured brain. Oncogene 32(26): 3165-3174

Ye, S.; Zhao, T.; Zhang, W.; Tang, Z.; Gao, C.; Ma, Z.; Xiong, J-Wei.; Peng, J.; Tan, W-Qiang.; Chen, J. 2020: P53 isoform Δ113p53 promotes zebrafish heart regeneration by maintaining redox homeostasis. Cell Death and Disease 11(7): 568

Gong, L.; Gong, H.; Pan, X.; Chang, C.; Ou, Z.; Ye, S.; Yin, L.; Yang, L.; Tao, T.; Zhang, Z.; Liu, C.; Lane, D.P.; Peng, J.; Chen, J. 2015: P53 isoform Δ113p53/Δ133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damage. Cell Research 25(3): 351-369

Fujita, K.; Mondal, A.M.; Horikawa, I.; Nguyen, G.H.; Kumamoto, K.; Sohn, J.J.; Bowman, E.D.; Mathe, E.A.; Schetter, A.J.; Pine, S.R.; Ji, H.; Vojtesek, B.; Bourdon, J-Christophe.; Lane, D.P.; Harris, C.C. 2009: P53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nature Cell Biology 11(9): 1135-1142

Guo, Y.; Rall-Scharpf, M.; Bourdon, J-Christophe.; Wiesmüller, L.; Biber, S. 2021: P53 isoforms differentially impact on the POLι dependent DNA damage tolerance pathway. Cell Death and Disease 12(10): 941

Olivares-Illana, V.; Fåhraeus, R. 2010: P53 isoforms gain functions. Oncogene 29(37): 5113-5119

Turnquist, C.; Horikawa, I.; Foran, E.; Major, E.O.; Vojtesek, B.; Lane, D.P.; Lu, X.; Harris, B.T.; Harris, C.C. 2016: P53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration. Cell Death and Differentiation 23(9): 1515-1528

von Muhlinen, N.; Horikawa, I.; Alam, F.; Isogaya, K.; Lissa, D.; Vojtesek, B.; Lane, D.P.; Harris, C.C. 2018: P53 isoforms regulate premature aging in human cells. Oncogene 37(18): 2379-2393

Garnett, S.; Dutchak, K.L.; McDonough, R.V.; Dankort, D. 2017: P53 loss does not permit escape from Braf V600E -induced senescence in a mouse model of lung cancer. Oncogene 36(45): 6325-6335

Alexandrova, E.M.; Mirza, S.A.; Xu, S.; Schulz-Heddergott, R.; Marchenko, N.D.; Moll, U.M. 2017: P53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo. Cell Death and Disease 8(3): E2661

Wasylyk, C.; Salvi, R.; Argentini, M.; Dureuil, C.; Delumeau, I.; Abecassis, J.; Debussche, L.; Wasylyk, B. 1999: P53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53. Oncogene 18(11): 1921-1934

Pirollo, K.F.; Hao, Z.; Rait, A.; Jang, Y.J.; Fee, W.E.; Ryan, P.; Chiang, Y.; Chang, E.H. 1997: P53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogene 14(14): 1735-1746

Thomas, A.; Giesler, T.; White, E. 2000: P53 mediates bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway. Oncogene 19(46): 5259-5269

Zhao, B-xing.; Chen, H-zi.; Lei, N-zi.; Li, G-deng.; Zhao, W-xiu.; Zhan, Y-yan.; Liu, B.; Lin, S-cai.; Wu, Q. 2006: P53 mediates the negative regulation of MDM2 by orphan receptor TR3. EMBO Journal 25(24): 5703-5715

Jung, J.; Liao, H.; Coker, S.A.; Liang, H.; Hancock, J.F.; Denicourt, C.; Venkatachalam, K. 2021: P53 mitigates the effects of oncogenic HRAS in urothelial cells via the repression of MCOLN1. Iscience 24(7): 102701

Contadini, C.; Monteonofrio, L.; Virdia, I.; Prodosmo, A.; Valente, D.; Chessa, L.; Musio, A.; Fava, L.L.; Rinaldo, C.; Di Rocco, G.; Soddu, S. 2019: P53 mitotic centrosome localization preserves centrosome integrity and works as sensor for the mitotic surveillance pathway. Cell Death and Disease 10(11): 850

Rieckmann, T.; Kriegs, M.; Nitsch, L.; Hoffer, K.; Rohaly, G.; Kocher, S.; Petersen, C.; Dikomey, E.; Dornreiter, I.; Dahm-Daphi, J. 2013: P53 modulates homologous recombination at I-SceI-induced double-strand breaks through cell-cycle regulation. Oncogene 32(8): 968-975

Arias-Lopez, C.; Lazaro-Trueba, I.; Kerr, P.; Lord, C.J.; Dexter, T.; Iravani, M.; Ashworth, A.; Silva, A. 2006: P53 modulates homologous recombination by transcriptional regulation of the RAD51 gene. Embo Reports 7(2): 219-224

Wang, X.W.; Yeh, H.; Schaeffer, L.; Roy, R.; Moncollin, V.; Egly, J.M.; Wang, Z.; Freidberg, E.C.; Evans, M.K.; Taffe, B.G. 1995: P53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genetics 10(2): 188-195

Nistér, M.; Tang, M.; Zhang, X-Qun.; Yin, C.; Beeche, M.; Hu, X.; Enblad, G.; van Dyke, T.; Wahl, G.M. 2005: P53 must be competent for transcriptional regulation to suppress tumor formation. Oncogene 24(22): 3563-3573

Tyner, S.D.; Venkatachalam, S.; Choi, J.; Jones, S.; Ghebranious, N.; Igelmann, H.; Lu, X.; Soron, G.; Cooper, B.; Brayton, C.; Park, S.Hee.; Thompson, T.; Karsenty, G.; Bradley, A.; Donehower, L.A. 2002: P53 mutant mice that display early ageing-associated phenotypes. Nature 415(6867): 45-53

Campomenosi, P.; Monti, P.; Aprile, A.; Abbondandolo, A.; Frebourg, T.; Gold, B.; Crook, T.; Inga, A.; Resnick, M.A.; Iggo, R.; Fronza, G. 2001: P53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements. Oncogene 20(27): 3573-3579

Inga, A.; Monti, P.; Fronza, G.; Darden, T.; Resnick, M.A. 2001: P53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay. Oncogene 20(4): 501-513

Boehden, G.S.; Akyüz, N.; Roemer, K.; Wiesmüller, L. 2003: P53 mutated in the transactivation domain retains regulatory functions in homology-directed double-strand break repair. Oncogene 22(26): 4111-4117

Adamson, D.J.; Thompson, W.D.; Dawson, A.A.; Bennett, B.; Haites, N.E. 1995: P53 mutation and expression in lymphoma. British Journal of Cancer 72(1): 150-154

Honda, K.; Sbisà, E.; Tullo, A.; Papeo, P.A.; Saccone, C.; Poole, S.; Pignatelli, M.; Mitry, R.R.; Ding, S.; Isla, A.; Davies, A.; Habib, N.A. 1998: P53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation. British Journal of Cancer 77(5): 776-782

Runnebaum, I.B.; Köhler, T.; Stickeler, E.; Kieback, H.R.; Kreienberg, R. 1996: P53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma. British Journal of Cancer 74(8): 1157-1160

Crook, T.; Brooks, L.A.; Crossland, S.; Osin, P.; Barker, K.T.; Waller, J.; Philp, E.; Smith, P.D.; Yulug, I.; Peto, J.; Parker, G.; Allday, M.J.; Crompton, M.R.; Gusterson, B.A. 1998: P53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. Oncogene 17(13): 1681-1689

Mineta, H.; Borg, A.; Dictor, M.; Wahlberg, P.; Akervall, J.; Wennerberg, J. 1998: P53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma. British Journal of Cancer 78(8): 1084-1090

Baker, L.; Quinlan, P.R.; Patten, N.; Ashfield, A.; Birse-Stewart-Bell, L-J.; McCowan, C.; Bourdon, J-C.; Purdie, C.A.; Jordan, L.B.; Dewar, J.A.; Wu, L.; Thompson, A.M. 2010: P53 mutation, deprivation and poor prognosis in primary breast cancer. British Journal of Cancer 102(4): 719-726

Koh, J.Y.; Cho, N.P.; Kong, G.; Lee, J.D.; Yoon, K. 1998: P53 mutations and human papillomavirus DNA in oral squamous cell carcinoma: correlation with apoptosis. British Journal of Cancer 78(3): 354-359

Faille, A.; De Cremoux, P.; Extra, J.M.; Linares, G.; Espie, M.; Bourstyn, E.; De Rocquancourt, A.; Giacchetti, S.; Marty, M.; Calvo, F. 1994: P53 mutations and overexpression in locally advanced breast cancers. British Journal of Cancer 69(6): 1145-1150

Bailey, J.M.; Hendley, A.M.; Lafaro, K.J.; Pruski, M.A.; Jones, N.C.; Alsina, J.; Younes, M.; Maitra, A.; McAllister, F.; Iacobuzio-Donahue, C.A.; Leach, S.D. 2016: P53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells. Oncogene 35(32): 4282-4288

Vet, J.A.; Bringuier, P.P.; Poddighe, P.J.; Karthaus, H.F.; Debruyne, F.M.; Schalken, J.A. 1994: P53 mutations have no additional prognostic value over stage in bladder cancer. British Journal of Cancer 70(3): 496-500

McGregor, J.M.; Berkhout, R.J.; Rozycka, M.; ter Schegget, J.; Bouwes Bavinck, J.N.; Brooks, L.; Crook, T. 1997: P53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status. Oncogene 15(14): 1737-1740

Muller, P.A.J.; Vousden, K.H. 2013: P53 mutations in cancer. Nature Cell Biology 15(1): 2-8

König, E.A.; Kusser, W.C.; Day, C.; Porzsolt, F.; Glickman, B.W.; Messer, G.; Schmid, M.; de Châtel, R.; Marcsek, Z.L.; Demeter, J. 2000: P53 mutations in hairy cell leukemia. Leukemia 14(4): 706-711

Zerp, S.F.; van Elsas, A.; Peltenburg, L.T.; Schrier, P.I. 1999: P53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis. British Journal of Cancer 79(5-6): 921-926

Takagi, Y.; Osada, H.; Kuroishi, T.; Mitsudomi, T.; Kondo, M.; Niimi, T.; Saji, S.; Gazdar, A.F.; Takahashi, T.; Minna, J.D.; Takahashi, T. 1998: P53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking. British Journal of Cancer 77(10): 1568-1572

Epstein, C.B.; Attiyeh, E.F.; Hobson, D.A.; Silver, A.L.; Broach, J.R.; Levine, A.J. 1998: P53 mutations isolated in yeast based on loss of transcription factor activity: similarities and differences from p53 mutations detected in human tumors. Oncogene 16(16): 2115-2122

Oren, M.; Kotler, E. 2016: P53 mutations promote proteasomal activity. Nature Cell Biology 18(8): 833-835

Nylander, K.; Nilsson, P.; Mehle, C.; Roos, G. 1995: P53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck. British Journal of Cancer 71(4): 826-830

Zhang, D.W.; Jeang, K-T.; Lee, C.G.L. 2006: P53 negatively regulates the expression of FAT10, a gene upregulated in various cancers. Oncogene 25(16): 2318-2327

Quinn, D.I.; Stricker, P.D.; Kench, J.G.; Grogan, J.; Haynes, A-Maree.; Henshall, S.M.; Grygiel, J.J.; Delprado, W.; Turner, J.J.; Horvath, L.G.; Mahon, K.L. 2019: P53 nuclear accumulation as an early indicator of lethal prostate cancer. British Journal of Cancer 121(7): 578-583

Charni, M.; Aloni-Grinstein, R.; Molchadsky, A.; Rotter, V. 2017: P53 on the crossroad between regeneration and cancer. Cell Death and Differentiation 24(1): 8-14

Gallo, O.; Bianchi, S.; Giovannucci-Uzzielli, M.L.; Santoro, R.; Lenzi, S.; Salimbeni, C.; Abbruzzese, M.; Alajmo, E. 1995: P53 oncoprotein overexpression correlates with mutagen-induced chromosome fragility in head and neck cancer patients with multiple malignancies. British Journal of Cancer 71(5): 1008-1012

Garg, K.; Leitao, M.M.; Wynveen, C.A.; Sica, G.L.; Shia, J.; Shi, W.; Soslow, R.A. 2010: P53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 23(1): 80-92

Ferrandina, G.; Fagotti, A.; Salerno, M.G.; Natali, P.G.; Mottolese, M.; Maneschi, F.; De Pasqua, A.; Benedetti-Panici, P.; Mancuso, S.; Scambia, G. 1999: P53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer. British Journal of Cancer 81(4): 733-740

Jiang, A.; Yu, C.; Zhang, P.; Chen, W.; Liu, W.; Hu, X.; Zhang, J. 2006: P53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line. Experimental and Molecular Medicine 38(6): 625-633

Quintás-Cardama, A.; Hu, C.; Qutub, A.; Qiu, Y.H.; Zhang, X.; Post, S.M.; Zhang, N.; Coombes, K.; Kornblau, S.M. 2017: P53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status. Leukemia 31(6): 1296-1305

Battistella, M.; Cuccuini, W.; Elbouchtaoui, M.; Leboeuf, C.; Plassa, L-François.; Bouhidel, F.; Rigolet, A.; Meignin, Véronique.; Socié, Gérard.; Ratajczak, P.; Janin, A. 2014: P53 phosphorylation and TP53 copy-number alterations in chronic graft-versus-host oral lichen preceding squamous cell carcinoma. Journal of Investigative Dermatology 134(3): 864-867

Yu, T.; You, X.; Zhou, H.; Kang, A.; He, W.; Li, Z.; Li, B.; Xia, J.; Zhu, H.; Zhao, Y.; Yu, G.; Xiong, Y.; Yang, Y. 2020: P53 plays a central role in the development of osteoporosis. Aging 12(11): 10473-10487

Helland, A.; Langerød, A.; Johnsen, H.; Olsen, A.O.; Skovlund, E.; Børresen-Dale, A.L. 1998: P53 polymorphism and risk of cervical cancer. Nature 396(6711): 530

Josefsson, A.M.; Magnusson, P.K.; Ylitalo, N.; Quarforth-Tubbin, P.; Pontén, J.; Adami, H.O.; Gyllensten, U.B. 1998: P53 polymorphism and risk of cervical cancer. Nature 396(6711): 531; Author Reply 532

Hildesheim, A.; Schiffman, M.; Brinton, L.A.; Fraumeni, J.F.; Herrero, R.; Bratti, M.C.; Schwartz, P.; Mortel, R.; Barnes, W.; Greenberg, M.; McGowan, L.; Scott, D.R.; Martin, M.; Herrera, J.E.; Carrington, M. 1998: P53 polymorphism and risk of cervical cancer. Nature 396(6711): 531-532

Hsieh, L-L.; Huang, T-H.; Chen, I-H.; Liao, C-T.; Wang, H-M.; Lai, C-H.; Liou, S-H.; Chang, J.T-C.; Cheng, A-J. 2005: P53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan. British Journal of Cancer 92(1): 30-35

Whibley, C.; Pharoah, P.D.P.; Hollstein, M. 2009: P53 polymorphisms: cancer implications. Nature Reviews. Cancer 9(2): 95-107

Tong, X.; Gu, J.; Chen, M.; Wang, T.; Zou, H.; Song, R.; Zhao, H.; Bian, J.; Liu, Z. 2020: P53 positively regulates osteoprotegerin-mediated inhibition of osteoclastogenesis by downregulating TSC2-induced autophagy in vitro. Differentiation; Research in Biological Diversity 114: 58-66

Yonekura, I.; Takai, K.; Asai, A.; Kawahara, N.; Kirino, T. 2006: P53 potentiates hippocampal neuronal death caused by global ischemia. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 26(10): 1332-1340

Farhang Ghahremani, M.; Goossens, S.; Nittner, D.; Bisteau, X.; Bartunkova, S.; Zwolinska, A.; Hulpiau, P.; Haigh, K.; Haenebalcke, L.; Drogat, B.; Jochemsen, A.; Roger, P.P.; Marine, J-C.; Haigh, J.J. 2013: P53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway. Cell Death and Differentiation 20(7): 888-897

Wang, X.; Wu, Z.; Li, Y.; Yang, Y.; Xiao, C.; Liu, X.; Xiang, X.; Wei, J.; Shao, D.; Liu, K.; Deng, X.; Wu, J.; Qiu, Y.; Li, B.; Ma, Z. 2020: P53 promotes ZDHHC1-mediated IFITM3 palmitoylation to inhibit Japanese encephalitis virus replication. Plos Pathogens 16(10): E1009035

Royds, J.A.; Hibma, M.; Dix, B.R.; Hananeia, L.; Russell, I.A.; Wiles, A.; Wynford-Thomas, D.; Braithwaite, A.W. 2006: P53 promotes adenoviral replication and increases late viral gene expression. Oncogene 25(10): 1509-1520

Nam, S.Y.; Sabapathy, K. 2011: P53 promotes cellular survival in a context-dependent manner by directly inducing the expression of haeme-oxygenase-1. Oncogene 30(44): 4476-4486

Zheng, H.; Chen, L.; Pledger, W.J.; Fang, J.; Chen, J. 2014: P53 promotes repair of heterochromatin DNA by regulating JMJD2b and SUV39H1 expression. Oncogene 33(6): 734-744

Jiang, W.; Ananthaswamy, H.N.; Muller, H.K.; Kripke, M.L. 1999: P53 protects against skin cancer induction by UV-B radiation. Oncogene 18(29): 4247-4253

Kumari, A.; Schultz, N.; Helleday, T. 2004: P53 protects from replication-associated DNA double-strand breaks in mammalian cells. Oncogene 23(13): 2324-2329

Jaks, V.; Jõers, A.; Kristjuhan, A.; Maimets, T. 2001: P53 protein accumulation in addition to the transactivation activity is required for p53-dependent cell cycle arrest after treatment of cells with camptothecin. Oncogene 20(10): 1212-1219

Yang-Hartwich, Y.; Soteras, M.G.; Lin, Z.P.; Holmberg, J.; Sumi, N.; Craveiro, V.; Liang, M.; Romanoff, E.; Bingham, J.; Garofalo, F.; Alvero, A.; Mor, G. 2015: P53 protein aggregation promotes platinum resistance in ovarian cancer. Oncogene 34(27): 3605-3616

Horne, G.M.; Anderson, J.J.; Tiniakos, D.G.; McIntosh, G.G.; Thomas, M.D.; Angus, B.; Henry, J.A.; Lennard, T.W.; Horne, C.H. 1996: P53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry. British Journal of Cancer 73(1): 29-35

Govender, D.; Harilal, P.; Hadley, G.P.; Chetty, R. 1998: P53 protein expression in nephroblastomas: a predictor of poor prognosis. British Journal of Cancer 77(2): 314-318

Iuzzolino, P.; Ghimenton, C.; Nicolato, A.; Giorgiutti, F.; Fina, P.; Doglioni, C.; Barbareschi, M. 1994: P53 protein in low-grade astrocytomas: a study with long-term follow-up. British Journal of Cancer 69(3): 586-591

Levesque, M.A.; D'Costa, M.; Diamandis, E.P. 1996: P53 protein is absent from the serum of patients with lung cancer. British Journal of Cancer 74(9): 1434-1440

Tamir, Y.; Bengal, E. 1998: P53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene. Oncogene 17(3): 347-356

Jaros, E.; Lunec, J.; Perry, R.H.; Kelly, P.J.; Pearson, A.D. 1993: P53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis. British Journal of Cancer 68(4): 801-807

Lee, E.J.; Gerhold, M.; Palmer, M.W.; Christen, R.D. 2003: P53 protein regulates the effects of amifostine on apoptosis, cell cycle progression, and cytoprotection. British Journal of Cancer 88(5): 754-759

Midgley, C.A.; Lane, D.P. 1997: P53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene 15(10): 1179-1189

Courtois, Séphanie.; Caron de Fromentel, C.; Hainaut, P. 2004: P53 protein variants: structural and functional similarities with p63 and p73 isoforms. Oncogene 23(3): 631-638

Schneider, J.; Presek, P.; Braun, A.; Bauer, P.; Konietzko, N.; Wiesner, B.; Woitowitz, H.J. 1999: P53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer. British Journal of Cancer 80(12): 1987-1994

Hafner, A.; Stewart-Ornstein, J.; Purvis, J.E.; Forrester, W.C.; Bulyk, M.L.; Lahav, G. 2017: P53 pulses lead to distinct patterns of gene expression albeit similar DNA-binding dynamics. Nature Structural and Molecular Biology 24(10): 840-847

Moretti, F.; Farsetti, A.; Soddu, S.; Misiti, S.; Crescenzi, M.; Filetti, S.; Andreoli, M.; Sacchi, A.; Pontecorvi, A. 1997: P53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells. Oncogene 14(6): 729-740

Pawge, G.; Khatik, G.L. 2021: P53 regulated senescence mechanism and role of its modulators in age-related disorders. Biochemical Pharmacology 190: 114651

Winters, Z.E.; Ongkeko, W.M.; Harris, A.L.; Norbury, C.J. 1998: P53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells. Oncogene 17(6): 673-684

Miki, T.; Matsumoto, T.; Zhao, Z.; Lee, C.Chi. 2013: P53 regulates Period2 expression and the circadian clock. Nature Communications 4: 2444

Lin, J.; Tang, H.; Jin, X.; Jia, G.; Hsieh, J-Tsong. 2002: P53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3. Oncogene 21(19): 3082-3088

Montero, J.; Dutta, C.; van Bodegom, D.; Weinstock, D.; Letai, A. 2013: P53 regulates a non-apoptotic death induced by ROS. Cell Death and Differentiation 20(11): 1465-1474

Jiang, P.; Du, W.; Wang, X.; Mancuso, A.; Gao, X.; Wu, M.; Yang, X. 2011: P53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nature Cell Biology 13(3): 310-316

Sawada, M.; Nakashima, S.; Kiyono, T.; Nakagawa, M.; Yamada, J.; Yamakawa, H.; Banno, Y.; Shinoda, J.; Nishimura, Y.; Nozawa, Y.; Sakai, N. 2001: P53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells. Oncogene 20(11): 1368-1378

Chang, C-Ju.; Chao, C-Hong.; Xia, W.; Yang, J-Yen.; Xiong, Y.; Li, C-Wei.; Yu, W-Hsuan.; Rehman, S.K.; Hsu, J.L.; Lee, H-Huan.; Liu, M.; Chen, C-Te.; Yu, D.; Hung, M-Chie. 2011: P53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nature Cell Biology 13(3): 317-323

Kawauchi, K.; Araki, K.; Tobiume, K.; Tanaka, N. 2008: P53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nature Cell Biology 10(5): 611-618

Hu, W.; Feng, Z.; Teresky, A.K.; Levine, A.J. 2007: P53 regulates maternal reproduction through LIF. Nature 450(7170): 721-724

Huang, Y.; Yu, P.; Li, W.; Ren, G.; Roberts, A.I.; Cao, W.; Zhang, X.; Su, J.; Chen, X.; Chen, Q.; Shou, P.; Xu, C.; Du, L.; Lin, L.; Xie, N.; Zhang, L.; Wang, Y.; Shi, Y. 2014: P53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation. Oncogene 33(29): 3830-3838

Laezza, C.; D'Alessandro, A.; Di Croce, L.; Picardi, P.; Ciaglia, E.; Pisanti, S.; Malfitano, A.M.; Comegna, M.; Faraonio, R.; Gazzerro, P.; Bifulco, M. 2015: P53 regulates the mevalonate pathway in human glioblastoma multiforme. Cell Death and Disease 6: E1909

Marcel, V.; Vijayakumar, V.; Fernández-Cuesta, L.; Hafsi, H.; Sagne, C.; Hautefeuille, A.; Olivier, M.; Hainaut, P. 2010: P53 regulates the transcription of its Delta133p53 isoform through specific response elements contained within the TP53 P2 internal promoter. Oncogene 29(18): 2691-2700

Li, L.; Mao, Y.; Zhao, L.; Li, L.; Wu, J.; Zhao, M.; Du, W.; Yu, L.; Jiang, P. 2019: P53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis. Nature 567(7747): 253-256

Budde, A.; Grummt, I. 1999: P53 represses ribosomal gene transcription. Oncogene 18(4): 1119-1124

Ji, Z.; Njauw, C.Ni.; Taylor, M.; Neel, V.; Flaherty, K.T.; Tsao, H. 2012: P53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition. Journal of Investigative Dermatology 132(2): 356-364

Harris, C.R.; Dewan, A.; Zupnick, A.; Normart, R.; Gabriel, A.; Prives, C.; Levine, A.J.; Hoh, J. 2009: P53 responsive elements in human retrotransposons. Oncogene 28(44): 3857-3865

Lozano, G.; Elledge, S.J. 2000: P53 sends nucleotides to repair DNA. Nature 404(6773): 24-25

Furth, N.; Aylon, Y.; Oren, M. 2018: P53 shades of Hippo. Cell Death and Differentiation 25(1): 81-92

Furth, N.; Aylon, Y.; Oren, M. 2018: P53 shades of Hippo. Cell Death and Differentiation 25(1): 81-92

Peterson, L.F.; Mitrikeska, E.; Giannola, D.; Lui, Y.; Sun, H.; Bixby, D.; Malek, S.N.; Donato, N.J.; Wang, S.; Talpaz, M. 2011: P53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cells. Leukemia 25(5): 761-769

Marine, J-C. 2010: P53 stabilization: the importance of nuclear import. Cell Death and Differentiation 17(2): 191-192

Lopez-Crapez, E.; Bibeau, F.; Thézenas, S.; Ychou, M.; Simony-Lafontaine, J.; Thirion, A.; Azria, D.; Grenier, J.; Senesse, P. 2005: P53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis. British Journal of Cancer 92(12): 2114-2121

Rosenfeldt, M.T.; O'Prey, J.; Morton, J.P.; Nixon, C.; MacKay, G.; Mrowinska, A.; Au, A.; Rai, T.Singh.; Zheng, L.; Ridgway, R.; Adams, P.D.; Anderson, K.I.; Gottlieb, E.; Sansom, O.J.; Ryan, K.M. 2013: P53 status determines the role of autophagy in pancreatic tumour development. Nature 504(7479): 296-300

Maughan, B.L.; Guedes, L.B.; Boucher, K.; Rajoria, G.; Liu, Z.; Klimek, S.; Zoino, R.; Antonarakis, E.S.; Lotan, T.L. 2018: P53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases 21(2): 260-268

Wilson, G.D.; Richman, P.I.; Dische, S.; Saunders, M.I.; Robinson, B.; Daley, F.M.; Ross, D.A. 1995: P53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy. British Journal of Cancer 71(6): 1248-1252

Zheng, A.; Castren, K.; Säily, M.; Savolainen, E.R.; Koistinen, P.; Vähäkangas, K. 1999: P53 status of newly established acute myeloid leukaemia cell lines. British Journal of Cancer 79(3-4): 407-415

Akeno, N.; Miller, A.L.; Ma, X.; Wikenheiser-Brokamp, K.A. 2015: P53 suppresses carcinoma progression by inhibiting mTOR pathway activation. Oncogene 34(5): 589-599

Yang, Z.J.P.; Broz, D.Kenzelmann.; Noderer, W.L.; Ferreira, J.P.; Overton, K.W.; Spencer, S.L.; Meyer, T.; Tapscott, S.J.; Attardi, L.D.; Wang, C.L. 2015: P53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress. Cell Death and Differentiation 22(4): 560-573

Dalton, W.B.; Yu, B.; Yang, V.W. 2010: P53 suppresses structural chromosome instability after mitotic arrest in human cells. Oncogene 29(13): 1929-1940

Horii, T.; Yamamoto, M.; Morita, S.; Kimura, M.; Nagao, Y.; Hatada, I. 2015: P53 suppresses tetraploid development in mice. Scientific Reports 5: 8907

Wiman, K.G. 2013: P53 talks to PARP: the increasing complexity of p53-induced cell death. Cell Death and Differentiation 20(11): 1438-1439

Kawase, T.; Ichikawa, H.; Ohta, T.; Nozaki, N.; Tashiro, F.; Ohki, R.; Taya, Y. 2008: P53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis. Oncogene 27(27): 3797-3810

Gencel-Augusto, J.; Lozano, G. 2020: P53 tetramerization: at the center of the dominant-negative effect of mutant p53. Genes and Development 34(17-18): 1128-1146

Sun, H.; Li, L.; Li, W.; Yang, F.; Zhang, Z.; Liu, Z.; Du, W. 2021: P53 transcriptionally regulates SQLE to repress cholesterol synthesis and tumor growth. EMBO reports 22(10): e52537

Schuler, M.; Maurer, U.; Goldstein, J.C.; Breitenbücher, F.; Hoffarth, S.; Waterhouse, N.J.; Green, D.R. 2003: P53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation. Cell Death and Differentiation 10(4): 451-460

Feng, Z.; Jin, S.; Zupnick, A.; Hoh, J.; de Stanchina, E.; Lowe, S.; Prives, C.; Levine, A.J. 2006: P53 tumor suppressor protein regulates the levels of huntingtin gene expression. Oncogene 25(1): 1-7

Bartke, T.; Siegmund, D.; Peters, N.; Reichwein, M.; Henkler, F.; Scheurich, P.; Wajant, H. 2001: P53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells. Oncogene 20(5): 571-580

Liu, K.; Li, F.; Sun, Q.; Lin, N.; Han, H.; You, K.; Tian, F.; Mao, Z.; Li, T.; Tong, T.; Geng, M.; Zhao, Y.; Gu, W.; Zhao, W. 2019: P53 β-hydroxybutyrylation attenuates p53 activity. Cell Death and Disease 10(3): 243

Wolff, S.; Erster, S.; Palacios, G.; Moll, U.M. 2008: P53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Research 18(7): 733-744

Lin, L.; Ye, Y.; Zakeri, Z. 2006: P53, Apaf-1, caspase-3, and -9 are dispensable for Cdk5 activation during cell death. Cell Death and Differentiation 13(1): 141-150

Brunetti, B.; Bacci, B.; Angeli, C.; Benazzi, C.; Muscatello, L.V. 2021: P53, ER, and Ki67 Expression in Canine Mammary Carcinomas and Correlation with Pathological Variables and Prognosis. Veterinary Pathology 58(2): 325-331

Guzman, G.; Alagiozian-Angelova, V.; Layden-Almer, J.E.; Layden, T.J.; Testa, G.; Benedetti, E.; Kajdacsy-Balla, Aé.; Cotler, S.J. 2005: P53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 18(11): 1498-1503

Arakawa, H. 2005: P53, apoptosis and axon-guidance molecules. Cell Death and Differentiation 12(8): 1057-1065

Gal, A.A.; Sheppard, M.N.; Nolen, J.D.L.; Cohen, C. 2004: P53, cellular proliferation, and apoptosis-related factors in thymic neuroendocrine tumors. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 17(1): 33-39

Clarke, A.R.; Howard, L.A.; Harrison, D.J.; Winton, D.J. 1997: P53, mutation frequency and apoptosis in the murine small intestine. Oncogene 14(17): 2015-2018

Travaglino, A.; Raffone, A.; Gencarelli, A.; Neola, D.; Oliviero, D.Alessandro.; Alfano, R.; Campanino, M.Raffaela.; Cariati, F.; Zullo, F.; Mollo, A.; Insabato, L. 2021: P53, p16 and ki67 as immunohistochemical prognostic markers in uterine smooth muscle tumors of uncertain malignant potential (STUMP). Pathology Research and Practice 226: 153592

Lee, S-H.; Lee, S-J.; Chung, J-Y.; Jung, Y-S.; Choi, S-Y.; Hwang, S.H.; Choi, D.; Ha, N-C.; Park, B-J. 2009: P53, secreted by K-Ras-Snail pathway, is endocytosed by K-Ras-mutated cells; implication of target-specific drug delivery and early diagnostic marker. Oncogene 28(19): 2005-2014

Wiebusch, L.; Hagemeier, C. 2010: P53- and p21-dependent premature APC/C-Cdh1 activation in G2 is part of the long-term response to genotoxic stress. Oncogene 29(24): 3477-3489

Lee, P.; Hock, A.K.; Vousden, K.H.; Cheung, E.C. 2015: P53- and p73-independent activation of TIGAR expression in vivo. Cell Death and Disease 6: E1842

Junttila, M.R.; Evan, G.I. 2009: P53--a Jack of all trades but master of none. Nature Reviews. Cancer 9(11): 821-829

Rao, B.; Lain, S.; Thompson, A.M. 2013: P53-Based cyclotherapy: exploiting the 'guardian of the genome' to protect normal cells from cytotoxic therapy. British Journal of Cancer 109(12): 2954-2958

Bond, J.A.; Webley, K.; Wyllie, F.S.; Jones, C.J.; Craig, A.; Hupp, T.; Wynford-Thomas, D. 1999: P53-Dependent growth arrest and altered p53-immunoreactivity following metabolic labelling with 32P ortho-phosphate in human fibroblasts. Oncogene 18(25): 3788-3792

Cuomo, M.Emanuela.; Knebel, A.; Morrice, N.; Paterson, H.; Cohen, P.; Mittnacht, S. 2008: P53-Driven apoptosis limits centrosome amplification and genomic instability downstream of NPM1 phosphorylation. Nature Cell Biology 10(6): 723-730

Wang, Y.; Peng, J.; Mi, X.; Yang, M. 2021: P53-GSDME Elevation: a Path for CDK7 Inhibition to Suppress Breast Cancer Cell Survival. Frontiers in Molecular Biosciences 8: 697457

Daks, A.; Shuvalov, O.; Fedorova, O.; Petukhov, A.; Lezina, L.; Zharova, A.; Baidyuk, E.; Khudiakov, A.; Barlev, N.A. 2021: P53-Independent Effects of Set7/9 Lysine Methyltransferase on Metabolism of Non-Small Cell Lung Cancer Cells. Frontiers in Oncology 11: 706668

Hara, S.; Nakashima, S.; Kiyono, T.; Sawada, M.; Yoshimura, S.; Iwama, T.; Banno, Y.; Shinoda, J.; Sakai, N. 2004: P53-Independent ceramide formation in human glioma cells during gamma-radiation-induced apoptosis. Cell Death and Differentiation 11(8): 853-861

Ma, S.; Kong, D.; Fu, X.; Liu, L.; Liu, Y.; Xue, C.; Tian, Z.; Li, L.; Liu, X. 2021: P53-Induced Autophagy Regulates Chemotherapy and Radiotherapy Resistance in Multidrug Resistance Cancer Cells. Dose-Response:aPublicationofInternationalHormesisSociety 19(4): 15593258211048046

Saleme, B.; Das, S.K.; Zhang, Y.; Boukouris, A.E.; Lorenzana Carrillo, M.A.; Jovel, J.; Wagg, C.S.; Lopaschuk, G.D.; Michelakis, E.D.; Sutendra, G. 2020: P53-Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio-oncology. Journal of the American Heart Association 9(15): E017247

Hsu, F-F.; Lin, T-Y.; Chen, J-Y.; Shieh, S-Y. 2010: P53-Mediated transactivation of LIMK2b links actin dynamics to cell cycle checkpoint control. Oncogene 29(19): 2864-2876

Lv, T.; Lv, H.; Fei, J.; Xie, Y.; Lian, D.; Hu, J.; Tang, L.; Shi, X.; Wang, J.; Zhang, S.; Li, F.; Jiang, X.; Yi, Y. 2020: P53-R273H promotes cancer cell migration via upregulation of neuraminidase-1. Journal of Cancer 11(23): 6874-6882

Lv, T.; Wu, X.; Sun, L.; Hu, Q.; Wan, Y.; Wang, L.; Zhao, Z.; Tu, X.; Xiao, Z-Xiong.Jim. 2017: P53-R273H upregulates neuropilin-2 to promote cell mobility and tumor metastasis. Cell Death and Disease 8(8): E2995

Brosh, R.; Shalgi, R.; Liran, A.; Landan, G.; Korotayev, K.; Nguyen, G.Huong.; Enerly, E.; Johnsen, H.; Buganim, Y.; Solomon, H.; Goldstein, I.; Madar, S.; Goldfinger, N.; Børresen-Dale, A-Lise.; Ginsberg, D.; Harris, C.C.; Pilpel, Y.; Oren, M.; Rotter, V. 2008: P53-Repressed mi RNAs are involved with E2F in a feed-forward loop promoting proliferation. Molecular Systems Biology 4: 229

Lilling, G.; Elena, N.; Sidi, Y.; Bakhanashvili, M. 2003: P53-associated 3'-->5' exonuclease activity in nuclear and cytoplasmic compartments of cells. Oncogene 22(2): 233-245

Zuchero, J.Bradley.; Coutts, A.S.; Quinlan, M.E.; Thangue, N.B.La.; Mullins, R.Dyche. 2009: P53-cofactor JMY is a multifunctional actin nucleation factor. Nature Cell Biology 11(4): 451-459

Kemp, C.J.; Wheldon, T.; Balmain, A. 1994: P53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nature Genetics 8(1): 66-69

Gorgoulis, V.G.; Pratsinis, H.; Zacharatos, P.; Demoliou, C.; Sigala, F.; Asimacopoulos, P.J.; Papavassiliou, A.G.; Kletsas, D. 2005: P53-dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions. Laboratory Investigation; a Journal of Technical Methods and Pathology 85(4): 502-511

Jung, E.Sun.; Choi, H.; Song, H.; Hwang, Y.Jin.; Kim, A.; Ryu, H.; Mook-Jung, I. 2016: P53-dependent SIRT6 expression protects Aβ42-induced DNA damage. Scientific Reports 6: 25628

Sonnemann, J.; Marx, C.; Becker, S.; Wittig, S.; Palani, C.D.; Krämer, O.H.; Beck, J.F. 2014: P53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors. British Journal of Cancer 110(3): 656-667

Candéias, S.Michel.; Mancini, Séphane.Jean.Charles.; Touvrey, Cédric.; Borel, E.; Jouvin-Marche, E.; Marche, P.Noël. 2004: P53-dependent and p53-independent pathways for radiation-induced immature thymocyte differentiation. Oncogene 23(10): 1922-1929

Caelles, C.; Helmberg, A.; Karin, M. 1994: P53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370(6486): 220-223

MacLaren, A.P.; Chapman, R.S.; Wyllie, A.H.; Watson, C.J. 2001: P53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death and Differentiation 8(3): 210-218

Wu, W.; Wei, T.; Li, Z.; Zhu, J. 2021: P53-dependent apoptosis is essential for the antitumor effect of paclitaxel response to DNA damage in papillary thyroid carcinoma. International Journal of Medical Sciences 18(14): 3197-3205

Almog, N.; Goldfinger, N.; Rotter, V. 2000: P53-dependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53. Oncogene 19(30): 3395-3403

Allan, L.A.; Fried, M. 1999: P53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells: p21WAF1/CIP1 repression in UV induced apoptosis. Oncogene 18(39): 5403-5412

Morgenbesser, S.D.; Williams, B.O.; Jacks, T.; DePinho, R.A. 1994: P53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371(6492): 72-74

Norimura, T.; Nomoto, S.; Katsuki, M.; Gondo, Y.; Kondo, S. 1996: P53-dependent apoptosis suppresses radiation-induced teratogenesis. Nature Medicine 2(5): 577-580

Zhang, J.; Tan, P.; Guo, L.; Gong, J.; Ma, J.; Li, J.; Lee, M.; Fang, S.; Jing, J.; Johnson, G.; Sun, D.; Cao, W-Ming.; Dashwood, R.; Han, L.; Zhou, Y.; Dong, W-Guo.; Huang, Y. 2019: P53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance. Oncogene 38(11): 1905-1919

Hall, A.R.; Dix, B.R.; O'Carroll, S.J.; Braithwaite, A.W. 1998: P53-dependent cell death/apoptosis is required for a productive adenovirus infection. Nature Medicine 4(9): 1068-1072

Modugno, M.; Tagliabue, E.; Ardini, E.; Berno, V.; Galmozzi, E.; De Bortoli, M.; Castronovo, V.; Ménard, S. 2002: P53-dependent downregulation of metastasis-associated laminin receptor. Oncogene 21(49): 7478-7487

Mitkin, N.A.; Hook, C.D.; Schwartz, A.M.; Biswas, S.; Kochetkov, D.V.; Muratova, A.M.; Afanasyeva, M.A.; Kravchenko, J.E.; Bhattacharyya, A.; Kuprash, D.V. 2015: P53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells. Scientific Reports 5: 9330

Benson, E.K.; Mungamuri, S.K.; Attie, O.; Kracikova, M.; Sachidanandam, R.; Manfredi, J.J.; Aaronson, S.A. 2014: P53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes. Oncogene 33(30): 3959-3969

Chang, H.W.; Lee, M.; Lee, Y.S.; Kim, S.H.; Lee, J.C.; Park, J.J.; Nam, H.Y.; Kim, M.R.; Han, M.W.; Kim, S.W.; Kim, S.Y. 2021: P53-dependent glutamine usage determines susceptibility to oxidative stress in radioresistant head and neck cancer cells. Cellular Signalling 77: 109820

Tung, L.Tze.; Wang, H.; Belle, J.I.; Petrov, J.C.; Langlais, D.; Nijnik, A. 2021: P53-dependent induction of P2X7 on hematopoietic stem and progenitor cells regulates hematopoietic response to genotoxic stress. Cell Death and Disease 12(10): 923

Ohnishi, T.; Wang, X.; Ohnishi, K.; Takahashi, A. 1998: P53-dependent induction of WAF1 by cold shock in human glioblastoma cells. Oncogene 16(11): 1507-1511

Martel, V.; Filhol, O.; Colas, P.; Cochet, C. 2006: P53-dependent inhibition of mammalian cell survival by a genetically selected peptide aptamer that targets the regulatory subunit of protein kinase CK2. Oncogene 25(56): 7343-7353

Blume, C.J.; Hotz-Wagenblatt, A.; Hüllein, J.; Sellner, L.; Jethwa, A.; Stolz, T.; Slabicki, M.; Lee, K.; Sharathchandra, A.; Benner, A.; Dietrich, S.; Oakes, C.C.; Dreger, P.; te Raa, D.; Kater, A.P.; Jauch, A.; Merkel, O.; Oren, M.; Hielscher, T.; Zenz, T. 2015: P53-dependent non-coding RNA networks in chronic lymphocytic leukemia. Leukemia 29(10): 2015-2023

Benchimol, S. 2001: P53-dependent pathways of apoptosis. Cell Death and Differentiation 8(11): 1049-1051

Inagaki-Ohara, K.; Yada, S.; Takamura, N.; Reaves, M.; Yu, X.; Liu, E.; Rooney, I.; Nicholas, S.; Castro, A.; Ware, C.F.; Green, D.R.; Lin, T. 2001: P53-dependent radiation-induced crypt intestinal epithelial cells apoptosis is mediated in part through TNF-TNFR1 system. Oncogene 20(7): 812-818

Post, S.M.; Quintás-Cardama, A.; Terzian, T.; Smith, C.; Eischen, C.M.; Lozano, G. 2010: P53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis. Oncogene 29(9): 1260-1269

Jõers, A.; Jaks, V.; Kase, J.; Maimets, T. 2004: P53-dependent transcription can exhibit both on/off and graded response after genotoxic stress. Oncogene 23(37): 6175-6185

Collavin, L.; Lunardi, A.; Del Sal, G. 2010: P53-family proteins and their regulators: hubs and spokes in tumor suppression. Cell Death and Differentiation 17(6): 901-911

Tsai, R.Y.L. 2015: P53-guided response to nucleostemin loss in normal versus cancer cells. Cell Death and Disease 6: E2030

Amanullah, A.; Liebermann, D.A.; Hoffman, B. 2000: P53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation. Oncogene 19(26): 2967-2977

Terradillos, O.; Pollicino, T.; Lecoeur, H.; Tripodi, M.; Gougeon, M.L.; Tiollais, P.; Buendia, M.A. 1998: P53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 17(16): 2115-2123

Malcomson, R.D.; Oren, M.; Wyllie, A.H.; Harrison, D.J. 1995: P53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs. British Journal of Cancer 72(4): 952-957

Lee, H.J.; Gallardo, M.; Ma, H.; Zhang, X.; Larsson, C.A.; Mejia, A.; Hornbaker, M.J.; Qi, Y.; Su, X.; Pageon, L.R.; Quintas-Cardama, A.; Post, S.M. 2016: P53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL. Blood Cancer Journal 6: E434

Hirose, T.; Sowa, Y.; Takahashi, S.; Saito, S.; Yasuda, C.; Shindo, N.; Furuichi, K.; Sakai, T. 2003: P53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. Oncogene 22(49): 7762-7773

Dimitriadi, M.; Poulogiannis, G.; Liu, L.; Bäcklund, L.M.; Pearson, D.M.; Ichimura, K.; Collins, V.P. 2008: P53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours. British Journal of Cancer 99(7): 1144-1152

Christoffersen, N.R.; Shalgi, R.; Frankel, L.B.; Leucci, E.; Lees, M.; Klausen, M.; Pilpel, Y.; Nielsen, F.C.; Oren, M.; Lund, A.H. 2010: P53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death and Differentiation 17(2): 236-245

Takano, S.; Wadhwa, R.; Mitsui, Y.; Kaul, S.C. 2001: P53-independent upregulation of p21WAF1 in NIH 3T3 cells malignantly transformed by mot-2. Cell Research 11(1): 55-60

Suzuki, N.; Idogawa, M.; Tange, S.; Ohashi, T.; Sasaki, Y.; Nakase, H.; Tokino, T. 2020: P53-induced ARVCF modulates the splicing landscape and supports the tumor suppressive function of p53. Oncogene 39(10): 2202-2211

Geley, S.; Hartmann, B.L.; Hattmannstorfer, R.; Löffler, M.; Ausserlechner, M.J.; Bernhard, D.; Sgonc, R.; Strasser-Wozak, E.M.; Ebner, M.; Auer, B.; Kofler, R. 1997: P53-induced apoptosis in the human T-ALL cell line CCRF-CEM. Oncogene 15(20): 2429-2437

Cuenin, S.; Tinel, A.; Janssens, S.; Tschopp, J. 2008: P53-induced protein with a death domain (PIDD) isoforms differentially activate nuclear factor-kappaB and caspase-2 in response to genotoxic stress. Oncogene 27(3): 387-396

Marney, C.B.; Anderson, E.S.; Adnan, M.; Peng, K.-L.; Hu, Y.; Weinhold, N.; Schmitt, A.M. 2021: P53-intact cancers escape tumor suppression through loss of long noncoding RNA Dino. Cell Reports 35(13): 109329

Ao, Y.; Rohde, L.H.; Naumovski, L. 2001: P53-interacting protein 53BP2 inhibits clonogenic survival and sensitizes cells to doxorubicin but not paclitaxel-induced apoptosis. Oncogene 20(21): 2720-2725

Linke, S.P.; Harris, M.P.; Neugebauer, S.E.; Clarkin, K.C.; Shepard, H.M.; Maneval, D.C.; Wahl, G.M. 1997: P53-mediated accumulation of hypophosphorylated pRb after the G1 restriction point fails to halt cell cycle progression. Oncogene 15(3): 337-345

Deng, L.; Yao, P.; Li, L.; Ji, F.; Zhao, S.; Xu, C.; Lan, X.; Jiang, P. 2020: P53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival. Nature Communications 11(1): 1755

Meley, D.; Spiller, D.G.; White, M.R.H.; McDowell, H.; Pizer, B.; Sée, V. 2010: P53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma. Cell Death and Disease 1: E41

Li, S.; Wang, M.; Wang, Y.; Guo, Y.; Tao, X.; Wang, X.; Cao, Y.; Tian, S.; Li, Q. 2021: P53-mediated ferroptosis is required for 1-methyl-4-phenylpyridinium-induced senescence of PC12 cells. Toxicology in Vitro: An International Journal Published in Association with Bibra 73: 105146

Mungamuri, S.Kumar.; Benson, E.Kay.; Wang, S.; Gu, W.; Lee, S.W.; Aaronson, S.A. 2012: P53-mediated heterochromatin reorganization regulates its cell fate decisions. Nature Structural and Molecular Biology 19(5): 478-84 S1

Huang, C-Yang.; Pai, P-Ying.; Kuo, C-Hua.; Ho, T-Jung.; Lin, J-Ying.; Lin, D-Yu.; Tsai, F-Jen.; Padma, V.Vijaya.; Kuo, W-Wen.; Huang, C-Yang. 2017: P53-mediated miR-18 repression activates HSF2 for IGF-IIR-dependent myocyte hypertrophy in hypertension-induced heart failure. Cell Death and Disease 8(8): E2990

Kim, Y.Yeon.; Um, J-Hyun.; Shin, D.Jin.; Jeong, D.Jin.; Hong, Y.Bin.; Yun, J. 2021: P53-mediated regulation of mitochondrial dynamics plays a pivotal role in the senescence of various normal cells as well as cancer cells. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 35(2): e21319

López, I.; Tournillon, A-Sophie.; Prado Martins, R.; Karakostis, K.; Malbert-Colas, L.; Nylander, K.; Fåhraeus, R. 2017: P53-mediated suppression of BiP triggers BIK-induced apoptosis during prolonged endoplasmic reticulum stress. Cell Death and Differentiation 24(10): 1717-1729

Huang, J.; Logsdon, N.; Schmieg, F.I.; Simmons, D.T. 1998: P53-mediated transcription induces resistance of DNA to UV inactivation. Oncogene 17(4): 401-411

Croft, D.R.; Crighton, D.; Samuel, M.S.; Lourenco, F.C.; Munro, J.; Wood, J.; Bensaad, K.; Vousden, K.H.; Sansom, O.J.; Ryan, K.M.; Olson, M.F. 2011: P53-mediated transcriptional regulation and activation of the actin cytoskeleton regulatory RhoC to LIMK2 signaling pathway promotes cell survival. Cell Research 21(4): 666-682

Ruiz-Ruiz, M.C.; López-Rivas, A. 1999: P53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells. Cell Death and Differentiation 6(3): 271-280

Testoni, B.; Schinzari, V.; Guerrieri, F.; Gerbal-Chaloin, S.; Blandino, G.; Levrero, M. 2011: P53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor. Oncogene 30(23): 2670-2678

Litwak, S.A.; Loh, K.; Stanley, W.J.; Pappas, E.G.; Wali, J.A.; Selck, C.; Strasser, A.; Thomas, H.E.; Gurzov, E.N. 2016: P53-upregulated-modulator-of-apoptosis (PUMA) deficiency affects food intake but does not impact on body weight or glucose homeostasis in diet-induced obesity. Scientific Reports 6: 23802

Chang, H.Won.; Kim, M.Ra.; Lee, H.Ju.; Lee, H.Min.; Kim, G.Chul.; Lee, Y.Sun.; Nam, H.Yun.; Lee, M.; Jang, H.Jin.; Lee, K.Eun.; Lee, J.Cheol.; Byun, Y.; Kim, S.Who.; Kim, S.Yoon. 2019: P53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer. Oncogene 38(19): 3729-3742

Sano, H.; Futamura, M.; Gaowa, S.; Kamino, H.; Nakamura, Y.; Yamaguchi, K.; Tanaka, Y.; Yasufuku, I.; Nakakami, A.; Arakawa, H.; Yoshida, K. 2020: P53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers. Biochemical and Biophysical Research Communications 529(3): 582-589

Wang, W.; Liu, H.; Dai, X.; Fang, S.; Wang, X.; Zhang, Y.; Yao, H.; Zhang, X.; Chao, J. 2015: P53/PUMA expression in human pulmonary fibroblasts mediates cell activation and migration in silicosis. Scientific Reports 5: 16900

Gonin, S.; Diaz-Latoud, C.; Richard, M.J.; Ursini, M.V.; Imbo, A.; Manero, F.; Arrigo, A.P. 1999: P53/T-antigen complex disruption in T-antigen transformed NIH3T3 fibroblasts exposed to oxidative stress: correlation with the appearance of a Fas/APO-1/CD95 dependent, caspase independent, necrotic pathway. Oncogene 18(56): 8011-8023

Ma, Z.; Li, L.; Livingston, M.J.; Zhang, D.; Mi, Q.; Zhang, M.; Ding, H.-F.; Huo, Y.; Mei, C.; Dong, Z. 2020: P53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease. Journal of Clinical Investigation 130(9): 5011-5026

Murray-Zmijewski, F.; Lane, D.P.; Bourdon, J-C. 2006: P53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death and Differentiation 13(6): 962-972

Wu, Q.; Zhang, K.-J.; Jiang, S.-M.; Fu, L.; Shi, Y.; Tan, R.-B.; Cui, J.; Zhou, Y. 2020: P53: a Key Protein that Regulates Pulmonary Fibrosis. Oxidative Medicine and Cellular Longevity 2020: 6635794

Levine, B.; Abrams, J. 2008: P53: The Janus of autophagy?. Nature Cell Biology 10(6): 637-639

Wrighton, K.H. 2016: P53: Understanding the actions of 53BP1. Nature Reviews. Molecular Cell Biology 17(10): 608

Kastan, M.B.; Berkovich, E. 2007: P53: a two-faced cancer gene. Nature Cell Biology 9(5): 489-491

Lloyd, A.C. 2000: P53: only ARF the story. Nature Cell Biology 2(3): E48-E50

Sengupta, S.; Harris, C.C. 2005: P53: traffic cop at the crossroads of DNA repair and recombination. Nature Reviews. Molecular Cell Biology 6(1): 44-55

Amelio, I.; Knight, R.A.; Lisitsa, A.; Melino, G.; Antonov, A.V. 2016: P53MutaGene: an online tool to estimate the effect of p53 mutational status on gene regulation in cancer. Cell Death and Disease 7: E2148

Tanikawa, C.; Matsuda, K.; Fukuda, S.; Nakamura, Y.; Arakawa, H. 2003: P53RDL1 regulates p53-dependent apoptosis. Nature Cell Biology 5(3): 216-223

Ng, C-Ching.; Arakawa, H.; Fukuda, S.; Kondoh, H.; Nakamura, Y. 2003: P53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1. Oncogene 22(28): 4449-4458

Jamieson, A.; Thompson, E.F.; Huvila, J.; Gilks, C.B.; McAlpine, J.N. 2021: P53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 31(6): 907-913

Kameoka, S.; Duque, P.; Konarska, M.M. 2004: P54(nrb) associates with the 5' splice site within large transcription/splicing complexes. EMBO Journal 23(8): 1782-1791

Zhu, Z.; Zhao, X.; Zhao, L.; Yang, H.; Liu, L.; Li, J.; Wu, J.; Yang, F.; Huang, G.; Liu, J. 2016: P54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A. Oncogene 35(11): 1399-1410

Furutachi, S.; Matsumoto, A.; Nakayama, K.I.; Gotoh, Y. 2013: P57 controls adult neural stem cell quiescence and modulates the pace of lifelong neurogenesis. EMBO Journal 32(7): 970-981

Kavanagh, E.; Vlachos, P.; Emourgeon, V.; Rodhe, J.; Joseph, B. 2012: P57(KIP2) control of actin cytoskeleton dynamics is responsible for its mitochondrial pro-apoptotic effect. Cell Death and Disease 3: E311

Potikha, T.; Kassem, S.; Haber, E.P.; Ariel, I.; Glaser, B. 2005: P57Kip2 (cdkn1c): sequence, splice variants and unique temporal and spatial expression pattern in the rat pancreas. Laboratory Investigation; a Journal of Technical Methods and Pathology 85(3): 364-375

Joseph, B.; Andersson, E.R.; Vlachos, P.; Södersten, E.; Liu, L.; Teixeira, A.I.; Hermanson, O. 2009: P57Kip2 is a repressor of Mash1 activity and neuronal differentiation in neural stem cells. Cell Death and Differentiation 16(9): 1256-1265

Jia, H.; Cong, Q.; Chua, J.F.L.; Liu, H.; Xia, X.; Zhang, X.; Lin, J.; Habib, S.L.; Ao, J.; Zuo, Q.; Fu, C.; Li, B. 2015: P57Kip2 is an unrecognized DNA damage response effector molecule that functions in tumor suppression and chemoresistance. Oncogene 34(27): 3568-3581

Monti, B. 2021: P57kip2 nuclear export as a marker of oligodendrocytes differentiation: Towards an innovative phenotyping screening for the identification of myelin repair drugs. Ebiomedicine 66: 103298

Boriushkin, E.; Wang, J.J.; Li, J.; Bhatta, M.; Zhang, S.X. 2016: P58(IPK) suppresses NLRP3 inflammasome activation and IL-1β production via inhibition of PKR in macrophages. Scientific Reports 6: 25013

Aouacheria, A.; Ory, Séphane.; Schmitt, J-Robert.; Rigal, D.; Jurdic, P.; Gillet, G. 2002: P60(v-src) and serum control cell shape and apoptosis via distinct pathways in quail neuroretina cells. Oncogene 21(8): 1171-1186

Korulu, S.; Yildiz, A. 2020: P60-katanin: a novel interacting partner for p53. Molecular Biology Reports 47(6): 4295-4301

Leong, I. 2018: P62 - a new metabolic tumour suppressor. Nature Reviews. Endocrinology 14(6): 324

Caccamo, A.; Ferreira, E.; Branca, C.; Oddo, S. 2017: P62 improves AD-like pathology by increasing autophagy. Molecular Psychiatry 22(6): 865-873

Kobayashi, T.; Ishida, M.; Miki, H.; Matsumi, Y.; Fukui, T.; Hamada, M.; Tsuta, K.; Sekimoto, M. 2021: P62 is a useful predictive marker for tumour regression after chemoradiation therapy in patients with advanced rectal cancer: an immunohistochemical study. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland 23(5): 1083-1090

Thompson, H.Garrett.R.; Harris, J.W.; Wold, B.J.; Lin, F.; Brody, J.P. 2003: P62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells. Oncogene 22(15): 2322-2333

Foster, A.D.; Flynn, L.L.; Cluning, C.; Cheng, F.; Davidson, J.M.; Lee, A.; Polain, N.; Mejzini, R.; Farrawell, N.; Yerbury, J.J.; Layfield, R.; Akkari, P.A.; Rea, S.L. 2021: P62 overexpression induces TDP-43 cytoplasmic mislocalisation, aggregation and cleavage and neuronal death. Scientific Reports 11(1): 11474

Liu, S.; Ye, F.; Li, D.; He, C.; He, H.; Zhang, J. 2020: P62 overexpression promotes neoplastic stromal cell proliferation and is associated with the recurrence of giant cell tumor of bone. Oncology Letters 20(4): 86

Rusten, T.Erik.; Stenmark, H. 2010: P62, an autophagy hero or culprit?. Nature Cell Biology 12(3): 207-209

Eskelinen, E-Liisa.; Kageyama, S.; Komatsu, M. 2021: P62/SQSTM1 droplets initiate autophagosome biogenesis and oxidative stress control. Molecular and Cellular Oncology 8(2): 1890990

Xu, L-Z.; Li, S-S.; Zhou, W.; Kang, Z-J.; Zhang, Q-X.; Kamran, M.; Xu, J.; Liang, D-P.; Wang, C-L.; Hou, Z-J.; Wan, X-B.; Wang, H-J.; Lam, E.W-F.; Zhao, Z-W.; Liu, Q. 2017: P62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA. Oncogene 36(3): 304-317

Trocoli, A.; Bensadoun, P.; Richard, E.; Labrunie, G.; Merhi, F.; Schläfli, A.M.; Brigger, D.; Souquere, S.; Pierron, G.; Pasquet, J-M.; Soubeyran, P.; Reiffers, J.; Ségal-Bendirdjian, E.; Tschan, M.P.; Djavaheri-Mergny, M. 2014: P62/SQSTM1 upregulation constitutes a survival mechanism that occurs during granulocytic differentiation of acute myeloid leukemia cells. Cell Death and Differentiation 21(12): 1852-1861

Lee, S.Hyun.; Cho, W.Jin.; Najy, A.J.; Saliganan, A-Dexter.; Pham, T.; Rakowski, J.; Loughery, B.; Ji, C.Hoon.; Sakr, W.; Kim, S.; Kato, I.; Chung, W.Kuu.; Kim, H.E.; Kwon, Y.Tae.; Kim, H-Reh.C. 2021: P62/SQSTM1-induced caspase-8 aggresomes are essential for ionizing radiation-mediated apoptosis. Cell Death and Disease 12(11): 997

Cha-Molstad, H.; Yu, J.Eun.; Feng, Z.; Lee, S.Hyun.; Kim, J.Gi.; Yang, P.; Han, B.; Sung, K.Woon.; Yoo, Y.Dong.; Hwang, J.; McGuire, T.; Shim, S.Mi.; Song, H.Dong.; Ganipisetti, S.; Wang, N.; Jang, J.Min.; Lee, M.Jae.; Kim, S.Jun.; Lee, K.Ho.; Hong, J.Tae.; Ciechanover, A.; Mook-Jung, I.; Kim, K.Pyo.; Xie, X-Qun.; Kwon, Y.Tae.; Kim, B.Yeon. 2017: P62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis. Nature Communications 8(1): 102

Trelford, C.B.; Ng, E.; Campbell, C.I.; Di Guglielmo, G.M. 2021: P62/Sequestosome 1 regulates transforming growth factor beta signaling and epithelial to mesenchymal transition in A549 cells. Cellular Signalling 85: 110040

Huang, H.; Tan, K.S.; Zhou, S.; Yuan, T.; Liu, J.; Ong, H.H.; Chen, Q.; Gao, J.; Xu, M.; Zhu, Z.; Qiu, Q.; Wang, D.Y. 2020: P63+Krt5+ basal cells are increased in the squamous metaplastic epithelium of patients with radiation-induced chronic Rhinosinusitis. Radiation Oncology 15(1): 222

Emanuel, P.; Wang, B.; Wu, M.; Burstein, D.E. 2005: P63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 18(5): 645-650

Min, S.; Oyelakin, A.; Gluck, C.; Bard, J.E.; Song, E.-A.C.; Smalley, K.; Che, M.; Flores, E.; Sinha, S.; Romano, R.-A. 2020: P63 and its Target Follistatin Maintain Salivary Gland Stem/Progenitor Cell Function through TGF-β/Activin Signaling. Iscience 23(9): 101524

Woodstock, D.L.; Sammons, M.A.; Fischer, M. 2021: P63 and p53: Collaborative Partners or Dueling Rivals?. Frontiers in Cell and Developmental Biology 9: 701986

Flores, E.R.; Tsai, K.Y.; Crowley, D.; Sengupta, S.; Yang, A.; McKeon, F.; Jacks, T. 2002: P63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416(6880): 560-564

Fatt, M.P.; Cancino, G.I.; Miller, F.D.; Kaplan, D.R. 2014: P63 and p73 coordinate p53 function to determine the balance between survival, cell death, and senescence in adult neural precursor cells. Cell Death and Differentiation 21(10): 1546-1559

Deyoung, M.P.; Ellisen, L.W. 2007: P63 and p73 in human cancer: defining the network. Oncogene 26(36): 5169-5183

Giacobbe, A.; Compagnone, M.; Bongiorno-Borbone, L.; Antonov, A.; Markert, E.K.; Zhou, J.H.; Annicchiarico-Petruzzelli, M.; Melino, G.; Peschiaroli, A. 2016: P63 controls cell migration and invasion by transcriptional regulation of MTSS1. Oncogene 35(12): 1602-1608

Sheikh, H.A.; Fuhrer, K.; Cieply, K.; Yousem, S. 2004: P63 expression in assessment of bronchioloalveolar proliferations of the lung. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 17(9): 1134-1140

Steurer, S.; Riemann, C.; Büscheck, F.; Luebke, A.M.; Kluth, M.; Hube-Magg, C.; Hinsch, A.; Höflmayer, D.; Weidemann, S.ör.; Fraune, C.; Möller, K.; Menz, A.; Fisch, M.; Rink, M.; Bernreuther, C.; Lebok, P.; Clauditz, T.S.; Sauter, G.; Uhlig, R.; Wilczak, W.; Dum, D.; Simon, R.; Minner, S.; Burandt, E.; Krech, R.; Krech, T.; Marx, A.H. 2021: P63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors. Biomarker Research 9(1): 7

Hunt, J.L.; LiVolsi, V.A.; Barnes, E.Leon. 2004: P63 expression in sclerosing mucoepidermoid carcinomas with eosinophilia arising in the thyroid. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 17(5): 526-529

Koster, M.I. 2010: P63 in skin development and ectodermal dysplasias. Journal of Investigative Dermatology 130(10): 2352-2358

Asatsuma-Okumura, T.; Ando, H.; De Simone, M.; Yamamoto, J.; Sato, T.; Shimizu, N.; Asakawa, K.; Yamaguchi, Y.; Ito, T.; Guerrini, L.; Handa, H. 2019: P63 is a cereblon substrate involved in thalidomide teratogenicity. Nature Chemical Biology 15(11): 1077-1084

Mills, A.A.; Zheng, B.; Wang, X.J.; Vogel, H.; Roop, D.R.; Bradley, A. 1999: P63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398(6729): 708-713

Yallowitz, A.R.; Alexandrova, E.M.; Talos, F.; Xu, S.; Marchenko, N.D.; Moll, U.M. 2014: P63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis. Cell Death and Differentiation 21(4): 645-654

Melino, G. 2011: P63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death and Differentiation 18(9): 1487-1499

Yang, A.; Schweitzer, R.; Sun, D.; Kaghad, M.; Walker, N.; Bronson, R.T.; Tabin, C.; Sharpe, A.; Caput, D.; Crum, C.; McKeon, F. 1999: P63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398(6729): 714-718

Awais, R.; Spiller, D.G.; White, M.R.H.; Paraoan, L. 2016: P63 is required beside p53 for PERP-mediated apoptosis in uveal melanoma. British Journal of Cancer 115(8): 983-992

Suh, E-Kyung.; Yang, A.; Kettenbach, A.; Bamberger, C.; Michaelis, A.H.; Zhu, Z.; Elvin, J.A.; Bronson, R.T.; Crum, C.P.; McKeon, F. 2006: P63 protects the female germ line during meiotic arrest. Nature 444(7119): 624-628

Borrelli, S.; Candi, E.; Alotto, D.; Castagnoli, C.; Melino, G.; Viganò, M.A.; Mantovani, R. 2009: P63 regulates the caspase-8-FLIP apoptotic pathway in epidermis. Cell Death and Differentiation 16(2): 253-263

Su, X.; Chakravarti, D.; Flores, E.R. 2013: P63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis. Nature Reviews. Cancer 13(2): 136-143

Gebel, J.; Tuppi, M.; Chaikuad, A.; Hötte, K.; Schröder, M.; Schulz, L.; Löhr, F.; Gutfreund, N.; Finke, F.; Henrich, E.; Mezhyrova, J.; Lehnert, R.; Pampaloni, F.; Hummer, G.; Stelzer, E.H.K.; Knapp, S.; Dötsch, V. 2020: P63 uses a switch-like mechanism to set the threshold for induction of apoptosis. Nature Chemical Biology 16(10): 1078-1086

Zuo, W.; Zhang, T.; Wu, D.Zheng'An.; Guan, S.Ping.; Liew, A-Ann.; Yamamoto, Y.; Wang, X.; Lim, S.Joo.; Vincent, M.; Lessard, M.; Crum, C.P.; Xian, W.; McKeon, F. 2015: P63(+)Krt5(+) distal airway stem cells are essential for lung regeneration. Nature 517(7536): 616-620

Okuyama, T.; Kurata, S.; Tomimori, Y.; Fukunishi, N.; Sato, S.; Osada, M.; Tsukinoki, K.; Jin, H-F.; Yamashita, A.; Ito, M.; Kobayashi, S.; Hata, R-I.; Ikawa, Y.; Katoh, I. 2008: P63(TP63) elicits strong trans-activation of the MFG-E8/lactadherin/BA46 gene through interactions between the TA and DeltaN isoforms. Oncogene 27(3): 308-317

Vanbokhoven, H.; Melino, G.; Candi, E.; Declercq, W. 2011: P63, a story of mice and men. Journal of Investigative Dermatology 131(6): 1196-1207

Lodillinsky, C.; Infante, E.; Guichard, A.; Chaligné, R.; Fuhrmann, L.; Cyrta, J.; Irondelle, M.; Lagoutte, E.; Vacher, S.; Bonsang-Kitzis, H.; Glukhova, M.; Reyal, F.; Bièche, I.; Vincent-Salomon, A.; Chavrier, P. 2016: P63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer. Oncogene 35(3): 344-357

Blanpain, Cédric.; Fuchs, E. 2007: P63: revving up epithelial stem-cell potential. Nature Cell Biology 9(7): 731-733

Dohn, M.; Zhang, S.; Chen, X. 2001: P63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 20(25): 3193-3205

De Beule, T.; Boulanger, T.; Heye, S.; van Rooij, W.J.; van Zwam, W.H.; Stockx, L. 2021: P64 flow diverter: Results in 108 patients from a single center. Interventional Neuroradiology: Journal of Peritherapeutic Neuroradiology Surgical Procedures and Related Neurosciences 27(1): 51-59

Grassilli, E.; Cerrito, M.G.; Bonomo, S.; Giovannoni, R.; Conconi, D.; Lavitrano, M. 2021: P65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors. Frontiers in Cell and Developmental Biology 9: 690365

Debnath, J. 2010: P66(Shc) and Ras: controlling anoikis from the inside-out. Oncogene 29(41): 5556-5558

Haga, S.; Morita, N.; Irani, K.; Fujiyoshi, M.; Ogino, T.; Ozawa, T.; Ozaki, M. 2010: P66(Shc) has a pivotal function in impaired liver regeneration in aged mice by a redox-dependent mechanism. Laboratory Investigation; a Journal of Technical Methods and Pathology 90(12): 1718-1726

Ma, Z.; Liu, Z.; Wu, R-F.; Terada, L.S. 2010: P66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior. Oncogene 29(41): 5559-5567

Pellegrini, M.; Finetti, F.; Petronilli, V.; Ulivieri, C.; Giusti, F.; Lupetti, P.; Giorgio, M.; Pelicci, P.G.; Bernardi, P.; Baldari, C.T. 2007: P66SHC promotes T cell apoptosis by inducing mitochondrial dysfunction and impaired Ca2+ homeostasis. Cell Death and Differentiation 14(2): 338-347

Minami, Y.; Sonoda, N.; Hayashida, E.; Makimura, H.; Ide, M.; Ikeda, N.; Ohgidani, M.; Kato, T.A.; Seki, Y.; Maeda, Y.; Kanba, S.; Takayanagi, R.; Ogawa, Y.; Inoguchi, T. 2018: P66Shc Signaling Mediates Diabetes-Related Cognitive Decline. Scientific Reports 8(1): 3213

Lone, A.; Harris, R.A.; Singh, O.; Betts, D.H.; Cumming, R.C. 2018: P66Shc activation promotes increased oxidative phosphorylation and renders CNS cells more vulnerable to amyloid beta toxicity. Scientific Reports 8(1): 17081

Patrussi, L.; Capitani, N.; Cattaneo, F.; Manganaro, N.; Gamberucci, A.; Frezzato, F.; Martini, V.; Visentin, A.; Pelicci, P.Giuseppe.; D'Elios, M.M.; Trentin, L.; Semenzato, G.; Baldari, C.T. 2018: P66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes. Oncogene 37(11): 1534-1550

Miller, B.; Palygin, O.; El-Meanawy, A.; Mattson, D.L.; Geurts, A.M.; Staruschenko, A.; Sorokin, A. 2021: P66Shc-mediated hydrogen peroxide production impairs nephrogenesis causing reduction of number of glomeruli. Life Sciences 279: 119661

Xu, X.; Zhu, X.; Ma, M.; Han, Y.; Hu, C.; Yuan, S.; Yang, Y.; Xiao, L.; Liu, F.; Kanwar, Y.S.; Sun, L. 2016: P66Shc: A novel biomarker of tubular oxidative injury in patients with diabetic nephropathy. Scientific Reports 6: 29302

Koeller, C.M.; Smith, T.K.; Gulick, A.M.; Bangs, J.D. 2021: P67: a cryptic lysosomal hydrolase in Trypanosoma brucei?. Parasitology 148(10): 1271-1276

Ip, C.K.M.; Cheung, A.N.Y.; Ngan, H.Y.S.; Wong, A.S.T. 2011: P70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells. Oncogene 30(21): 2420-2432

Li, M.; Chen, H.; Sun, T.; Ma, Z.; Chen, X.; Wu, D.; Huang, W.; Wang, X. 2020: P70S6K Promotes Acquired Resistance of Erlotinib Through Induction of Epithelial-Mesenchymal Transition in Non-Small Cell Lung Carcinoma. Oncotargets and Therapy 13: 5257-5270

Lane, H.A.; Fernandez, A.; Lamb, N.J.; Thomas, G. 1993: P70s6k function is essential for G1 progression. Nature 363(6425): 170-172

Topin-Ruiz, S.èn.; Mellinger, A.él.; Lepeltier, E.; Bourreau, C.; Fouillet, J.; Riou, J.ér.ém.; Jaouen, G.ér.; Martin, L.; Passirani, C.; Clere, N. 2021: P722 ferrocifen loaded lipid nanocapsules improve survival of murine xenografted-melanoma via a potentiation of apoptosis and an activation of CD8+ T lymphocytes. International Journal of Pharmaceutics 593: 120111

Uboveja, A.; Satija, Y.Kumar.; Siraj, F.; Sharma, I.; Saluja, D. 2020: P73 - NAV3 axis plays a critical role in suppression of colon cancer metastasis. Oncogenesis 9(2): 12

Seeliger, M.A.; Moll, U.M. 2013: P73 - constitutively open for business. Cell Death and Differentiation 20(8): 972-973

Vikhanskaya, F.; Bani, M.R.; Borsotti, P.; Ghilardi, C.; Ceruti, R.; Ghisleni, G.; Marabese, M.; Giavazzi, R.; Broggini, M.; Taraboletti, G. 2001: P73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis. Oncogene 20(50): 7293-7300

Maeso-Alonso, L.; López-Ferreras, L.; Marques, M.M.; Marin, M.C. 2021: P73 as a Tissue Architect. Frontiers in Cell and Developmental Biology 9: 716957

Ichimiya, S.; Nimura, Y.; Kageyama, H.; Takada, N.; Sunahara, M.; Shishikura, T.; Nakamura, Y.; Sakiyama, S.; Seki, N.; Ohira, M.; Kaneko, Y.; McKeon, F.; Caput, D.; Nakagawara, A. 1999: P73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene 18(4): 1061-1066

Das, S.; Nama, S.; Antony, S.; Somasundaram, K. 2005: P73 beta-expressing recombinant adenovirus: a potential anticancer agent. Cancer Gene Therapy 12(4): 417-426

Willis, A.C.; Pipes, T.; Zhu, J.; Chen, X. 2003: P73 can suppress the proliferation of cells that express mutant p53. Oncogene 22(35): 5481-5495

Zhu, J.; Nozell, S.; Wang, J.; Jiang, J.; Zhou, W.; Chen, X. 2001: P73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner. Oncogene 20(30): 4050-4057

Fernandez-Garcia, B.; Vaqué, J.P.; Herreros-Villanueva, M.; Marques-Garcia, F.; Castrillo, F.; Fernandez-Medarde, A.; León, J.; Marín, M.C. 2007: P73 cooperates with Ras in the activation of MAP kinase signaling cascade. Cell Death and Differentiation 14(2): 254-265

Gong, H.; Zhang, Y.; Jiang, K.; Ye, S.; Chen, S.; Zhang, Q.; Peng, J.; Chen, J. 2018: P73 coordinates with Δ133p53 to promote DNA double-strand break repair. Cell Death and Differentiation 25(6): 1063-1079

Gonzalez-Cano, L.; Herreros-Villanueva, M.; Fernandez-Alonso, R.; Ayuso-Sacido, A.; Meyer, G.; Garcia-Verdugo, J.M.; Silva, A.; Marques, M.M.; Marin, M.C. 2010: P73 deficiency results in impaired self renewal and premature neuronal differentiation of mouse neural progenitors independently of p53. Cell Death and Disease 1: E109

Long, J.S.; Schoonen, P.M.; Graczyk, D.; O'Prey, J.; Ryan, K.M. 2015: P73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death. Oncogene 34(40): 5152-5162

Johnson, J.; Lagowski, J.; Lawson, S.; Liu, Y.; Kulesz-Martin, M. 2008: P73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis. Oncogene 27(19): 2780-2787

Talos, F.; Abraham, A.; Vaseva, A.V.; Holembowski, L.; Tsirka, S.E.; Scheel, A.; Bode, D.; Dobbelstein, M.; Brück, W.; Moll, U.M. 2010: P73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis. Cell Death and Differentiation 17(12): 1816-1829

Flores, E.R. 2011: P73 is critical for the persistence of memory. Cell Death and Differentiation 18(3): 381-382

Alexandrova, E.M.; Talos, F.; Moll, U.M. 2013: P73 is dispensable for commitment to neural stem cell fate, but is essential for neural stem cell maintenance and for blocking premature differentiation. Cell Death and Differentiation 20(2): 368

Kommagani, R.; Whitlatch, A.; Leonard, M.K.; Kadakia, M.P. 2010: P73 is essential for vitamin D-mediated osteoblastic differentiation. Cell Death and Differentiation 17(3): 398-407

Yuan, Z.M.; Shioya, H.; Ishiko, T.; Sun, X.; Gu, J.; Huang, Y.Y.; Lu, H.; Kharbanda, S.; Weichselbaum, R.; Kufe, D. 1999: P73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 399(6738): 814-817

Fernandez-Alonso, R.; Martin-Lopez, M.; Gonzalez-Cano, L.; Garcia, S.; Castrillo, F.; Diez-Prieto, I.; Fernandez-Corona, A.; Lorenzo-Marcos, M.E.; Li, X.; Claesson-Welsh, L.; Marques, M.M.; Marin, M.C. 2015: P73 is required for endothelial cell differentiation, migration and the formation of vascular networks regulating VEGF and TGFβ signaling. Cell Death and Differentiation 22(8): 1287-1299

Chen, X.; Zheng, Y.; Zhu, J.; Jiang, J.; Wang, J. 2001: P73 is transcriptionally regulated by DNA damage, p53, and p73. Oncogene 20(6): 769-774

Fets, L.; Anastasiou, D. 2013: P73 keeps metabolic control in the family. Nature Cell Biology 15(8): 891-893

Stirewalt, D.L.; Clurman, B.; Appelbaum, F.R.; Willman, C.L.; Radich, J.P. 1999: P73 mutations and expression in adult de novo acute myelogenous leukemia. Leukemia 13(7): 985-990

Beitzinger, M.; Hofmann, L.; Oswald, C.; Beinoraviciute-Kellner, R.; Sauer, M.; Griesmann, H.; Bretz, A.Catherine.; Burek, C.; Rosenwald, A.; Stiewe, T. 2008: P73 poses a barrier to malignant transformation by limiting anchorage-independent growth. EMBO Journal 27(5): 792-803

He, Z.; Liu, H.; Agostini, M.; Yousefi, S.; Perren, A.; Tschan, M.P.; Mak, T.W.; Melino, G.; Simon, H.U. 2013: P73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene. Cell Death and Differentiation 20(10): 1415-1424

Fuertes-Alvarez, S.; Maeso-Alonso, L.; Villoch-Fernandez, J.; Wildung, M.; Martin-Lopez, M.; Marshall, C.; Villena-Cortes, A.J.; Diez-Prieto, I.; Pietenpol, J.A.; Tissir, F.; Lizé, M.; Marques, M.M.; Marin, M.C. 2018: P73 regulates ependymal planar cell polarity by modulating actin and microtubule cytoskeleton. Cell Death and Disease 9(12): 1183

Amelio, I.; Markert, E.K.; Rufini, A.; Antonov, A.V.; Sayan, B.S.; Tucci, P.; Agostini, M.; Mineo, T.C.; Levine, A.J.; Melino, G. 2014: P73 regulates serine biosynthesis in cancer. Oncogene 33(42): 5039-5046

Vikhanskaya, F.; Toh, W.Hong.; Dulloo, I.; Wu, Q.; Boominathan, L.; Ng, H.Hui.; Vousden, K.H.; Sabapathy, K. 2007: P73 supports cellular growth through c-Jun-dependent AP-1 transactivation. Nature Cell Biology 9(6): 698-705

Alarcon-Vargas, D.; Fuchs, S.Y.; Deb, S.; Ronai, Z. 2000: P73 transcriptional activity increases upon cooperation between its spliced forms. Oncogene 19(6): 831-835

Terrinoni, A.; Ranalli, M.; Cadot, B.; Leta, A.; Bagetta, G.; Vousden, K.H.; Melino, G. 2004: P73-alpha is capable of inducing scotin and ER stress. Oncogene 23(20): 3721-3725

Yang, A.; Walker, N.; Bronson, R.; Kaghad, M.; Oosterwegel, M.; Bonnin, J.; Vagner, C.; Bonnet, H.; Dikkes, P.; Sharpe, A.; McKeon, F.; Caput, D. 2000: P73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404(6773): 99-103

Melino, G.; De Laurenzi, V.; Vousden, K.H. 2002: P73: Friend or foe in tumorigenesis. Nature Reviews. Cancer 2(8): 605-615

Irwin, M.S.; Miller, F.D. 2004: P73: regulator in cancer and neural development. Cell Death and Differentiation 11 Suppl. 1: S17-S22

Miro-Mur, F.; Meiller, A.; Haddada, H.; May, E. 2003: P73alpha expression induces both accumulation and activation of wt-p53 independent of the p73alpha transcriptional activity. Oncogene 22(35): 5451-5456

Platón-Corchado, Mía.; Barcelona, P.F.; Jmaeff, S.; Marchena, M.; Hernández-Pinto, A.M.; Hernández-Sánchez, C.; Saragovi, H.Uri.; de la Rosa, E.J. 2017: P75 NTR antagonists attenuate photoreceptor cell loss in murine models of retinitis pigmentosa. Cell Death and Disease 8(7): E2922

Vaidyanathan, S.; Krishnan, K.R.; Mansour, P.; Soni, B.M.; McDicken, I. 1998: P75 nerve growth factor receptor in the vesical urothelium of patients with neuropathic bladder: an immunohistochemical study. Spinal Cord 36(8): 541-547

Truzzi, F.; Marconi, A.; Atzei, P.; Panza, M.C.; Lotti, R.; Dallaglio, K.; Tiberio, R.; Palazzo, E.; Vaschieri, C.; Pincelli, C. 2011: P75 neurotrophin receptor mediates apoptosis in transit-amplifying cells and its overexpression restores cell death in psoriatic keratinocytes. Cell Death and Differentiation 18(6): 948-958

Makkerh, J.P.S.; Ceni, C.; Auld, D.S.; Vaillancourt, Fçois.; Dorval, G.; Barker, P.A. 2005: P75 neurotrophin receptor reduces ligand-induced Trk receptor ubiquitination and delays Trk receptor internalization and degradation. Embo Reports 6(10): 936-941

Caporali, A.; Meloni, M.; Nailor, A.; Mitić, T.; Shantikumar, S.; Riu, F.; Sala-Newby, G.B.; Rose, L.; Besnier, M.; Katare, R.; Voellenkle, C.; Verkade, P.; Martelli, F.; Madeddu, P.; Emanueli, C. 2015: P75(NTR)-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia. Nature Communications 6: 8024

Bredesen, D.E.; Ye, X.; Tasinato, A.; Sperandio, S.; Wang, J.J.; Assa-Munt, N.; Rabizadeh, S. 1998: P75NTR and the concept of cellular dependence: seeing how the other half die. Cell Death and Differentiation 5(5): 365-371

Yao, X-Q.; Jiao, S-S.; Saadipour, K.; Zeng, F.; Wang, Q-H.; Zhu, C.; Shen, L-L.; Zeng, G-H.; Liang, C-R.; Wang, J.; Liu, Y-H.; Hou, H-Y.; Xu, X.; Su, Y-P.; Fan, X-T.; Xiao, H-L.; Lue, L-F.; Zeng, Y-Q.; Giunta, B.; Zhong, J-H.; Walker, D.G.; Zhou, H-D.; Tan, J.; Zhou, X-F.; Wang, Y-J. 2015: P75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease. Molecular Psychiatry 20(11): 1301-1310

Li, J.; Zhao, M.; Wang, Y.; Shen, M.; Wang, S.; Tang, M.; Li, M.; Luo, Y.; Yang, K.; Wen, X. 2020: P75NTR optimizes the osteogenic potential of human periodontal ligament stem cells by up-regulating α1 integrin expression. Journal of cellular and molecular medicine 24(13): 7563-7575

Park, K.J.; Grosso, C.Ayala.; Aubert, I.; Kaplan, D.R.; Miller, F.D. 2010: P75NTR-dependent, myelin-mediated axonal degeneration regulates neural connectivity in the adult brain. Nature Neuroscience 13(5): 559-566

Lu, Q.; Qu, Y.; Ding, Y.; Kang, X. 2021: P75NTR/proBDNF Modulates Basal Cell Carcinoma (BCC) Immune Microenvironment via Necroptosis Signaling Pathway. Journal of Immunology Research 2021: 6652846

Barker, P.A. 1998: P75NTR: A study in contrasts. Cell Death and Differentiation 5(5): 346-356

Hirohashi, Y.; Wang, Q.; Liu, Q.; Du, X.; Zhang, H.; Sato, N.; Greene, M.I. 2006: P78/MCRS1 forms a complex with centrosomal protein Nde1 and is essential for cell viability. Oncogene 25(35): 4937-4946

Vasseur, S.; Hoffmeister, A.; Garcia-Montero, Aés.; Mallo, G.Vidal.; Feil, R.; Kühbandner, S.; Dagorn, J-Charles.; Iovanna, J.Lucio. 2002: P8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis. Oncogene 21(11): 1685-1694

Turvey, M.E.; Klingler-Hoffmann, M.; Hoffmann, P.; McColl, S.R. 2015: P84 forms a negative regulatory complex with p110γ to control PI3Kγ signalling during cell migration. Immunology and Cell Biology 93(8): 735-743

Cosentino, C.; Di Domenico, M.; Porcellini, A.; Cuozzo, C.; De Gregorio, G.; Santillo, M.R.; Agnese, S.; Di Stasio, R.; Feliciello, A.; Migliaccio, A.; Avvedimento, E.V. 2007: P85 regulatory subunit of PI3K mediates cAMP-PKA and estrogens biological effects on growth and survival. Oncogene 26(14): 2095-2103

Tian, L.; Choi, S-Chul.; Murakami, Y.; Allen, J.; Morse, H.C.; Qi, C-Feng.; Krzewski, K.; Coligan, J.E. 2014: P85α recruitment by the CD300f phosphatidylserine receptor mediates apoptotic cell clearance required for autoimmunity suppression. Nature Communications 5: 3146

Mak, V.C.; Li, X.; Rao, L.; Zhou, Y.; Tsao, S.-W.; Cheung, L.W. 2021: P85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair. Neoplasia 23(7): 718-730

Rao, L.; Mak, V.C.Y.; Zhou, Y.; Zhang, D.; Li, X.; Fung, C.C.Y.; Sharma, R.; Gu, C.; Lu, Y.; Tipoe, G.L.; Cheung, A.N.Y.; Mills, G.B.; Cheung, L.W.T. 2020: P85β regulates autophagic degradation of AXL to activate oncogenic signaling. Nature Communications 11(1): 2291

Di Cesare, A.; Paris, S.; Albertinazzi, C.; Dariozzi, S.; Andersen, J.; Mann, M.; Longhi, R.; de Curtis, I. 2000: P95-APP1 links membrane transport to Rac-mediated reorganization of actin. Nature Cell Biology 2(8): 521-530

Schwahn, D.J.; Medina, D. 1998: P96, a MAPK-related protein, is consistently downregulated during mouse mammary carcinogenesis. Oncogene 17(9): 1173-1178

Garrison, P.; Bangs, J.D. 2020: P97 Inhibitor CB-5083 Blocks ERAD in Trypanosoma brucei. Molecular and Biochemical Parasitology 239: 111313

Kaneko, Y.; Shimoda, K.; Ayala, R.; Goto, Y.; Panico, S.; Zhang, X.; Kondo, H. 2021: P97 and p47 function in membrane tethering in cooperation with FTCD during mitotic Golgi reassembly. EMBO Journal 40(9): E105853

Carlson, E.J.; Pitonzo, D.; Skach, W.R. 2006: P97 functions as an auxiliary factor to facilitate TM domain extraction during CFTR ER-associated degradation. EMBO Journal 25(19): 4557-4566

Ge, Y.; Tian, M.; Liu, L.; Wong, T.Pan.; Gong, B.; Wu, D.; Cho, T.; Lin, S.; Kast, Jürgen.; Lu, J.; Wang, Y.Tian. 2019: P97 regulates GluA1 homomeric AMPA receptor formation and plasma membrane expression. Nature Communications 10(1): 4089

Lee, S.Hyun.; McCormick, F. 2006: P97/DAP5 is a ribosome-associated factor that facilitates protein synthesis and cell proliferation by modulating the synthesis of cell cycle proteins. EMBO Journal 25(17): 4008-4019

Sonnenblick, A.; Venet, D.; Brohée, S.; Pondé, N.; Sotiriou, C. 2019: PAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation. Npj Breast Cancer 5: 7

Purbey, P.Kumar.; Jayakumar, P.Cyril.; Patole, M.S.; Galande, S. 2006: PC6-2/caspase-6 system to purify glutathione-S-transferase-free recombinant fusion proteins expressed in Escherichia coli. Nature Protocols 1(4): 1820-1827

Claude, C.; Deep, A.; Kneyber, M.; Siddiqui, S.; Renolleau, S.; Morin, L.; Jacquemin, E.; Teglas, J.-P.; Gajdos, V.; Tissières, P.; Durand, P. 2020: PCLIF-SOFA is a reliable outcome prognostication score of critically ill children with cirrhosis: an ESPNIC multicentre study. Annals of Intensive Care 10(1): 137

Wang, J.; Wang, X.; Liu, T.; Yuan, X.; Chen, H.; He, Y.; Wu, S.; Yuan, Z.; Li, H.; Que, Z.; Yu, L.; Zhang, Y. 2021: PCO2 and CO2 evasion from two small suburban rivers: Implications of the watershed urbanization process. Science of the Total Environment 788: 147787

Yeomans, J.; Sastry, A. 2021: PCONUS 2 and pCONUS 2-HPC for the treatment of wide-necked intracranial aneurysms: Periprocedural, 6-month, and early 2-year follow-up outcomes. Interventional Neuroradiology: Journal of Peritherapeutic Neuroradiology Surgical Procedures and Related Neurosciences 27(6): 805-814

Soubrier, F.; Cameron, B.; Manse, B.; Somarriba, S.; Dubertret, C.; Jaslin, G.; Jung, G.; Caer, C.L.; Dang, D.; Mouvault, J.M.; Scherman, D.; Mayaux, J.F.; Crouzet, J. 1999: PCOR: a new design of plasmid vectors for nonviral gene therapy. Gene Therapy 6(8): 1482-1488

De Santis, D.; Rossini, L.; Tassi, L.; Didato, G.; Tringali, G.; Cossu, M.; Bramerio, M.; Padelli, F.; Regondi, M.C.; Colciaghi, F.; Aronica, E.; Spreafico, R.; Garbelli, R. 2020: PCREB expression in human tissues from epilepsy surgery. Epilepsia 61(6): 1240-1252

Li, S.; Yu, K.; Wu, G.; Zhang, Q.; Wang, P.; Zheng, J.; Liu, Z.-X.; Wang, J.; Gao, X.; Cheng, H. 2021: PCysMod: Prediction of Multiple Cysteine Modifications Based on Deep Learning Framework. Frontiers in Cell and Developmental Biology 9: 617366

Dobrijevic, D.; Nematollahi, L.A.; Hailes, H.C.; Ward, J.M. 2020: PET expression vector customized for efficient seamless cloning. Biotechniques 69(5): 384-387

Grier, A.E.; Burleigh, S.; Sahni, J.; Clough, C.A.; Cardot, V.; Choe, D.C.; Krutein, M.C.; Rawlings, D.J.; Jensen, M.C.; Scharenberg, A.M.; Jacoby, K. 2016: PEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences. Molecular Therapy. Nucleic Acids 5: E306

Lu, T.; Zhang, X.; Huang, Y.; Guo, D.; Huang, F.; Xu, Q.; Hu, Y.; Ou-Yang, L.; Lin, J.; Yan, Z.; Qu, X. 2020: PFISTA-SENSE-ResNet for parallel MRi reconstruction. Journal of Magnetic Resonance 318: 106790

Liu, M-Qi.; Zeng, W-Feng.; Fang, P.; Cao, W-Qian.; Liu, C.; Yan, G-Quan.; Zhang, Y.; Peng, C.; Wu, J-Qiang.; Zhang, X-Jin.; Tu, H-Jun.; Chi, H.; Sun, R-Xiang.; Cao, Y.; Dong, M-Qiu.; Jiang, B-Yun.; Huang, J-Ming.; Shen, H-Li.; Wong, C.C.L.; He, S-Min.; Yang, P-Yuan. 2017: PGlyco 2.0 enables precision N-glycoproteomics with comprehensive quality control and one-step mass spectrometry for intact glycopeptide identification. Nature Communications 8(1): 438

Zeng, W-Feng.; Liu, M-Qi.; Zhang, Y.; Wu, J-Qiang.; Fang, P.; Peng, C.; Nie, A.; Yan, G.; Cao, W.; Liu, C.; Chi, H.; Sun, R-Xiang.; Wong, C.C.L.; He, S-Min.; Yang, P. 2016: PGlyco: a pipeline for the identification of intact N-glycopeptides by using HCD- and CID-MS/MS and MS3. Scientific Reports 6: 25102

Pujara, N.; Giri, R.; Wong, K.Y.; Qu, Z.; Rewatkar, P.; Moniruzzaman, M.; Begun, J.; Ross, B.P.; McGuckin, M.; Popat, A. 2021: PH - Responsive colloidal carriers assembled from β-lactoglobulin and Epsilon poly-L-lysine for oral drug delivery. Journal of Colloid and Interface Science 589: 45-55

Farh, M.E.-A.; Abdellaoui, N.; Seo, J.-A. 2021: PH Changes have a Profound Effect on Gene Expression, Hydrolytic Enzyme Production, and Dimorphism in Saccharomycopsis fibuligera. Frontiers in Microbiology 12: 672661

Afzal, S.; Lone, M.S.; Nazir, N.; Dar, A.A. 2021: PH Changes in the Micelle-Water Interface of Surface-Active Ionic Liquids Dictate the Stability of Encapsulated Curcumin: An Insight Through a Unique Interfacial Reaction between Arenediazonium Ions and t-Butyl Hydroquinone. Acs Omega 6(23): 14985-15000

Bian, Y.; Chen, X.; Ren, Z.J. 2020: PH Dependence of Phosphorus Speciation and Transport in Flow-Electrode Capacitive Deionization. Environmental Science and Technology 54(14): 9116-9123

Amorim, J.és.V.; Wu, S.; Klimchuk, K.; Lau, C.; Williams, F.J.; Huang, Y.; Zhao, R. 2020: PH Dependence of the OH Reactivity of Organic Acids in the Aqueous Phase. Environmental Science and Technology 54(19): 12484-12492

Deng, S.; Ling, D.; Zhou, B.; Gong, Y.; Shen, X.; Liu, L.; Zhao, H. 2021: PH Effect of Natural Gas Hydrate on X80 Steel Solid-Liquid Phase Scouring Corrosion. Acs Omega 6(4): 3017-3023

Johnson, M.K.; Venkatesh, M.; Liu, N.; Breuer, C.R.; Shada, A.L.; Greenberg, J.A.; Lidor, A.O.; Funk, L.M. 2021: PH Impedance Parameters Associated with Improvement in GERD Health-Related Quality of Life Following Anti-reflux Surgery. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 25(1): 28-35

Murugan, E.; Venkatraman, A.; Lei, Z.; Mouvet, V.; Rui Yi Lim, R.; Muruganantham, N.; Goh, E.; Swee Lim Peh, G.; Beuerman, R.W.; Chaurasia, S.S.; Rajamani, L.; Mehta, J.S. 2016: PH Induced Conformational Transitions in the Transforming Growth Factor β-Induced Protein (TGFβIp) Associated Corneal Dystrophy Mutants. Scientific Reports 6: 23836

Dias, V.H.C.; Malacrida, A.M.; Dos Santos, A.R.; Batista, A.F.P.; Campanerut-Sá, P.A.Z.; Braga, G.; Bona, E.; Caetano, W.; Mikcha, J.M.G. 2021: PH interferes in photoinhibitory activity of curcumin nanoencapsulated with pluronic® P123 against Staphylococcus aureus. Photodiagnosis and Photodynamic Therapy 33: 102085

Hu, Q.; Zhang, Y.; Wang, T.; Sun, W.; Tong, Z. 2021: PH Responsive Strong Polyion Complex Shape Memory Hydrogel with Spontaneous Shape Changing and Information Encryption. Macromolecular Rapid Communications 42(9): E2000747

Zhao, X.; Zhao, K.-C.; Chen, L.-J.; Liu, Y.-S.; Liu, J.-L.; Yan, X.-P. 2020: PH Reversibly Switchable Nanocapsule for Bacteria-Targeting Near-Infrared Fluorescence Imaging-Guided Precision Photodynamic Sterilization. Acs Applied Materials and Interfaces 12(41): 45850-45858

Ludwanowski, S.; Ari, M.; Parison, K.; Kalthoum, S.; Straub, P.; Pompe, N.; Weber, S.; Walter, M.; Walther, A. 2020: PH Tuning of Water-Soluble Arylazopyrazole Photoswitches. Chemistry 26(58): 13203-13212

Baysal, E.; Sari, D.; Vural, F.; Çağırgan, Sçkin.; Saydam, Güray.; Töbü, M.; Şahin, F.; Soyer, N.; Gediz, Füsun.; Acarlar, C.; Timur, E.; Güngör, Aşe. 2021: PH Value in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation. Seminars in Oncology Nursing 2021: 151146

Li, C.; Wang, Y.; Zhang, S.; Zhang, J.; Wang, F.; Sun, Y.; Huang, L.; Bian, W. 2021: PH and ROS sequentially responsive podophyllotoxin prodrug micelles with surface charge-switchable and self-amplification drug release for combating multidrug resistance cancer. Drug Delivery 28(1): 680-691

Wang, C.; Liu, H.; Liu, S.; Wang, Z.; Zhang, J. 2020: PH and Redox Dual-Sensitive Covalent Organic Framework Nanocarriers to Resolve the Dilemma Between Extracellular Drug Loading and Intracellular Drug Release. Frontiers in Chemistry 8: 488

Wu, B.-Y.; Le, X.-X.; Jian, Y.-K.; Lu, W.; Yang, Z.-Y.; Zheng, Z.-K.; Théato, P.; Zhang, J.-W.; Zhang, A.; Chen, T. 2021: PH and Thermo Dual-Responsive Fluorescent Hydrogel Actuator. Macromolecular Rapid Communications 42(19): E2100527

Chaudhari, R.; Joshi, A.; Srivastava, R. 2017: PH and Urea Estimation in Urine Samples using Single Fluorophore and Ratiometric Fluorescent Biosensors. Scientific Reports 7(1): 5840

Kashif, M.; Bharati, A.P.; Chaturvedi, S.K.; Khan, R.H.; Ahmad, A.; Kumar, B.; Zamzami, M.A.; Ahmad, V.; Kumari, S. 2020: PH and alcohol induced structural transition in Ntf2 a nuclear transport factor of Saccharomyces cerevisiae. International Journal of Biological Macromolecules 159: 79-86

Zhang, B.; Zhang, L.; Duan, E.; Zhang, R.; Liu, J.; Shi, P.; Mei, Y.; Li, R.; Zhang, L. 2021: PH and charge reversal-driven nanoplatform for efficient delivery of therapeutics. Colloids and Surfaces. B Biointerfaces 208: 112106

Raja, S.Thirupathi.Kumara.; Thiruselvi, T.; Mandal, A.Baran.; Gnanamani, A. 2015: PH and redox sensitive albumin hydrogel: A self-derived biomaterial. Scientific Reports 5: 15977

Chen, L.; Zhuang, W.; Hu, C.; Yu, T.; Su, X.; Liang, Z.; Li, G.; Wang, Y. 2020: PH and singlet oxygen dual-responsive GEM prodrug micelles for efficient combination therapy of chemotherapy and photodynamic therapy. Journal of Materials Chemistry. B 8(26): 5645-5654

İsbir, C.; Kıllı, İs.; Taşkınlar, H.; Naycı, A. 2022: PH and specific gravity of corrosive agents as indicators in caustic injuries. Pediatrics International: Official Journal of the Japan Pediatric Society 64(1): E14931

Manning, R.H.; Edgar, W.M. 1993: PH changes in plaque after eating snacks and meals, and their modification by chewing sugared- or sugar-free gum. British Dental Journal 174(7): 241-244

Fersht, A.R.; Renard, M. 1974: PH dependence of chymotrypsin catalysis. Appendix: substrate binding to dimeric alpha-chymotrypsin studied by x-ray diffraction and the equilibrium method. Biochemistry 13(7): 1416-1426

Vesell, E.S. 1966: PH dependence of lactate dehydrogenase isozyme inhibition by substrate. Nature 210(5034): 421-422

Davletshina, L.N.; Semin, B.K. 2020: PH dependence of photosystem Ii photoinhibition: relationship with structural transition of oxygen-evolving complex at the pH of thylakoid lumen. Photosynthesis Research 145(2): 135-143

Quade, B.N.; Marshall, A.; Parker, M.D. 2020: PH dependence of the Slc4a11-mediated H+ conductance is influenced by intracellular lysine residues and modified by disease-linked mutations. American Journal of Physiology. Cell Physiology 319(2): C359-C370

Li, C.; Evans, J.; Wang, N.; Guo, T.; He, S. 2019: PH dependence of the chirality of nematic cellulose nanocrystals. Scientific Reports 9(1): 11290

Narvekar, A.; Gawali, S.L.; Hassan, P.A.; Jain, R.; Dandekar, P. 2020: PH dependent aggregation and conformation changes of rituximab using SAXS and its comparison with the standard regulatory approach of biophysical characterization. International Journal of Biological Macromolecules 164: 3084-3097

Boyer, M.J.; Horn, I.; Firestone, R.A.; Steele-Norwood, D.; Tannock, I.F. 1993: PH dependent cytotoxicity of N-dodecylimidazole: a compound that acquires detergent properties under acidic conditions. British Journal of Cancer 67(1): 81-87

Silin, V.I.; Hoogerheide, D.P. 2021: PH dependent electrical properties of the inner- and outer- leaflets of biomimetic cell membranes. Journal of Colloid and Interface Science 594: 279-289

Wijesinghe, D.; Arachchige, M.C.M.; Lu, A.; Reshetnyak, Y.K.; Andreev, O.A. 2013: PH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis. Scientific Reports 3: 3560

Sylvain, Fçois-Étienne.; Cheaib, B.; Llewellyn, M.; Gabriel Correia, T.; Barros Fagundes, D.; Luis Val, A.; Derome, N. 2016: PH drop impacts differentially skin and gut microbiota of the Amazonian fish tambaqui (Colossoma macropomum). Scientific Reports 6: 32032

Westphal, L.; Strehmel, N.; Eschen-Lippold, L.; Bauer, N.; Westermann, B.; Rosahl, S.; Scheel, D.; Lee, J. 2019: PH effects on plant calcium fluxes: lessons from acidification-mediated calcium elevation induced by the γ-glutamyl-leucine dipeptide identified from Phytophthora infestans. Scientific Reports 9(1): 4733

Liu, X.; Schlexer, P.; Xiao, J.; Ji, Y.; Wang, L.; Sandberg, R.B.; Tang, M.; Brown, K.S.; Peng, H.; Ringe, S.; Hahn, C.; Jaramillo, T.F.; Nørskov, J.K.; Chan, K. 2019: PH effects on the electrochemical reduction of CO (2) towards C 2 products on stepped copper. Nature Communications 10(1): 32

Glikman, D.; García Rey, N.; Richert, M.; Meister, K.; Braunschweig, B.ör. 2022: PH effects on the molecular structure and charging state of β-Escin biosurfactants at the air-water interface. Journal of Colloid and Interface Science 607(Part 2): 1754-1761

Zheng, T.; Jäättelä, M.; Liu, B. 2020: PH gradient reversal fuels cancer progression. International Journal of Biochemistry and Cell Biology 125: 105796

Volk, T.; Jähde, E.; Fortmeyer, H.P.; Glüsenkamp, K.H.; Rajewsky, M.F. 1993: PH in human tumour xenografts: effect of intravenous administration of glucose. British Journal of Cancer 68(3): 492-500

Chowhan, R.Kaur.; Hotumalani, S.; Rahaman, H.; Singh, L.Rajendrakumar. 2021: PH induced conformational alteration in human peroxiredoxin 6 might be responsible for its resistance against lysosomal pH or high temperature. Scientific Reports 11(1): 9657

Schlichting, I.; Reinstein, J. 1999: PH influences fluoride coordination number of the AlFx phosphoryl transfer transition state analog. Nature Structural Biology 6(8): 721-723

Hofstetter, F. 1947: PH measurements with the glass electrode in gastric juice. Gastroenterologia 72(3-4): 201-215

Heller, W.M. 1969: PH of intravenous solutions. New England Journal of Medicine 280(16): 901

Kossler, A.W. 1969: PH of intravenous solutions. New England Journal of Medicine 280(16): 901

Kautz, H.; Parker, E.A. 1969: PH of intravenous solutions. New England Journal of Medicine 280(16): 901-902

Doemel, W.N.; Brock, T.D. 1971: PH of very acid soils. Nature 229(5286): 574

Zhang, J.; Liu, L.; Wang, L.; Zhu, W.; Wang, H. 2020: PH responsive zwitterionic-to-cationic transition for safe self-defensive antibacterial application. Journal of Materials Chemistry. B 8(38): 8908-8913

Swami, R.; Kumar, Y.; Chaudhari, D.; Katiyar, S.S.; Kuche, K.; Katare, P.B.; Banerjee, S.K.; Jain, S. 2021: PH sensitive liposomes assisted specific and improved breast cancer therapy using co-delivery of SIRT1 shRNA and Docetaxel. Materials Science and Engineering. C Materials for Biological Applications 120: 111664

Harrow, B.R. 1969: PH vs acid load. New England Journal of Medicine 280(26): 1481

Harris, R.J.; Richards, P.G.; Symon, L.; Habib, A.H.; Rosenstein, J. 1987: PH, K+, and PO2 of the extracellular space during ischaemia of primate cerebral cortex. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 7(5): 599-604

Bouwstra, J.A.; Gooris, G.S.; Dubbelaar, F.E.; Weerheim, A.M.; Ponec, M. 1998: PH, cholesterol sulfate, and fatty acids affect the stratum corneum lipid organization. Journal of Investigative Dermatology. Symposium Proceedings 3(2): 69-74

Coloma, I.; Cortijo, M.; Fernández-Sánchez, I.és.; Perles, J.; Priego, J.é L.; Gutiérrez, C.; Jiménez-Aparicio, R.; Desvoyes, B.én.éd.; Herrero, S. 2020: PH- and Time-Dependent Release of Phytohormones from Diruthenium Complexes. Inorganic Chemistry 59(11): 7779-7788

Ghosh, G.; Fernández, G. 2020: PH- and concentration-dependent supramolecular self-assembly of a naturally occurring octapeptide. Beilstein Journal of Organic Chemistry 16: 2017-2025

Nam, S.H.; Jang, J.; Cheon, D.H.; Chong, S.-E.; Ahn, J.H.; Hyun, S.; Yu, J.; Lee, Y. 2021: PH-Activatable cell penetrating peptide dimers for potent delivery of anticancer drug to triple-negative breast cancer. Journal of Controlled Release: Official Journal of the Controlled Release Society 330: 898-906

Kanagaraj, K.; Liang, W.; Rao, M.; Yao, J.; Wu, W.; Cheng, G.; Ji, J.; Wei, X.; Peng, C.; Yang, C. 2020: PH-Controlled Chirality Inversion in Enantiodifferentiating Photocyclodimerization of 2-Antharacenecarboxylic Acid Mediated by γ-Cyclodextrin Derivatives. Organic Letters 22(14): 5273-5278

Guo, Y.; Yao, D.; Zheng, B.; Sun, X.; Zhou, X.; Wei, B.; Xiao, S.; He, M.; Li, C.; Liang, H. 2020: PH-Controlled Detachable DNA Circuitry and its Application in Resettable Self-Assembly of Spherical Nucleic Acids. Acs Nano 14(7): 8317-8327

Nghiem, T.-L.; Chakroun, R.; Janoszka, N.; Chen, C.; Klein, K.; Wong, C.K.; Gröschel, A.é H. 2020: PH-Controlled Hierarchical Assembly/Disassembly of Multicompartment Micelles in Water. Macromolecular Rapid Communications 41(18): E2000301

Cai, B.; Li, S.; Jiang, W.; Zhou, Y. 2021: PH-Controlled Stereoregular Polymerization of Poly(methyl methacrylate) in Vesicle Membranes. Langmuir: the Acs Journal of Surfaces and Colloids 37(43): 12746-12752

Carvounis, C.P.; Levine, S.D.; Hays, R.M. 1979: PH-Dependence of water and solute transport in toad urinary bladder. Kidney International 15(5): 513-519

Valle-González, E.R.; Jackman, J.A.; Yoon, B.Kyeong.; Mokrzecka, N.; Cho, N-Joon. 2020: PH-Dependent Antibacterial Activity of Glycolic Acid: Implications for Anti-Acne Formulations. Scientific Reports 10(1): 7491

Sarkar, A.; Roitberg, A.E. 2020: PH-Dependent Conformational Changes Lead to a Highly Shifted pKa for a Buried Glutamic Acid Mutant of SNase. Journal of Physical Chemistry. B 124(49): 11072-11080

Gaza, J.T.; Leyson, J.J.C.; Peña, G.T.; Nellas, R.B. 2021: PH-Dependent Conformations of an Antimicrobial Spider Venom Peptide, Cupiennin 1a, from Unbiased HREMD Simulations. Acs Omega 6(37): 24166-24175

Park, M.; Lee, J.S.; Jung, W.H.; Lee, Y.W. 2020: PH-Dependent Expression, Stability, and Activity of Malassezia restricta MrLip5 Lipase. Annals of Dermatology 32(6): 473-480

Hsieh, T.-L.; Law, S.; Garoff, S.; Tilton, R.D. 2021: PH-Dependent Interfacial Tension and Dilatational Modulus Synergism of Oil-Soluble Fatty Acid and Water-Soluble Cationic Surfactants at the Oil/Water Interface. Langmuir: the Acs Journal of Surfaces and Colloids 37(39): 11573-11581

Pan, Z.-Z.; Govedarica, A.; Nishihara, H.; Tang, R.; Wang, C.; Luo, Y.; Lv, W.; Kang, F.-Y.; Trifkovic, M.; Yang, Q.-H. 2021: PH-Dependent Morphology Control of Cellulose Nanofiber/Graphene Oxide Cryogels. Small 17(3): E2005564

Liu, Y.-Y.; Hua, X.; Zhang, Z.; Zhang, J.; Zhang, S.; Hu, P.; Long, Y.-T. 2020: PH-Dependent Water Clusters in Photoacid Solution: Real-Time Observation by ToF-SIMS at a Submicropore Confined Liquid-Vacuum Interface. Frontiers in Chemistry 8: 731

De Almeida Barbosa, N.M.; Gosset, P.; Réal, E.éo.; Ledentu, V.; Didier, P.; Ferré, N. 2020: PH-Dependent absorption spectrum of oxyluciferin analogues in the active site of firefly luciferase. Physical Chemistry Chemical Physics: Pccp 22(38): 21731-21740

Wang, C.; Chen, L.; Lu, Y.; Liu, J.; Zhao, R.; Sun, Y.; Sun, B.; Cuina, W. 2021: PH-Dependent complexation between β-lactoglobulin and lycopene: Multi-spectroscopy, molecular docking and dynamic simulation study. Food Chemistry 362: 130230

Wang, J.; Zhang, X.; Li, H.; Wang, C.; Li, H.; Keller, S.; Mishra, U.K.; Nener, B.D.; Parish, G.; Atkin, R. 2021: PH-Dependent surface charge at the interfaces between aluminum gallium nitride (AlGaN) and aqueous solution revealed by surfactant adsorption. Journal of Colloid and Interface Science 583: 331-339

Reddy, A.; Bozi, L.H.M.; Yaghi, O.K.; Mills, E.L.; Xiao, H.; Nicholson, H.E.; Paschini, M.; Paulo, J.A.; Garrity, R.; Laznik-Bogoslavski, D.; Ferreira, J.C.B.; Carl, C.S.; Sjøberg, K.A.; Wojtaszewski, J.ør.F.P.; Jeppesen, J.F.; Kiens, B.; Gygi, S.P.; Richter, E.A.; Mathis, D.; Chouchani, E.T. 2020: PH-Gated Succinate Secretion Regulates Muscle Remodeling in Response to Exercise. Cell 183(1): 62-75.E17

Mahajan, S.; Singh, D.; Sharma, R.; Singh, G.; Bedi, N. 2021: PH-Independent Dissolution and Enhanced Oral Bioavailability of Aripiprazole-Loaded Solid Self-microemulsifying Drug Delivery System. Aaps Pharmscitech 22(1): 24

Zeng, H.; Zhang, G.; Ji, Q.; Liu, H.; Hua, X.; Xia, H.; Sillanpää, M.; Qu, J. 2020: PH-Independent Production of Hydroxyl Radical from Atomic H*-Mediated Electrocatalytic H2O2 Reduction: a Green Fenton Process without Byproducts. Environmental Science and Technology 54(22): 14725-14731

Hofer, F.; Kamenik, A.S.; Fernández-Quintero, M.L.; Kraml, J.; Liedl, K.R. 2020: PH-Induced Local Unfolding of the Phl p 6 Pollen Allergen from cpH-MD. Frontiers in Molecular Biosciences 7: 603644

Raoufi, N.; Kadkhodaee, R.; Fang, Y.; Phillips, G.O. 2020: PH-Induced structural transitions in whey protein isolate and ultrasonically solubilized Persian gum mixture. Ultrasonics Sonochemistry 68: 105190

Rath, M.; Weaver, J.; Wang, M.; Woehl, T. 2021: PH-Mediated Aggregation-to-Separation Transition for Colloids Near Electrodes in Oscillatory Electric Fields. Langmuir: the Acs Journal of Surfaces and Colloids 37(31): 9346-9355

Ai, Q.; Fu, Q.; Liang, F. 2020: PH-Mediated Single Molecule Conductance of Cucurbit[7]uril. Frontiers in Chemistry 8: 736

Wang, S. 2021: PH-Responsive Amphiphilic Carboxylate Polymers: Design and Potential for Endosomal Escape. Frontiers in Chemistry 9: 645297

Liang, J.; Liu, F.; Zou, J.; Xu, H.H.K.; Han, Q.; Wang, Z.; Li, B.; Yang, B.; Ren, B.; Li, M.; Peng, X.; Li, J.; Zhang, S.; Zhou, X.; Cheng, L. 2020: PH-Responsive Antibacterial Resin Adhesives for Secondary Caries Inhibition. Journal of Dental Research 99(12): 1368-1376

Yang, X.; Yu, T.; Zeng, Y.; Lian, K.; Zhou, X.; Ke, J.; Li, Y.; Yuan, H.; Hu, F. 2020: PH-Responsive Biomimetic Polymeric Micelles as Lymph Node-Targeting Vaccines for Enhanced Antitumor Immune Responses. Biomacromolecules 21(7): 2818-2828

Liu, Z.; Xie, Z.; Wu, X.; Chen, Z.; Li, W.; Jiang, X.; Cao, L.; Zhang, D.; Wang, Q.; Xue, P.; Zhang, H. 2021: PH-responsive black phosphorus quantum dots for tumor-targeted photodynamic therapy. Photodiagnosis and Photodynamic Therapy 35: 102429

Shimanovich, U.; Levin, A.; Eliaz, D.; Michaels, T.; Toprakcioglu, Z.; Frohm, B.; De Genst, E.; Linse, S.; Åkerfeldt, K.S.; Knowles, T.P.J. 2021: PH-Responsive Capsules with a Fibril Scaffold Shell Assembled from an Amyloidogenic Peptide. Small 17(26): E2007188

Gong, Y.; Mohd, S.; Wu, S.; Liu, S.; Pei, Y.; Luo, X. 2021: PH-Responsive Cellulose-Based Microspheres Designed as an Effective Oral Delivery System for Insulin. Acs Omega 6(4): 2734-2741

Zheng, L.L.; Li, J.Z.; Li, Y.X.; Gao, J.B.; Dong, J.X.; Gao, Z.F. 2021: PH-Responsive DNA Motif: from Rational Design to Analytical Applications. Frontiers in Chemistry 9: 732770

Zhang, C.-H.; Cai, K.; Zhang, P.-G.; Wu, Z.; Ma, M.; Chen, B. 2022: PH-Responsive DNA nanoassembly for detection and combined therapy of tumor. Biosensors and Bioelectronics 195: 113654

Cao, Z.; Li, W.; Liu, R.; Li, C.; Song, Y.; Liu, G.; Chen, Y.; Lu, C.; Lu, A.; Liu, Y. 2020: PH-Responsive Fluorescence Enhanced Nanogel for Targeted Delivery of AUR and CDDP Against Breast Cancer. International Journal of Nanomedicine 15: 8369-8382

Duan, Q.; Wang, F.; Zhang, H.; Lu, K. 2020: PH-Responsive Host-Guest Complexations Between a Water-Soluble Pillar[6]arene Dodecyl-Ammonium Chloride and Aromatic Sulfonic Acids. Frontiers in Chemistry 8: 588201

Makhathini, S.S.; Omolo, C.A.; Gannimani, R.; Mocktar, C.; Govender, T. 2020: PH-Responsive Micelles from an Oleic Acid Tail and Propionic Acid Heads Dendritic Amphiphile for the Delivery of Antibiotics. Journal of Pharmaceutical Sciences 109(8): 2594-2606

Mehmood, R.; Ariotti, N.; Yang, J.L.; Koshy, P.; Sorrell, C.C. 2018: PH-Responsive Morphology-Controlled Redox Behavior and Cellular Uptake of Nanoceria in Fibrosarcoma. Acs Biomaterials Science and Engineering 4(3): 1064-1072

Shahid, N.; Erum, A.; Zaman, M.; Tulain, U.R.; Shoaib, Q.-U.-A.; Majeed, A.; Rasool, M.F.; Imran, I.; Alshehri, S.; Noorani, B.; Alqahtani, F. 2021: PH-Responsive Nanocomposite Based Hydrogels for the Controlled Delivery of Ticagrelor; in Vitro and in Vivo Approaches. International Journal of Nanomedicine 16: 6345-6366

Xu, C.; Guan, X.; Lin, L.; Wang, Q.; Gao, B.; Zhang, S.; Li, Y.; Tian, H. 2018: PH-Responsive Natural Polymeric Gene Delivery Shielding System Based on Dynamic Covalent Chemistry. Acs Biomaterials Science and Engineering 4(1): 193-199

Wang, D.; Fan, Z.; Zhang, X.; Li, H.; Sun, Y.; Cao, M.; Wei, G.; Wang, J. 2021: PH-Responsive Self-Assemblies from the Designed Folic Acid-Modified Peptide Drug for Dual-Targeting Delivery. Langmuir: the Acs Journal of Surfaces and Colloids 37(1): 339-347

Ishizaki, Y.; Yamamoto, S.; Miyashita, T.; Mitsuishi, M. 2021: PH-Responsive Ultrathin Nanoporous SiO2 Films for Selective Ion Permeation. Langmuir: the Acs Journal of Surfaces and Colloids 37(18): 5627-5634

Kang, X.; Kang, W.; Yang, H.; Hou, X.; Zhu, T.; Wang, P.; Li, M.; Jiang, H.; Zhang, M. 2020: PH-Responsive aggregates transition from spherical micelles to WLMs induced by hydrotropes based on the dynamic imine bond. Soft Matter 16(42): 9705-9711

Freemont, T.J.; Saunders, B.R. 2008: PH-Responsive microgel dispersions for repairing damaged load-bearing soft tissue. Soft Matter 4(5): 919-924

Zhang, Z.; Wells, C.J.R.; King, A.M.; Bear, J.C.; Davies, G.-L.; Williams, G.R. 2020: PH-Responsive nanocomposite fibres allowing MRi monitoring of drug release. Journal of Materials Chemistry. B 8(32): 7264-7274

Dai, S.; Ravi, P.; Tam, K.C. 2008: PH-Responsive polymers: synthesis, properties and applications. Soft Matter 4(3): 435-449

Burns, K.E.; McCleerey, T.P.; Thévenin, D. 2016: PH-Selective Cytotoxicity of pHLIP-Antimicrobial Peptide Conjugates. Scientific Reports 6: 28465

Kim, D.H.; Seo, J.; Na, K. 2020: PH-Sensitive Carbon Dots for Enhancing Photomediated Antitumor Immunity. Molecular Pharmaceutics 17(7): 2532-2545

Lee, N.-K.; Park, S.S.; Ha, C.-S. 2020: PH-Sensitive Drug Delivery System Based on Mesoporous Silica Modified with Poly-L-Lysine (PLL) as a Gatekeeper. Journal of Nanoscience and Nanotechnology 20(11): 6925-6934

Yang, Q.; Dong, Y.; Wang, X.; Lin, Z.; Yan, M.; Wang, W.; Dong, A.; Zhang, J.; Huang, P.; Wang, C. 2021: PH-Sensitive Polycations for siRNA Delivery: Effect of Asymmetric Structures of Tertiary Amine Groups. Macromolecular Bioscience 21(5): E2100025

Liu, P.; Xu, G.; Pranantyo, D.; Xu, L.Q.; Neoh, K.-G.; Kang, E.-T. 2018: PH-Sensitive Zwitterionic Polymer as an Antimicrobial Agent with Effective Bacterial Targeting. Acs Biomaterials Science and Engineering 4(1): 40-46

Skvortsov, I.A.; Zimcik, P.; Stuzhin, P.A.; Novakova, V. 2020: PH-Sensitive subphthalocyanines and subazaphthalocyanines. Dalton Transactions 49(32): 11090-11098

Jin, J.; Dai, S.; Li, X.; Liu, Y.; Lu, H. 2021: PH-Switchable Latexes Based on the Nonionic Amphiphilic Diblock Copolymer with a Chargeable End-Group on the Core-Forming Block. Langmuir: the Acs Journal of Surfaces and Colloids 37(20): 6123-6131

Karaky, K.; Brochon, C.; Schlatter, G.; Hadziioannou, G. 2008: PH-Switchable supramolecular "sliding" gels based on polyrotaxanes of polyethyleneimine-block-poly(ethylene oxide)-block-polyethyleneimine block copolymer and : synthesis and swelling behaviour. Soft Matter 4(6): 1165-1168

Zhuang, J.; Wright Carlsen, R.; Sitti, M. 2015: PH-Taxis of Biohybrid Microsystems. Scientific Reports 5: 11403

Scalzone, A.; Bonifacio, M.A.; Cometa, S.; Cucinotta, F.; De Giglio, E.; Ferreira, A.M.; Gentile, P. 2020: PH-Triggered Adhesiveness and Cohesiveness of Chondroitin Sulfate-Catechol Biopolymer for Biomedical Applications. Frontiers in Bioengineering and Biotechnology 8: 712

Wei, H.; Vikesland, P.J. 2015: PH-Triggered Molecular Alignment for Reproducible SERS Detection via an AuNP/Nanocellulose Platform. Scientific Reports 5: 18131

Ress, J.; Martin, U.; Bosch, J.; Bastidas, D.M. 2020: PH-Triggered Release of NaNO2 Corrosion Inhibitors from Novel Colophony Microcapsules in Simulated Concrete Pore Solution. Acs Applied Materials and Interfaces 12(41): 46686-46700

Hata, Y.; Kojima, T.; Maeda, T.; Sawada, T.; Serizawa, T. 2020: PH-Triggered Self-Assembly of Cellulose Oligomers with Gelatin into a Double-Network Hydrogel. Macromolecular Bioscience 20(9): E2000187

Park, D.; Cheng, J.; Park, J.B.; Shin, S.; Lee, S.-H.; Hong, B.H.; Kim, S.H.; Hyun, J.; Yang, C. 2019: PH-Triggered Silk Fibroin/Alginate Structures Fabricated in Aqueous Two-Phase System. Acs Biomaterials Science and Engineering 5(11): 5897-5905

Huang, L.; Jiang, S.; Cai, B.; Wang, G.; Wang, Z.; Wang, L. 2021: PH-Triggered nanoreactors as oxidative stress amplifiers for combating multidrug-resistant biofilms. Chemical Communications 57(38): 4662-4665

Elsner, N.; Kozlovskaya, V.; Sukhishvili, S.A.; Fery, A. 2006: PH-Triggered softening of crosslinked hydrogen-bonded capsules. Soft Matter 2(11): 966-972

Bossard, F.éd.ér.; Aubry, T.; Gotzamanis, G.; Tsitsilianis, C. 2006: PH-Tunable rheological properties of a telechelic cationic polyelectrolyte reversible hydrogel. Soft Matter 2(6): 510-516

Wang, H.; Shi, W.; Zeng, D.; Huang, Q.; Xie, J.; Wen, H.; Li, J.; Yu, X.; Qin, L.; Zhou, Y. 2021: PH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer. Journal of Nanobiotechnology 19(1): 152

Shi, W.; Fang, W.-X.; Wang, J.-C.; Qiao, X.; Wang, B.; Guo, X. 2021: PH-controlled mechanism of photocatalytic RhB degradation over g-C3N4 under sunlight irradiation. Photochemical and Photobiological Sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology 20(2): 303-313

Sathiyaseelan, A.; Saravanakumar, K.; Mariadoss, A.V.A.; Wang, M.-H. 2021: PH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment. Carbohydrate Polymers 262: 117907

Tseng, W-Hsuan.; Chen, S-Hua.; Hiramatsu, H. 2020: PH-controlled stacking direction of the β-strands in peptide fibrils. Scientific Reports 10(1): 22199

Ishak, S.; Mandal, S.; Lee, H-Seung.; Singh, J.Kumar. 2021: PH-controlled synthesis of sustainable lauric acid/SiO 2 phase change material for scalable thermal energy storage. Scientific Reports 11(1): 15012

Einholz, C.; Nohr, D.; Rodriguez, R.; Topitsch, A.; Kern, M.; Goldmann, J.; Chileshe, E.; Okasha, M.; Weber, S.; Schleicher, E. 2021: PH-dependence of signaling-state formation in Drosophila cryptochrome. Archives of Biochemistry and Biophysics 700: 108787

Zhang, X.; Liu, X.; Su, G.; Li, M.; Liu, J.; Wang, C.; Xu, D. 2021: PH-dependent and dynamic interactions of cystatin C with heparan sulfate. Communications Biology 4(1): 198

Guo, J.; Li, Y.; Sun, J.; Sun, R.; Zhou, S.; Duan, J.; Feng, W.; Liu, G.; Jiang, F. 2021: PH-dependent biological sulfidogenic processes for metal-laden wastewater treatment: Sulfate reduction or sulfur reduction?. Water Research 204: 117628

Hughes, N.R. 1973: PH-dependent changes in composition of carcinoembryonic antigen. Nature 243(5409): 523-526

Piszkiewicz, D. 1974: PH-dependent conformational change of gastrin. Nature 248(446): 341-342

Laptenko, O.; Kim, S-Sup.; Lee, J.; Starodubtseva, M.; Cava, F.; Berenguer, J.; Kong, X-Peng.; Borukhov, S. 2006: PH-dependent conformational switch activates the inhibitor of transcription elongation. EMBO Journal 25(10): 2131-2141

Darussalam, E.Y.; Peterfi, O.; Deckert-Gaudig, T.; Roussille, L.; Deckert, V. 2021: PH-dependent disintegration of insulin amyloid fibrils monitored with atomic force microscopy and surface-enhanced Raman spectroscopy. Spectrochimica Acta. Part a Molecular and Biomolecular Spectroscopy 256: 119672

Zhang, L.; Wu, F.; Lee, S.C.; Zhao, H.; Zhang, L. 2014: PH-dependent drug-drug interactions for weak base drugs: potential implications for new drug development. Clinical Pharmacology and Therapeutics 96(2): 266-277

Broesder, A.; Woerdenbag, H.J.; Prins, G.H.; Nguyen, D.N.; Frijlink, H.W.; Hinrichs, W.L.J. 2020: PH-dependent ileocolonic drug delivery, part I: in vitro and clinical evaluation of novel systems. Drug Discovery Today 25(8): 1362-1373

Broesder, A.; Kosta, A.-M.M.A.C.; Woerdenbag, H.J.; Nguyen, D.N.; Frijlink, H.W.; Hinrichs, W.L.J. 2020: PH-dependent ileocolonic drug delivery, part II: preclinical evaluation of novel drugs and novel excipients. Drug Discovery Today 25(8): 1374-1388

Lim, D.G.; Kang, E.; Jeong, S.H. 2020: PH-dependent nanodiamonds enhance the mechanical properties of 3D-printed hyaluronic acid nanocomposite hydrogels. Journal of Nanobiotechnology 18(1): 88

Yamashiro, T.; Yasujima, T.; Said, H.M.; Yuasa, H. 2020: PH-dependent pyridoxine transport by SLC19A2 and SLC19A3: Implications for absorption in acidic microclimates. Journal of Biological Chemistry 295(50): 16998-17008

England, C.J.; Gray, T.C.; Malla, S.R.L.; Oliveira, S.A.; Martin, B.R.; Beall, G.W.; Lewis, L.K. 2021: PH-dependent sedimentation of DNA in the presence of divalent, but not monovalent, metal ions. Analytical Biochemistry 616: 114099

Wang, J.; Wang, J.; Ning, X.; Liu, J.; Xia, H.; Wan, G.; Bai, Q. 2021: PH-dependent selective separation of acidic and basic proteins using quaternary ammoniation functionalized cysteine-zwitterionic stationary phase with RPLC/IEC mixed-mode chromatography. Talanta 225: 122084

Deissler, H.; Krammer, H.; Gillessen, A. 2021: PH-dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: do drug delivery concepts determine therapeutic efficacy? (Review). Biomedical Reports 15(5): 96

Cristofari, C.; Rigo, R.; Greco, M.Laura.; Ghezzo, M.; Sissi, C. 2019: PH-driven conformational switch between non-canonical DNA structures in a C-rich domain of EGFR promoter. Scientific Reports 9(1): 1210

Wang, L.; Guo, C.; Chen, F.; Ning, J.; Zhong, Y.; Hu, Y. 2021: PH-induced hydrothermal synthesis of Bi2WO6 nanoplates with controlled crystal facets for switching bifunctional photocatalytic water oxidation/reduction activity. Journal of Colloid and Interface Science 602: 868-879

Roshal, D.; Konevtsova, O.; Lošdorfer Božič, A.; Podgornik, R.; Rochal, S. 2019: PH-induced morphological changes of proteinaceous viral shells. Scientific Reports 9(1): 5341

Vinothkumar, K.R.; Smits, S.H.J.; Kühlbrandt, W. 2005: PH-induced structural change in a sodium/proton antiporter from Methanococcus jannaschii. EMBO Journal 24(15): 2720-2729

Qu, F.; Chen, Y.; Jiang, D.; Zhao, X.-E. 2021: PH-modulated aggregation-induced emission of Au/Cu nanoclusters and its application to the determination of urea and dissolved ammonia. Mikrochimica Acta 188(4): 113

Li, C.; Roy, J.K.; Park, K.-C.; Cho, A.E.; Lee, J.; Kim, Y.-W. 2021: PH-promoted O-α-glucosylation of flavonoids using an engineered α-glucosidase mutant. Bioorganic Chemistry 107: 104581

Gunathilake, R.; Schurer, N.Y.; Shoo, B.A.; Celli, A.; Hachem, J-Pierre.; Crumrine, D.; Sirimanna, G.; Feingold, K.R.; Mauro, T.M.; Elias, P.M. 2009: PH-regulated mechanisms account for pigment-type differences in epidermal barrier function. Journal of Investigative Dermatology 129(7): 1719-1729

Yang, L.; Huang, J.; Cao, L.; Shi, L.; Yu, Q.; Kong, X.; Jie, Y. 2016: PH-regulated template-free assembly of Sb4O5Cl2 hollow microsphere crystallites with self-narrowed bandgap and optimized photocatalytic performance. Scientific Reports 6: 27765

Zhong, Y.; Zou, Y.; Liu, L.; Li, R.; Xue, F.; Yi, T. 2020: PH-responsive Ag2S nanodots loaded with heat shock protein 70 inhibitor for photoacoustic imaging-guided photothermal cancer therapy. Acta Biomaterialia 115: 358-370

Li, Y.; Yue, S.; Cao, J.; Zhu, C.; Wang, Y.; Hai, X.; Song, W.; Bi, S. 2020: PH-responsive DNA nanomicelles for chemo-gene synergetic therapy of anaplastic large cell lymphoma. Theranostics 10(18): 8250-8263

Wang, L.; Wei, P.; Stumpf, S.; Schubert, U.S.; Hoeppener, S. 2020: PH-responsive SERS substrates based on AgNP-polyMETAC composites on patterned self-assembled monolayers. Nanotechnology 31(46): 465604

Emami, E.; Mousazadeh, M.H. 2021: PH-responsive zwitterionic carbon dots for detection of rituximab antibody. Luminescence: the Journal of Biological and Chemical Luminescence 36(5): 1198-1208

Gontsarik, M.; Mansour, A.B.; Hong, L.; Guizar-Sicairos, M.; Salentinig, S. 2021: PH-responsive aminolipid nanocarriers for antimicrobial peptide delivery. Journal of Colloid and Interface Science 603: 398-407

Dong, J.; Yu, Y.; Pei, Y.; Pei, Z. 2022: PH-responsive aminotriazole doped metal organic frameworks nanoplatform enables self-boosting reactive oxygen species generation through regulating the activity of catalase for targeted chemo/chemodynamic combination therapy. Journal of Colloid and Interface Science 607(Part 2): 1651-1660

Xiong, F.; Qin, Z.; Chen, H.; Lan, Q.; Wang, Z.; Lan, N.; Yang, Y.; Zheng, L.; Zhao, J.; Kai, D. 2020: PH-responsive and hyaluronic acid-functionalized metal-organic frameworks for therapy of osteoarthritis. Journal of Nanobiotechnology 18(1): 139

Klaus, T.; Deshmukh, S. 2021: PH-responsive antibodies for therapeutic applications. Journal of Biomedical Science 28(1): 11

Song, S.; Zhao, Y.; Li, Y.; Yang, X.; Wang, D.; Wen, Z.; Yang, M.; Lin, Q. 2021: PH-responsive copper-cluster-based dual-emission ratiometric fluorescent probe for imaging of bacterial metabolism. Talanta 221: 121621

Xie, Y.; Xu, Y.; Xu, J. 2021: PH-responsive pickering foam created from self-aggregate polymer using dynamic covalent bond. Journal of Colloid and Interface Science 597: 383-392

Hsu, C.-W.; Hsieh, M.-H.; Xiao, M.-C.; Chou, Y.-H.; Wang, T.-H.; Chiang, W.-H. 2020: PH-responsive polymeric micelles self-assembled from benzoic-imine-containing alkyl-modified PEGylated chitosan for delivery of amphiphilic drugs. International Journal of Biological Macromolecules 163: 1106-1116

Albuquerque, L.J.C.; Sincari, V.; Jäger, A.; Kucka, J.; Humajova, J.; Pankrac, J.; Paral, P.; Heizer, T.; Janouškova, O.; Davidovich, I.; Talmon, Y.; Pouckova, P.; Štěpánek, P.; Sefc, L.; Hruby, M.; Giacomelli, F.C.; Jäger, E.éz. 2021: PH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects. Journal of Controlled Release: Official Journal of the Controlled Release Society 332: 529-538

Yan, J.; Xia, D.; Zhou, W.; Li, Y.; Xiong, P.; Li, Q.; Wang, P.; Li, M.; Zheng, Y.; Cheng, Y. 2020: PH-responsive silk fibroin-based CuO/Ag micro/nano coating endows polyetheretherketone with synergistic antibacterial ability, osteogenesis, and angiogenesis. Acta Biomaterialia 115: 220-234

Watanabe, K.; Sakata, A.; Saijo, Y.; Baba, T. 2020: PH-sensitive GaInAsP photonic crystal fractal band-edge laser. Optics Letters 45(22): 6202-6205

Boron, W.F.; Hogan, E.; Russell, J.M. 1988: PH-sensitive activation of the intracellular-pH regulation system in squid axons by ATP-gamma-S. Nature 332(6161): 262-265

Wang, X.; Zheng, Y.; Xue, Y.; Wu, Y.; Liu, Y.; Cheng, X.; Tang, R. 2021: PH-sensitive and tumor-targeting nanogels based on ortho ester-modified PEG for improving the in vivo anti-tumor efficiency of doxorubicin. Colloids and Surfaces. B Biointerfaces 207: 112024

Altman, A.; Kong, K-Fai. 2019: PH-sensitive anti-CTLA4 antibodies: yes to efficacy, no to toxicity. Cell Research 29(8): 601-602

Fukuda, Y.; Honda, Y. 1975: PH-sensitive cells at ventro--lateral surface of rat medulla oblongata. Nature 256(5515): 317-318

Rashidzadeh, H.; Rezaei, S.Jamal.Tabatabaei.; Zamani, S.; Sarijloo, E.; Ramazani, A. 2020: PH-sensitive curcumin conjugated micelles for tumor triggered drug delivery. Journal of Biomaterials Science. Polymer Edition 2020: 1-17

Xu, J.; Fang, Q.; Yang, L.; Gao, J.; Xue, Y.; Wang, X.; Tang, R. 2020: PH-sensitive deoxycholic acid dimer for improving doxorubicin delivery and antitumor activity in vivso. Colloids and Surfaces. B Biointerfaces 196: 111319

Sheng, Y.; Dai, W.; Gao, J.; Li, H.; Tan, W.; Wang, J.; Deng, L.; Kong, Y. 2020: PH-sensitive drug delivery based on chitosan wrapped graphene quantum dots with enhanced fluorescent stability. Materials Science and Engineering. C Materials for Biological Applications 112: 110888

Hong, W.; Shi, H.; Qiao, M.; Zhang, Z.; Yang, W.; Dong, L.; Xie, F.; Zhao, C.; Kang, L. 2017: PH-sensitive micelles for the intracellular co-delivery of curcumin and Pluronic L61 unimers for synergistic reversal effect of multidrug resistance. Scientific Reports 7: 42465

Xu, Y.; Wang, S.; Yang, L.; Dong, Y.; Zhang, Y.; Yan, G.; Tang, R. 2021: PH-sensitive micelles self-assembled from star-shaped TPGS copolymers with ortho ester linkages for enhanced MDR reversal and chemotherapy. Asian Journal of Pharmaceutical Sciences 16(3): 363-373

Park, Y.I.; Kwon, S.-H.; Lee, G.; Motoyama, K.; Kim, M.W.; Lin, M.; Niidome, T.; Choi, J.H.; Lee, R. 2021: PH-sensitive multi-drug liposomes targeting folate receptor β for efficient treatment of non-small cell lung cancer. Journal of Controlled Release: Official Journal of the Controlled Release Society 330: 1-14

Budker, V.; Gurevich, V.; Hagstrom, J.E.; Bortzov, F.; Wolff, J.A. 1996: PH-sensitive, cationic liposomes: a new synthetic virus-like vector. Nature Biotechnology 14(6): 760-764

Wang, Y.; Zhang, L.; Wang, P.; Xu, X.; Zhou, G. 2020: PH-shifting encapsulation of curcumin in egg white protein isolate for improved dispersity, antioxidant capacity and thermal stability. Food Research International 137: 109366

Jiang, W.; Strohman, M.J.; Somasundaram, S.; Ayyangar, S.; Hou, T.; Wang, N.; Mellins, E.D. 2015: PH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity. Scientific Reports 5: 17333

Laquerbe, S.; Carvalho, A.; Schmutz, M.; Poirier, A.; Baccile, N.; Ben Messaoud, G. 2021: PH-switchable pickering emulsions stabilized by polyelectrolyte-biosurfactant complex coacervate colloids. Journal of Colloid and Interface Science 600: 23-36

Zohreh, N.; Rastegaran, Z.; Hosseini, S.H.; Akhlaghi, M.; Istrate, C.; Busuioc, C. 2021: PH-triggered intracellular release of doxorubicin by a poly(glycidyl methacrylate)-based double-shell magnetic nanocarrier. Materials Science and Engineering. C Materials for Biological Applications 118: 111498

Wang, Z.; Yao, J.; Guan, Z.; Wu, H.; Cheng, H.; Yan, G.; Tang, R. 2021: PH-triggered small molecule nano-prodrugs emulsified from tryptamine-cinnamaldehyde twin drug for targeted synergistic glioma therapy. Colloids and Surfaces. B Biointerfaces 207: 112052

GhavamiNejad, A.; SamariKhalaj, M.; Aguilar, L.Erik.; Park, C.Hee.; Kim, C.Sang. 2016: PH/NIR Light-Controlled Multidrug Release via a Mussel-Inspired Nanocomposite Hydrogel for Chemo-Photothermal Cancer Therapy. Scientific Reports 6: 33594

Gu, R.; Wang, L.; Huang, X.; Zhang, J.; Ou, C.; Si, W.; Yu, J.; Wang, W.; Dong, X. 2020: PH/glutathione-responsive release of SO2 induced superoxide radical accumulation for gas therapy of cancer. Chemical Communications 56(94): 14865-14868

Makarasara, W.; Kumasaka, N.; Assawamakin, A.; Takahashi, A.; Intarapanich, A.; Ngamphiw, C.; Kulawonganunchai, S.; Ruangrit, U.; Fucharoen, S.; Kamatani, N.; Tongsima, S. 2009: PHCR: a parallel haplotype configuration reduction algorithm for haplotype interaction analysis. Journal of Human Genetics 54(11): 634-641

Brunner, A.; Riss, P.; Heinze, G.; Brustmann, H. 2012: PHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant. British Journal of Cancer 107(1): 84-90

Webb, B.A.; Aloisio, F.M.; Charafeddine, R.A.; Cook, J.; Wittmann, T.; Barber, D.L. 2021: PHLARE: a new biosensor reveals decreased lysosome pH in cancer cells. Molecular Biology of the Cell 32(2): 131-142

Crawford, T.; Moshnikova, A.; Roles, S.; Weerakkody, D.; DuPont, M.; Carter, L.M.; Shen, J.; Engelman, D.M.; Lewis, J.S.; Andreev, O.A.; Reshetnyak, Y.K. 2020: PHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery. Scientific Reports 10(1): 18356

Li, Y.; Tsien, R.W. 2012: PHTomato, a red, genetically encoded indicator that enables multiplex interrogation of synaptic activity. Nature Neuroscience 15(7): 1047-1053

Liu, A.; Huang, X.; He, W.; Xue, F.; Yang, Y.; Liu, J.; Chen, L.; Yuan, L.; Xu, P. 2021: PHmScarlet is a pH-sensitive red fluorescent protein to monitor exocytosis docking and fusion steps. Nature Communications 12(1): 1413

Oliveira, N.F.B.; Silva, T.ás.F.D.; Reis, P.B.P.S.; Machuqueiro, M. 2021: PK a Calculations in Membrane Proteins from Molecular Dynamics Simulations. Methods in Molecular Biology 2315: 185-195

Del Vecchio, G.; Labuz, D.; Temp, J.; Seitz, V.; Kloner, M.; Negrete, R.; Rodriguez-Gaztelumendi, A.; Weber, M.; Machelska, H.; Stein, C. 2019: PK a of opioid ligands as a discriminating factor for side effects. Scientific Reports 9(1): 19344

Hopmann, R.F.; Brugnoni, G.P. 1973: PK of thiamine C(2)H. Nature: new Biology 246(153): 157-158

Pereira, R.W.; Ramabhadran, R.O. 2020: PK-Yay: a Black-Box Method Using Density Functional Theory and Implicit Solvation Models to Compute Aqueous pKa Values of Weak and Strong Acids. Journal of Physical Chemistry. a 124(43): 9061-9074

Lin, C-Hsin.; Chiu, C-Chiang.; Huang, C-Hsien.; Yang, H-Ting.; Lane, H-Yuan. 2019: PLG72 levels increase in early phase of Alzheimer's disease but decrease in late phase. Scientific Reports 9(1): 13221

O'Shea, J.P.; Chou, M.F.; Quader, S.A.; Ryan, J.K.; Church, G.M.; Schwartz, D. 2013: PLogo: a probabilistic approach to visualizing sequence motifs. Nature Methods 10(12): 1211-1212

Bruno, C.A.; O'Brien, C.; Bryant, S.; Mejaes, J.I.; Estrin, D.J.; Pizzano, C.; Barker, D.J. 2021: PMAT: An open-source software suite for the analysis of fiber photometry data. Pharmacology Biochemistry and Behavior 201: 173093

Li, J.; Song, J.; Kang, L.; Huang, L.; Zhou, S.; Hu, L.; Zheng, J.; Li, C.; Zhang, X.; He, X.; Zhao, D.; Bu, Z.; Weng, C. 2021: PMGF505-7R determines pathogenicity of African swine fever virus infection by inhibiting IL-1β and type i IFN production. Plos Pathogens 17(7): E1009733

Mombeni, M.; Arjmand, S.; Siadat, S.O.R.; Alizadeh, H.; Abbasi, A. 2020: PMOX: a new powerful promoter for recombinant protein production in yeast Pichia pastoris. Enzyme and Microbial Technology 139: 109582

Adema, G.J.; Bakker, A.B.; de Boer, A.J.; Hohenstein, P.; Figdor, C.G. 1996: PMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL. British Journal of Cancer 73(9): 1044-1048

Yang, H.; Al-Hurani, M.F.; Xu, J.; Fan, L.; Schmid, R.A.; Zhao, H.; Yao, F. 2021: PN1 but not pN0/N2 predicts survival benefits of prophylactic cranial irradiation in small-cell lung cancer patients after surgery. Annals of Translational Medicine 9(7): 562

Wang, F.; Qiao, H-Huan.; Xu, R-Gang.; Sun, J.; Zhu, R.; Mao, D.; Ni, J-Quan. 2019: PNP Transgenic RNAi System Manual in Drosophila. Bio-Protocol 9(3):E3158

Comline, R.S.; Silver, M. 1968: PO2 levels in the placental circulation of the mare and ewe. Nature 217(5123): 76-77

Edge, N.D. 1967: PPy: a measure of potentiating activity. Nature 216(5119): 1014-1015

Ning, Q.; Deng, A.; Zou, T.; Zhao, X. 2021: PQLyCar: Peptide-based dynamic query-driven sample rescaling strategy for identifying carboxylation sites combined with KNN and SVM. Analytical Biochemistry 633: 114386

Jones, G.N.; Rooney, C.; Griffin, N.; Roudier, M.; Young, L.A.; Garcia-Trinidad, A.; Hughes, G.D.; Whiteaker, J.R.; Wilson, Z.; Odedra, R.; Zhao, L.; Ivey, R.G.; Howat, W.J.; Harrington, E.A.; Barrett, J.Carl.; Ramos-Montoya, A.; Lau, A.; Paulovich, A.G.; Cadogan, E.B.; Pierce, A.J. 2018: PRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry. British Journal of Cancer 119(10): 1233-1243

Jiang, H.; Karnezis, A.N.; Tao, M.; Guida, P.M.; Zhu, L. 2000: PRB and p107 have distinct effects when expressed in pRB-deficient tumor cells at physiologically relevant levels. Oncogene 19(34): 3878-3887

Zhu, X.; Pattenden, S.; Bremner, R. 1999: PRB is required for interferon-gamma-induction of the MHC class II abeta gene. Oncogene 18(35): 4940-4947

Chew, Y.P.; Ellis, M.; Wilkie, S.; Mittnacht, S. 1998: PRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F. Oncogene 17(17): 2177-2186

Russo, G.; Claudio, P.Paolo.; Fu, Y.; Stiegler, P.; Yu, Z.; Macaluso, M.; Giordano, A. 2003: PRB2/p130 target genes in non-small lung cancer cells identified by microarray analysis. Oncogene 22(44): 6959-6969

Lloyd, T.E.; Bellen, H.J. 2001: PRIMing synaptic vesicles for fusion. Nature Neuroscience 4(10): 965-966

Panigone, S.; Debernardi, S.; Taya, Y.; Fontanella, E.; Airoldi, R.; Delia, D. 2000: PRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide. Oncogene 19(35): 4035-4041

Rampalli, A.M.; Gao, C.Y.; Chauthaiwale, V.M.; Zelenka, P.S. 1998: PRb and p107 regulate E2F activity during lens fiber cell differentiation. Oncogene 16(3): 399-408

Kasten, M.M.; Giordano, A. 1998: PRb and the cdks in apoptosis and the cell cycle. Cell Death and Differentiation 5(2): 132-140

Lu, Z.; Marcelin, G.; Bauzon, F.; Wang, H.; Fu, H.; Dun, S.Le.; Zhao, H.; Li, X.; Jo, Y-Hwan.; Wardlaw, S.; Dun, N.; Chua, S.; Zhu, L. 2013: PRb is an obesity suppressor in hypothalamus and high-fat diet inhibits pRb in this location. EMBO Journal 32(6): 844-857

Bertin-Ciftci, J.; Barré, B.; Le Pen, J.; Maillet, L.; Couriaud, C.; Juin, P.; Braun, F. 2013: PRb/E2F-1-mediated caspase-dependent induction of Noxa amplifies the apoptotic effects of the Bcl-2/Bcl-xL inhibitor ABT-737. Cell Death and Differentiation 20(5): 755-764

Pucci, B.; Claudio, P.Paolo.; Masciullo, V.; Bellincampi, L.; Terrinoni, A.; Khalili, K.; Melino, G.; Giordano, A. 2002: PRb2/p130 promotes radiation-induced cell death in the glioblastoma cell line HJC12 by p73 upregulation and Bcl-2 downregulation. Oncogene 21(38): 5897-5905

Macaluso, M.; Cinti, C.; Russo, G.; Russo, A.; Giordano, A. 2003: PRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer. Oncogene 22(23): 3511-3517

De Falco, G.; Giordano, A. 2006: PRb2/p130: a new candidate for retinoblastoma tumor formation. Oncogene 25(38): 5333-5340

De Falco, G.; Comes, F.; Simone, C. 2006: PRb: master of differentiation. Coupling irreversible cell cycle withdrawal with induction of muscle-specific transcription. Oncogene 25(38): 5244-5249

Spyratos, F.; Andrieu, C.; Hacène, K.; Chambon, P.; Rio, M.C. 1994: PS2 and response to adjuvant hormone therapy in primary breast cancer. British Journal of Cancer 69(2): 394-397

Thompson, A.M.; Hawkins, R.A.; Elton, R.A.; Steel, C.M.; Chetty, U.; Carter, D.C. 1993: PS2 is an independent factor of good prognosis in primary breast cancer. British Journal of Cancer 68(1): 93-96

Soubeyran, I.; Quénel, N.; Coindre, J.M.; Bonichon, F.; Durand, M.; Wafflart, J.; Mauriac, L. 1996: PS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients. British Journal of Cancer 74(7): 1120-1125

Xu, X.; Ng, B.; Sim, B.; Radulescu, C.I.; Yusof, N.Amirah.Binte.Mohammad.; Goh, W.Ing.; Lin, S.; Lim, J.Soon.Yew.; Cha, Y.; Kusko, R.; Kay, C.; Ratovitski, T.; Ross, C.; Hayden, M.R.; Wright, G.; Pouladi, M.A. 2020: PS421 huntingtin modulates mitochondrial phenotypes and confers neuroprotection in an HD hiPSC model. Cell Death and Disease 11(9): 809

An, J.; Ponthier, C.M.; Sack, R.; Seebacher, J.; Stadler, M.B.; Donovan, K.A.; Fischer, E.S. 2017: PSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4 CRBN ubiquitin ligase. Nature Communications 8: 15398

Woo, C.G.; Son, S.-M.; Lim, Y.H.; Lee, D.; Park, J.-J.; Kim, E.-G.; Shin, E.-Y.; Lee, O.-J. 2022: PSlugS158 immunohistochemistry is a novel promising mitotic marker for FFPE samples: a pilot study. Virchows Archiv: An International Journal of Pathology 480(2): 449-457

Langner, C.; Hutterer, G.; Chromecki, T.; Winkelmayer, I.; Rehak, P.; Zigeuner, R. 2006: PT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 19(2): 272-279

Sano, T.; Kato, M.; Sassa, N.; Sadachi, R.; Hirakawa, A.; Kamihira, O.; Hirabayashi, T.; Nishikimi, T.; Katsuno, S.; Kimura, T.; Hattori, R.; Gotoh, M.; Tsuzuki, T. 2021: PT3 subclassification of renal pelvic cancer considering the tumor location improves the patients' prognostic accuracy. Virchows Archiv: An International Journal of Pathology 478(6): 1089-1097

Naskar, S.; Wan, H.; Kemenes, Görgy. 2014: PT305-CaMKII stabilizes a learning-induced increase in AMPA receptors for ongoing memory consolidation after classical conditioning. Nature Communications 5: 3967

Bolla, M.; Collette, L. 2009: PT3N0M0 prostate cancer: a plea for adjuvant radiation. Nature Reviews. Urology 6(8): 410-412

Benedyk, T.H.; Muenzner, J.; Connor, V.; Han, Y.; Brown, K.; Wijesinghe, K.J.; Zhuang, Y.; Colaco, S.; Stoll, G.A.; Tutt, O.S.; Svobodova, S.; Svergun, D.I.; Bryant, N.A.; Deane, J.E.; Firth, A.E.; Jeffries, C.M.; Crump, C.M.; Graham, S.C. 2021: PUL21 is a viral phosphatase adaptor that promotes herpes simplex virus replication and spread. Plos Pathogens 17(8): E1009824

Muradov, J.H.; Finnen, R.ée.L.; Gulak, M.A.; Hay, T.J.M.; Banfield, B.W. 2021: PUL21 regulation of pUs3 kinase activity influences the nature of nuclear envelope deformation by the HSV-2 nuclear egress complex. Plos Pathogens 17(8): E1009679

Patel, S.; Guerenne, L.; Gorombei, P.; Omidvar, N.; Schlageter, M-H.; Alex, A.A.; Ganesan, S.; West, R.; Adès, L.; Mathews, V.; Krief, P.; Pla, M.; Fenaux, P.; Chomienne, C.; Padua, R.A. 2015: PVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice. Blood Cancer Journal 5: E374

Thoma, C.R.; Frew, I.J.; Hoerner, C.R.; Montani, M.; Moch, H.; Krek, W. 2007: PVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nature Cell Biology 9(5): 588-595

Frew, I.J.; Thoma, C.R.; Georgiev, S.; Minola, A.; Hitz, M.; Montani, M.; Moch, H.; Krek, W. 2008: PVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation. EMBO Journal 27(12): 1747-1757

Hu, L.; Wu, H.; Jiang, T.; Kuang, M.; Liu, B.; Guo, X.; He, D.; Chen, M.; Gu, J.; Gu, J.; Chang, L.; Feng, M.; Ruan, Y. 2021: PVHL promotes lysosomal degradation of YAP in lung adenocarcinoma. Cellular Signalling 83: 110002

Sevilla-Montero, J.; Bienes-Martínez, R.; Labrousse-Arias, D.; Fuertes-Yebra, E.; Ordóñez, Ángel.; Calzada, Mía.J. 2020: PVHL-mediated regulation of the anti-angiogenic protein thrombospondin-1 decreases migration of Clear Cell Renal Carcinoma Cell Lines. Scientific Reports 10(1): 1175

Roa, I.ñi.; Torralba, A.; Díaz de Lezcano, I.; Martínez-Moneo, E. 2022: Paediatric gastrointestinal stromal tumour: An infrequent case of iron deficiency anaemia in an adolescent. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 54(1): 140-141

Bazin, A.; Gautreau, G.; Médigue, C.; Vallenet, D.; Calteau, A. 2020: PanRGP: a pangenome-based method to predict genomic islands and explore their diversity. Bioinformatics 36(Suppl_2): I651-I658

Brunner, E.; Peter, O.; Schweizer, L.; Basler, K. 1997: Pangolin encodes a Lef-1 homologue that acts downstream of Armadillo to transduce the Wingless signal in Drosophila. Nature 385(6619): 829-833

Graham, C.J. 2021: Parkrun - more than a run in the park. Journal of the Royal College of Physicians of Edinburgh 51(3): 310-317

Stoffel, M.A.; Nakagawa, S.; Schielzeth, H. 2021: PartR2: partitioning R2 in generalized linear mixed models. Peerj 9: E11414

Helmus, R.; Ter Laak, T.L.; van Wezel, A.P.; de Voogt, P.; Schymanski, E.L. 2021: PatRoon: open source software platform for environmental mass spectrometry based non-target screening. Journal of Cheminformatics 13(1): 1

Velinder, M.; Lee, D.; Marth, G. 2020: Ped_draw: pedigree drawing with ease. Bmc Bioinformatics 21(1): 569

Serizay, J.; Ahringer, J. 2021: PeriodicDNA: an R/Bioconductor package to investigate k-mer periodicity in DNA. F1000research 10: 141

Mollerstrom, J. 1948: Periodicity of the hepatic function within 24 hours and the intermediate metabolism; practical applications concerning the pathogenesis of diabetes and its treatment. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 24(52): 1693-1695

Byun, J.; Jong, J.A.; Gangat, A.; Flowers, T.; Gazo, A.; Shah, I. 2020: PhactMi Benchmarking Survey on Content Development and Inquiry Management. Therapeutic Innovation and Regulatory Science 54(6): 1263-1268

Yin, J.; Du, Y.; Qin, R.; Shen, S.; Mandrekar, S. 2021: Phase1RMD: An R package for repeated measures dose-finding designs with novel toxicity and efficacy endpoints. Plos one 16(9): E0256391

De Maio, N.; Boulton, W.; Weilguny, L.; Walker, C.R.; Turakhia, Y.; Corbett-Detig, R.; Goldman, N. 2021: PhastSim: efficient simulation of sequence evolution for pandemic-scale datasets. Biorxiv: the Preprint Server for Biology 2021

Ceriani, R.; Calfún, C.; Whitlock, K.E. 2021: Phoenixin(smim20), a gene coding for a novel reproductive ligand, is expressed in the brain of adult zebrafish. Gene Expression Patterns: Gep 39: 119164

Shamsaei, B.; Chojnacki, S.; Pilarczyk, M.; Najafabadi, M.; Niu, W.; Chen, C.; Ross, K.; Matlock, A.; Muhlich, J.; Chutipongtanate, S.; Zheng, J.; Turner, J.; Vidović, D.ši.; Jaffe, J.; MacCoss, M.; Wu, C.; Pillai, A.; Ma'ayan, A.; Schürer, S.; Kouril, M.; Medvedovic, M.; Meller, J. 2020: PiNET: a versatile web platform for downstream analysis and visualization of proteomics data. Nucleic Acids Research 48(W1): W85-W93

Zhang, L.; Meng, X.; Li, D.; Han, X. 2020: PiR-001773 and piR-017184 promote prostate cancer progression by interacting with PCDH9. Cellular Signalling 76: 109780

Qi, T.; Cao, H.; Sun, H.; Feng, H.; Li, N.; Wang, C.; Wang, L. 2020: PiR-19166 inhibits migration and metastasis through CTTN/MMPs pathway in prostate carcinoma. Aging 12(18): 18209-18220

Liu, Y.; Dong, Y.; He, X.; Gong, A.; Gao, J.; Hao, X.; Wang, S.; Fan, Y.; Wang, Z.; Li, M.; Xu, W. 2021: PiR-hsa-211106 Inhibits the Progression of Lung Adenocarcinoma Through Pyruvate Carboxylase and Enhances Chemotherapy Sensitivity. Frontiers in Oncology 11: 651915

Saint-Leandre, B.; Capy, P.; Hua-Van, A.; Filée, J. 2020: PiRNA and Transposon Dynamics in Drosophila: a Female Story. Genome Biology and Evolution 12(6): 931-947

Beyret, E.; Liu, N.; Lin, H. 2012: PiRNA biogenesis during adult spermatogenesis in mice is independent of the ping-pong mechanism. Cell Research 22(10): 1429-1439

Onishi, R.; Yamanaka, S.; Siomi, M.C. 2021: PiRNA- and siRNA-mediated transcriptional repression in Drosophila, mice, and yeast: new insights and biodiversity. EMBO reports 22(10): e53062

Li, B.; Hong, J.; Hong, M.; Wang, Y.; Yu, T.; Zang, S.; Wu, Q. 2019: PiRNA-823 delivered by multiple myeloma-derived extracellular vesicles promoted tumorigenesis through re-educating endothelial cells in the tumor environment. Oncogene 38(26): 5227-5238

Barreñada, O.; Larriba, E.; Brieño-Enriquez, M.A.; Mazo, J.ús.D. 2021: PiRNA-IPdb: a PIWI-bound pi RNAs database to mining NGS sncRNA data and beyond. Bmc Genomics 22(1): 765

Li, F.; Yuan, P.; Rao, M.; Jin, C-Hui.; Tang, W.; Rong, Y-Fei.; Hu, Y-Ping.; Zhang, F.; Wei, T.; Yin, Q.; Liang, T.; Wu, L.; Li, J.; Li, D.; Liu, Y.; Lou, W.; Zhao, S.; Liu, M-Fang. 2020: PiRNA-independent function of PIWIL1 as a co-activator for anaphase promoting complex/cyclosome to drive pancreatic cancer metastasis. Nature Cell Biology 22(4): 425-438

Satoh, T.; Iitsuka, T.; Shiraishi, A.; Hozumi, A.; Satake, H.; Sasakura, Y. 2018: PiRNA-like small RNAs are responsible for the maternal-specific knockdown in the ascidian Ciona intestinalis Type A. Scientific Reports 8(1): 5869

Teixeira, F.Karam.; Okuniewska, M.; Malone, C.D.; Coux, Rémi-Xavier.; Rio, D.C.; Lehmann, R. 2017: PiRNA-mediated regulation of transposon alternative splicing in the soma and germ line. Nature 552(7684): 268-272

Yao, F.; Ma, L. 2020: PiRNA-unbound PIWIL1 promotes metastasis. Nature Cell Biology 22(4): 359-360

Dufourt, Jérémy.; Bontonou, Génaëlle.; Chartier, A.; Jahan, C.; Meunier, A-Cécile.; Pierson, Séphanie.; Harrison, P.F.; Papin, C.; Beilharz, T.H.; Simonelig, M. 2017: PiRNAs and Aubergine cooperate with Wispy poly(A) polymerase to stabilize mRNAs in the germ plasm. Nature Communications 8(1): 1305

Ow, M.C.; Hall, S.E. 2021: PiRNAs and endo-siRNAs: Small molecules with large roles in the nervous system. Neurochemistry International 148: 105086

Clyde, D. 2019: PiRNAs make sense of retroviral invaders. Nature Reviews. Genetics 20(12): 704

Simonelig, M. 2014: PiRNAs, master regulators of gene expression. Cell Research 24(7): 779-780

Eslava-Avilés, E.; Arenas-Huertero, F. 2021: PiRNAs: nature, biogenesis, regulation, and their potential clinical utility. Boletin Medico del Hospital Infantil de Mexico 78(5): 432-442

Kim, S.W.; Lee, J.H.; Han, J.S.; Shin, S.P.; Park, T.S. 2021: PiggyBac Transposition and the Expression of Human Cystatin C in Transgenic Chickens. Animals: An Open Access Journal from Mdpi 11(6)

Mitra, R.; Fain-Thornton, J.; Craig, N.L. 2008: PiggyBac can bypass DNA synthesis during cut and paste transposition. EMBO Journal 27(7): 1097-1109

Nakanishi, H.; Higuchi, Y.; Kawakami, S.; Yamashita, F.; Hashida, M. 2010: PiggyBac transposon-mediated long-term gene expression in mice. Molecular Therapy: the Journal of the American Society of Gene Therapy 18(4): 707-714

Singla, M.; Ghosh, D.; Shukla, K.K. 2021: Pin ¯ -TSVM: a Robust Transductive Support Vector Machine and its Application to the Detection of COVID-19 Infected Patients. Neural Processing Letters 53(6): 3981-4010

Germain, P.-L.; Sonrel, A.; Robinson, M.D. 2020: PipeComp, a general framework for the evaluation of computational pipelines, reveals performant single cell RNA-seq preprocessing tools. Genome Biology 21(1): 227

Boritsch, E.C.; Frigui, W.; Cascioferro, A.; Malaga, W.; Etienne, G.; Laval, Fçoise.; Pawlik, A.; Le Chevalier, F.; Orgeur, M.; Ma, L.; Bouchier, C.; Stinear, T.P.; Supply, P.; Majlessi, L.; Daffé, M.; Guilhot, C.; Brosch, R. 2016: Pks5-recombination-mediated surface remodelling in Mycobacterium tuberculosis emergence. Nature Microbiology 1: 15019

Chen, W.; Yao, C.; Guo, Y.; Wang, Y.; Xue, Z. 2020: PmTM-align: scalable pairwise and multiple structure alignment with Apache Spark and OpenMP. Bmc Bioinformatics 21(1): 426

Duc Chinh, N.; Haneul, Y.; Minh Hieu, N.; Manh Hung, N.; Duc Quang, N.; Kim, C.; Kim, D. 2021: Pn-Heterojunction of the SWCNT/ZnO nanocomposite for temperature dependent reaction with hydrogen. Journal of Colloid and Interface Science 584: 582-591

Zhang, D.; Yang, Y.; Liang, C.; Liu, J.; Wang, H.; Liu, S.; Yan, Q. 2019: PoFUT1 promotes uterine angiogenesis and vascular remodeling via enhancing the O-fucosylation on uPA. Cell Death and Disease 10(10): 775

Zhang, B-Cun.; Zhou, Z-Jun.; Sun, L. 2016: Pol-miR-731, a teleost miRNA upregulated by megalocytivirus, negatively regulates virus-induced type I interferon response, apoptosis, and cell cycle arrest. Scientific Reports 6: 28354

Taira, Y.; Wada, H.; Hayashi, S.; Kageyama, Y. 2021: Polished rice mediates ecdysone-dependent control of Drosophila embryonic organogenesis. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 26(5): 269-281

Shukla, A.; Yan, J.; Pagano, D.J.; Dodson, A.E.; Fei, Y.; Gorham, J.; Seidman, J.G.; Wickens, M.; Kennedy, S. 2020: Poly(UG)-tailed RNAs in genome protection and epigenetic inheritance. Nature 582(7811): 283-288

Clark, L.V.; Lipka, A.E.; Sacks, E.J. 2019: PolyRAD: Genotype Calling with Uncertainty from Sequencing Data in Polyploids and Diploids. G3 9(3): 663-673

Brandt, C.; Krautwurst, S.; Spott, R.; Lohde, M.; Jundzill, M.; Marquet, M.; Hölzer, M. 2021: PoreCov-An Easy to Use, Fast, and Robust Workflow for SARS-CoV-2 Genome Reconstruction via Nanopore Sequencing. Frontiers in Genetics 12: 711437

Hoffarth, S.; Zitzer, A.; Wiewrodt, R.; Hähnel, P.S.; Beyer, V.; Kreft, A.; Biesterfeld, S.; Schuler, M. 2008: Pp32/PHAPI determines the apoptosis response of non-small-cell lung cancer. Cell Death and Differentiation 15(1): 161-170

Marx, M.; Dorsch, O. 1997: Pp60c-src is required for the induction of a quiescent mesangial cell phenotype. Kidney International 51(1): 110-118

Wu, Q.; Zhang, C.; Zhang, K.; Chen, Q.; Wu, S.; Huang, H.; Huang, T.; Zhang, N.; Wang, X.; Li, W.; Liu, Y.; Zhang, J. 2020: PpGalNAc-T4-catalyzed O-Glycosylation of TGF-β type Ⅱ receptor regulates breast cancer cells metastasis potential. Journal of Biological Chemistry 2020: 100119

Wang, B.; Grant, R.A.; Laub, M.T. 2020: PpGpp Coordinates Nucleotide and Amino-Acid Synthesis in E. coli During Starvation. Molecular Cell 80(1): 29-42.E10

Ito, D.; Kawamura, H.; Oikawa, A.; Ihara, Y.; Shibata, T.; Nakamura, N.; Asano, T.; Kawabata, S-Ichiro.; Suzuki, T.; Masuda, S. 2020: PpGpp functions as an alarmone in metazoa. Communications Biology 3(1): 671

Cabrer-Panes, J.D.; Fernández-Coll, L.ç; Fernández-Vázquez, J.; Gaviria-Cantin, T.C.; El Mouali, Y.; Åberg, A.; Balsalobre, C. 2020: PpGpp mediates the growth phase-dependent regulation of agn43, a phase variable gene, by stimulating its promoter activity. Environmental Microbiology Reports 12(4): 444-453

Kim, K.; Islam, M.; Jung, H-Won.; Lim, D.; Kim, K.; Lee, S-Gwon.; Park, C.; Lee, J.Chul.; Shin, M. 2021: PpGpp signaling plays a critical role in virulence of Acinetobacter baumannii. Virulence 12(1): 2122-2132

Du Toit, A. 2018: PpGpp triggers the switch. Nature Reviews. Microbiology 16(8): 454

Dalebroux, Z.D.; Swanson, M.S. 2012: PpGpp: magic beyond RNA polymerase. Nature Reviews. Microbiology 10(3): 203-212

Mező, G.áb.; Tripodi Angelo Pierluigi, A.; Ranđelovič, I.; Enyedi, N.ór.K.; Biri-Kovács, B.át.; Tóvári, J.óz. 2021: Application of Asn-Gly-Arg sequence based cyclic peptides for targeted tumor therapy. Magyar Onkologia 65(2): 113-120

Rinaldi, L.; Delle Donne, R.; Sepe, M.; Porpora, M.; Garbi, C.; Chiuso, F.; Gallo, A.; Parisi, S.; Russo, L.; Bachmann, V.; Huber, R.G.; Stefan, E.; Russo, T.; Feliciello, A. 2016: Praja2 regulates KSR1 stability and mitogenic signaling. Cell Death and Disease 7: E2230

Pastore, B.; Hertz, H.L.; Price, I.F.; Tang, W. 2021: Pre-piRNA trimming and 2'-O-methylation protect pi RNAs from 3' tailing and degradation in C. elegans. Cell Reports 36(9): 109640

Islam, M.K.B.; Rahman, J.; Hasan, M.A.M.; Ahmad, S. 2021: PredForm-Site: Formylation site prediction by incorporating multiple features and resolving data imbalance. Computational Biology and Chemistry 94: 107553

Liang, R.; An, J.; Zheng, Y.; Li, J.; Wang, Y.; Jia, Y.; Zhang, J.; Lu, Q. 2021: Predicting and improving the probability of live birth for women undergoing frozen-thawed embryo transfer: a data-driven estimation and simulation model. Computer Methods and Programs in Biomedicine 198: 105780

Quinn, T.P.; Richardson, M.F.; Lovell, D.; Crowley, T.M. 2017: Propr: An R-package for Identifying Proportionally Abundant Features Using Compositional Data Analysis. Scientific Reports 7(1): 16252

Mwai, K.; Kibinge, N.; Tuju, J.; Kamuyu, G.; Kimathi, R.; Mburu, J.; Chepsat, E.; Nyamako, L.; Chege, T.; Nkumama, I.; Kinyanjui, S.; Musenge, E.; Osier, F. 2021: ProtGear: a protein microarray data pre-processing suite. Computational and Structural Biotechnology Journal 19: 2518-2525

Wurz, A.I.; O'Bryant, C.T.; Hughes, R.M. 2021: ProtaTETHER: a method for the incorporation of linkers in biomacromolecules. Methods in Enzymology 647: 83-106

Graw, S.; Tang, J.; Zafar, M.K.; Byrd, A.K.; Bolden, C.; Peterson, E.C.; Byrum, S.D. 2020: ProteiNorm - a User-Friendly Tool for Normalization and Analysis of TMT and Label-Free Protein Quantification. Acs Omega 5(40): 25625-25633

Boon, K-Loong.; Grainger, R.J.; Ehsani, P.; Barrass, J.David.; Auchynnikava, T.; Inglehearn, C.F.; Beggs, J.D. 2007: Prp8 mutations that cause human retinitis pigmentosa lead to a U5 snRNP maturation defect in yeast. Nature Structural and Molecular Biology 14(11): 1077-1083

Morden, C.W.; Golden, S.S. 1989: PsbA genes indicate common ancestry of prochlorophytes and chloroplasts. Nature 337(6205): 382-385

Strittmatter, L.M.; Capitanchik, C.; Newman, A.J.; Hallegger, M.; Norman, C.M.; Fica, S.M.; Oubridge, C.; Luscombe, N.M.; Ule, J.; Nagai, K. 2021: PsiCLIP reveals dynamic RNA binding by DEAH-box helicases before and after exon ligation. Nature Communications 12(1): 1488

Klein, J.; Zaia, J. 2019: Psims - A Declarative Writer for mzML and mzIdentML for Python. Molecular and Cellular Proteomics: Mcp 18(3): 571-575

Ahmed, F.; Senthil-Kumar, M.; Dai, X.; Ramu, V.S.; Lee, S.; Mysore, K.S.; Zhao, P.X. 2020: PssRNAit: a Web Server for Designing Effective and Specific Plant si RNAs with Genome-Wide Off-Target Assessment. Plant Physiology 184(1): 65-81

Ahmed, F.; Senthil-Kumar, M.; Dai, X.; Ramu, V.S.; Lee, S.; Mysore, K.S.; Zhao, P.Xuechun. 2020: PssRNAit: A Web Server for Designing Effective and Specific Plant si RNAs with Genome-Wide Off-Target Assessment. Plant Physiology 184(1): 65-81

Hayes, M.; Gao, X.; Yu, L.X.; Paria, N.; Henkelman, R.Mark.; Wise, C.A.; Ciruna, B. 2014: Ptk7 mutant zebrafish models of congenital and idiopathic scoliosis implicate dysregulated Wnt signalling in disease. Nature Communications 5: 4777

Dormatey, R.; Sun, C.; Ali, K.; Fiaz, S.; Xu, D.; Calderón-Urrea, A.; Bi, Z.; Zhang, J.; Bai, J. 2021: PtxD/Phi as alternative selectable marker system for genetic transformation for bio-safety concerns: a review. Peerj 9: E11809

Wang, X.; He, S.; Li, J.; Wang, J.; Wang, C.; Wang, M.; He, D.; Lv, X.; Zhong, Q.; Wang, H.; Wang, Z. 2020: PulseTD: RNA life cycle dynamics analysis based on pulse model of 4sU-seq time course sequencing data. Peerj 8: E9371

Savitzky, B.H.; Zeltmann, S.E.; Hughes, L.A.; Brown, H.G.; Zhao, S.; Pelz, P.M.; Pekin, T.C.; Barnard, E.S.; Donohue, J.; Rangel DaCosta, L.; Kennedy, E.; Xie, Y.; Janish, M.T.; Schneider, M.M.; Herring, P.; Gopal, C.; Anapolsky, A.; Dhall, R.; Bustillo, K.C.; Ercius, P.; Scott, M.C.; Ciston, J.; Minor, A.M.; Ophus, C. 2021: Py4DSTEM: a Software Package for Four-Dimensional Scanning Transmission Electron Microscopy Data Analysis. Microscopy and Microanalysis: the Official Journal of Microscopy Society of America Microbeam Analysis Society Microscopical Society of Canada 27(4): 712-743

Hammad, G.ég.; Reyt, M.; Beliy, N.; Baillet, M.; Deantoni, M.; Lesoinne, A.; Muto, V.; Schmidt, C. 2021: PyActigraphy: Open-source python package for actigraphy data visualization and analysis. Plos Computational Biology 17(10): E1009514

Zhang, Y.; Shang, Q.; Zhang, G. 2021: PyDRMetrics - a Python toolkit for dimensionality reduction quality assessment. Heliyon 7(2): E06199

Odinokov, A.V.; Dubinets, N.O.; Bagaturyants, A.A. 2018: PyEFP: Automatic decomposition of the complex molecular systems into rigid polarizable fragments. Journal of Computational Chemistry 39(13): 807-814

Hemmerich, J.; Tenhaef, N.; Wiechert, W.; Noack, S. 2021: PyFOOMB: Python framework for object oriented modeling of bioprocesses. Engineering in Life Sciences 21(3-4): 242-257

Luo, Z.-H.; Shi, M.-W.; Yang, Z.; Zhang, H.-Y.; Chen, Z.-X. 2020: PyMeSHSim: an integrative python package for biomedical named entity recognition, normalization, and comparison of MeSH terms. Bmc Bioinformatics 21(1): 252

Akam, T.; Walton, M.E. 2019: PyPhotometry: Open source Python based hardware and software for fiber photometry data acquisition. Scientific Reports 9(1): 3521

Sladek, V.; Yamamoto, Y.; Harada, R.; Shoji, M.; Shigeta, Y.; Sladek, V. 2021: PyProGA-A PyMOL plugin for protein residue network analysis. Plos one 16(7): E0255167

Bauer, A.; Prechová, M.; Fischer, L.; Thievessen, I.; Gregor, M.; Fabry, B. 2021: PyTFM: a tool for traction force and monolayer stress microscopy. Plos Computational Biology 17(6): E1008364

Andresen, K.S. 1949: Pyloric stenosis; some cases were operatively treated in the period 1931-41. Ugeskrift for Laeger 111(31): 854

Jungo, A.; Scheidegger, O.; Reyes, M.; Balsiger, F. 2021: Pymia: a Python package for data handling and evaluation in deep learning-based medical image analysis. Computer Methods and Programs in Biomedicine 198: 105796

Singh, U.; Li, J.; Seetharam, A.; Wurtele, E.S. 2021: Pyrpipe: a Python package for RNA-Seq workflows. Nar Genomics and Bioinformatics 3(2): Lqab 049

Pieniak, M.; Oleszkiewicz, A.; Klockow, M.; Yoshino, A.; Haehner, A.; Hummel, T. 2022: Q-Powders: a quick test for screening retronasal olfactory disorders with tasteless powders. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 279(2): 779-784

Crossley, M.P.; Bocek, M.J.; Hamperl, S.; Swigut, T.; Cimprich, K.A. 2020: QDRIP: a method to quantitatively assess RNA-DNA hybrid formation genome-wide. Nucleic Acids Research 48(14): E84

Zhu, Y.; Biernacka, A.; Pardo, B.; Dojer, N.; Forey, R.; Skrzypczak, M.; Fongang, B.; Nde, J.; Yousefi, R.; Pasero, P.; Ginalski, K.; Rowicka, M. 2019: QDSB-Seq is a general method for genome-wide quantification of DNA double-strand breaks using sequencing. Nature Communications 10(1): 2313

Gorantla, V.R.; Bond, V.; Dorsey, J.; Tedesco, S.; Kaur, T.; Simpson, M.; Pemminati, S.; Millis, R.M. 2019: QEEG Measures of Attentional and Memory Network Functions in Medical Students: Novel Targets for Pharmacopuncture to Improve Cognition and Academic Performance. Journal of Pharmacopuncture 22(3): 166-170

Luu, H.M.; Kim, D.-H.; Kim, J.-W.; Choi, S.-H.; Park, S.-H. 2021: QMTNet: Accelerated quantitative magnetization transfer imaging with artificial neural networks. Magnetic Resonance in Medicine 85(1): 298-308

Luh, L.M.; Das, I.; Bertolotti, A. 2017: QMotor, a set of rules for sensitive, robust and quantitative measurement of motor performance in mice. Nature Protocols 12(7): 1451-1457

Zhang, W.; Deng, S.; Zhao, Y.; Xu, W.; Liu, Q.; Zhang, Y.; Ren, C.; Cheng, Z.; Xu, M.; Liu, B. 2021: QMrdd2, a novel quantitative resistance locus for maize rough dwarf disease. Bmc Plant Biology 21(1): 307

Oliveira, E.S.C.; Pontes, F.áv.L.D.; Acho, L.D.R.; do Rosário, A.S.; da Silva, B.ár.J.ín.P.; de A Bezerra, J.; Campos, F.R.; Lima, E.S.; Machado, M.B. 2021: QNMR quantification of phenolic compounds in dry extract of Myrcia multiflora leaves and its antioxidant, anti-AGE, and enzymatic inhibition activities. Journal of Pharmaceutical and Biomedical Analysis 201: 114109

Witte, A.K.; Mester, P.; Rossmanith, P. 2021: QPCR Validation on the Basis of the Listeria monocytogenes prfA Assay. Methods in Molecular Biology 2220: 41-53

Ma, H.; Bell, K.N.; Loker, R.N. 2021: QPCR and qRT-PCR analysis: Regulatory points to consider when conducting biodistribution and vector shedding studies. Molecular Therapy. Methods and Clinical Development 20: 152-168

Vandersea, M.W.; Kibler, S.R.; Van Sant, S.B.; Tester, P.A.; Sullivan, K.; Eckert, G.; Cammarata, C.; Reece, K.; Scott, G.; Place, A.; Holderied, K.; Hondolero, D.; Litaker, R.W. 2017: QPCR assays for Alexandrium fundyense and A. ostenfeldii (Dinophyceae) identified from Alaskan waters and a review of species-specific Alexandrium molecular assays. Phycologia 56(3): 303-320

Claeys Boúúaert, D.; Van Poucke, M.; De Smet, L.; Verbeke, W.; de Graaf, D.C.; Peelman, L. 2021: QPCR assays with dual-labeled probes for genotyping honey bee variants associated with varroa resistance. Bmc Veterinary Research 17(1): 179

Khoury, S.; Tran, N. 2020: QPCR multiplex detection of microRNA and messenger RNA in a single reaction. Peerj 8: E9004

Krolicka, A.; Gomiero, A.; Baussant, T. 2020: QPCR-based assessment of microfaunal indicators of oil for monitoring benthos around oil and gas platforms. Science of the Total Environment 736: 139527

Barry, D.E.; Veillard, M.; James, C.T.; Brummelhuis, L.; Pila, E.A.; Turnbull, A.; Oploo, A.O.-v.; Han, X.; Hanington, P.C. 2021: QPCR-based environmental monitoring of Myxobolus cerebralis and phylogenetic analysis of its tubificid hosts in Alberta, Canada. Diseases of Aquatic Organisms 145: 119-137

Nicolae, M.; Rajasekaran, S. 2015: QPMS9: an efficient algorithm for quorum Planted Motif Search. Scientific Reports 5: 7813

Asha Devi, S.; Davargaon, R.S.; Subramanyam, M.V.V. 2022: QRT-PCR Analysis of GLUT-4 and Assessment of Trolox as an Effective Antioxidant in Diabetic Cardiomyoblasts. Methods in Molecular Biology 2343: 247-258

Zhang, K.; Zhang, Y.; Wu, W.; Zhan, X.; Anis, G.Bakr.; Rahman, M.Habibur.; Hong, Y.; Riaz, A.; Zhu, A.; Cao, Y.; Sun, L.; Yang, Z.; Yang, Q.; Cao, L.; Cheng, S. 2018: QSE7 is a major quantitative trait locus (QTL) influencing stigma exsertion rate in rice (Oryza sativa L.). Scientific Reports 8(1): 14523

Wagner, T.; Sinning, C.; Haumann, J.; Magnussen, C.; Blankenberg, S.; Reichenspurner, H.; Grahn, H. 2020: QSOFA Score Is Useful to Assess Disease Severity in Patients with Heart Failure in the Setting of a Heart Failure Unit (HFU). Frontiers in Cardiovascular Medicine 7: 574768

Spagnolello, O.; Ceccarelli, G.; Borrazzo, C.; Macrì, A.; Suppa, M.; Baldini, E.; Garramone, A.; Alessandri, F.; Celani, L.; Vullo, F.; Angeletti, S.; Ciccozzi, M.; Mastroianni, C.; Bertazzoni, G.; D'Ettorre, G. 2021: QSOFA as a new community-acquired pneumonia severity score in the emergency setting. Emergency Medicine Journal: Emj 38(12): 906-912

Andrews, J.O.; Conway, W.; Cho, W-K.; Narayanan, A.; Spille, J-H.; Jayanth, N.; Inoue, T.; Mullen, S.; Thaler, J.; Cissé, I.I. 2018: QSR: a quantitative super-resolution analysis tool reveals the cell-cycle dependent organization of RNA Polymerase I in live human cells. Scientific Reports 8(1): 7424

Lee, H-Chi.; Chang, S-Shin.; Choudhary, S.; Aalto, A.P.; Maiti, M.; Bamford, D.H.; Liu, Y. 2009: QiRNA is a new type of small interfering RNA induced by DNA damage. Nature 459(7244): 274-277

Yong, D.; Kobayashi, C.; Da Costa, G.S.; Bessell, M.S.; Chiti, A.; Frebel, A.; Lind, K.; Mackey, A.D.; Nordlander, T.; Asplund, M.; Casey, A.R.; Marino, A.F.; Murphy, S.J.; Schmidt, B.P. 2021: R-Process elements from magnetorotational hypernovae. Nature 595(7866): 223-226

Ahmed, S.Seher.; Schattgen, S.A.; Frakes, A.E.; Sikoglu, E.M.; Su, Q.; Li, J.; Hampton, T.G.; Denninger, A.R.; Kirschner, D.A.; Kaspar, B.; Matalon, R.; Gao, G. 2016: RAAV Gene Therapy in a Canavan's Disease Mouse Model Reveals Immune Impairments and an Extended Pathology Beyond the Central Nervous System. Molecular Therapy: the Journal of the American Society of Gene Therapy 24(6): 1030-1041

Li, J.; Dressman, D.; Tsao, Y.P.; Sakamoto, A.; Hoffman, E.P.; Xiao, X. 1999: RAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy. Gene Therapy 6(1): 74-82

Morscheid, Y.P.; Venkatesan, J.K.; Schmitt, G.; Orth, P.; Zurakowski, D.; Speicher-Mentges, S.; Menger, M.D.; Laschke, M.W.; Cucchiarini, M.; Madry, H. 2021: RAAV-Mediated Human FGF-2 Gene Therapy Enhances Osteochondral Repair in a Clinically Relevant Large Animal Model over time in Vivo. American Journal of Sports Medicine 49(4): 958-969

Lange, C.; Madry, H.; Venkatesan, J.K.; Schmitt, G.; Speicher-Mentges, S.; Zurakowski, D.; Menger, M.D.; Laschke, M.W.; Cucchiarini, M. 2021: RAAV-Mediated sox9 Overexpression Improves the Repair of Osteochondral Defects in a Clinically Relevant Large Animal Model over time in Vivo and Reduces Perifocal Osteoarthritic Changes. American Journal of Sports Medicine 49(13): 3696-3707

Cucchiarini, M.; Schetting, S.; Terwilliger, E.F.; Kohn, D.; Madry, H. 2009: RAAV-mediated overexpression of FGF-2 promotes cell proliferation, survival, and alpha-SMA expression in human meniscal lesions. Gene Therapy 16(11): 1363-1372

Frisch, J.; Rey-Rico, A.; Venkatesan, J.K.; Schmitt, G.; Madry, H.; Cucchiarini, M. 2016: RAAV-mediated overexpression of sox9, TGF-β and IGF-I in minipig bone marrow aspirates to enhance the chondrogenic processes for cartilage repair. Gene Therapy 23(3): 247-255

Valdmanis, P.N.; Lisowski, L.; Kay, M.A. 2012: RAAV-mediated tumorigenesis: still unresolved after an AAV assault. Molecular Therapy: the Journal of the American Society of Gene Therapy 20(11): 2014-2017

Ross, J.A.; Tasfaout, H.; Levy, Y.; Morgan, J.; Cowling, B.S.; Laporte, J.; Zanoteli, E.; Romero, N.B.; Lowe, D.A.; Jungbluth, H.; Lawlor, M.W.; Mack, D.L.; Ochala, J. 2020: RAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy. Acta Neuropathologica Communications 8(1): 167

Beltran, W.A.; Boye, S.L.; Boye, S.E.; Chiodo, V.A.; Lewin, A.S.; Hauswirth, W.W.; Aguirre, G.D. 2010: RAAV2/5 gene-targeting to rods:dose-dependent efficiency and complications associated with different promoters. Gene Therapy 17(9): 1162-1174

Gregorevic, P.; Allen, J.M.; Minami, E.; Blankinship, M.J.; Haraguchi, M.; Meuse, L.; Finn, E.; Adams, M.E.; Froehner, S.C.; Murry, C.E.; Chamberlain, J.S. 2006: RAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nature Medicine 12(7): 787-789

Ishii, A.; Okada, H.; Hayashita-Kinoh, H.; Shin, J.-H.; Tamaoka, A.; Okada, T.; Takeda, S.'i. 2020: RAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates. Molecular Therapy. Methods and Clinical Development 18: 44-49

Rocca, C.J.; Ur, S.N.; Harrison, F.; Cherqui, S. 2014: RAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study. Gene Therapy 21(6): 618-628

Lian, F.; Ye, Q.; Feng, B.; Cheng, H.; Niu, S.; Fan, N.; Wang, D.; Wang, Z. 2020: RAAV9-UPII-TK-EGFP can precisely transduce a suicide gene and inhibit the growth of bladder tumors. Cancer Biology and Therapy 21(12): 1171-1178

Theil, S.; Rifa, E. 2021: RANOMALY: AmplicoN wOrkflow for Microbial community AnaLYsis. F1000research 10: 7

Hua, H.; Dong, X.; Zhang, Y.; Fang, F.; Zhang, B.; Li, X.; Yu, Q.; Zheng, K.; Yan, C. 2021: RCsHscB derived from Clonorchis sinensis has therapeutic effect on dextran sodium sulfate-induced chronic ulcerative colitis in mice. Nan Fang Yi Ke da Xue Xue Bao 41(5): 664-670

Son, J.; Hannan, K.M.; Poortinga, G.; Hein, N.; Cameron, D.P.; Ganley, A.R.D.; Sheppard, K.E.; Pearson, R.B.; Hannan, R.D.; Sanij, E. 2020: RDNA Chromatin Activity Status as a Biomarker of Sensitivity to the RNA Polymerase i Transcription Inhibitor CX-5461. Frontiers in Cell and Developmental Biology 8: 568

Tao, B.; Lo, L.J.; Peng, J.; He, J. 2020: RDNA subtypes and their transcriptional expression in zebrafish at different developmental stages. Biochemical and Biophysical Research Communications 529(3): 819-825

Kwok, C.Kit.; Marsico, G.; Sahakyan, A.B.; Chambers, V.S.; Balasubramanian, S. 2016: RG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome. Nature Methods 13(10): 841-844

Iyer, M.S.; Wang, F.-M.; Jayapalan, R.R.; Veeramani, S.; Rajangam, I. 2021: RGO based immunosensor amplified using MWCNT and CNF nanocomposite as analytical tool for CA125 detection. Analytical Biochemistry 634: 114393

Vinesh, V.; Ashokkumar, M.; Neppolian, B. 2020: RGO supported self-assembly of 2D nano sheet of (g-C3N4) into rod-like nano structure and its application in sonophotocatalytic degradation of an antibiotic. Ultrasonics Sonochemistry 68: 105218

Kumar, S.; Kaushik, R.D.; Upadhyay, G.K.; Purohit, L.P. 2021: RGO-ZnO nanocomposites as efficient photocatalyst for degradation of 4-BP and DEP using high temperature refluxing method in in-situ condition. Journal of Hazardous Materials 406: 124300

Zhao, Y.; Liang, X.; Hu, X.; Fan, J. 2021: RGO/Bi2WO6 composite as a highly efficient and stable visible-light photocatalyst for norfloxacin degradation in aqueous environment. Journal of Colloid and Interface Science 589: 336-346

Laurenzi, T.; Parravicini, C.; Palazzolo, L.; Guerrini, U.; Gianazza, E.; Calabresi, L.; Eberini, I. 2021: RHDL modeling and the anchoring mechanism of LCAT activation. Journal of Lipid Research 62: 100006

Nagai, T.; Akizawa, T.; Kohjiro, S.; Koiwa, F.; Nabeshima, K.; Niikura, K.; Kino, K.; Kanamori, N.; Kinugasa, E.; Ideura, T. 1996: RHuEPO enhances the production of plasminogen activator inhibitor-1 in cultured endothelial cells. Kidney International 50(1): 102-107

Marsh, J.T.; Brown, W.S.; Wolcott, D.; Carr, C.R.; Harper, R.; Schweitzer, S.V.; Nissenson, A.R. 1991: RHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney International 39(1): 155-163

Hunault-Berger, M.; Tanguy-Schmidt, A.; Rachieru, P.; Lévy, V.; Truchan-Graczyk, M.; Francois, S.; Gardembas-Pain, M.; Dib, M.; Foussard, C.; Piard, N.; Godon, A.; Solal-Celigny, P.; Ifrah, N. 2005: RHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot study. Bone Marrow Transplantation 35(9): 903-907

Dong, W.; Chen, M.; Wang, J.; Xia, L.; Wang, Q.; Nie, X.; Feng, Y.; Fang, Y. 2021: RHuPH20-facilitated subcutaneous administration of monoclonal antibodies in cancer therapy. ImmunoTherapy 13(1): 79-88

Kaur, G.; Sts, C.; Nimker, C.; Bansal, A. 2015: RIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium. Cellular and Molecular Immunology 12(1): 96-106

Kaur, G.; Chitradevi; Charu; Bansal, A. 2017: RIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium. Cellular and Molecular Immunology 14(5): 478

Geerts, M.; Schnaufer, A.; Van den Broeck, F. 2021: RKOMICS: an R package for processing mitochondrial minicircle assemblies in population-scale genome projects. Bmc Bioinformatics 22(1): 468

Kleinbub, J.R.; Ramseyer, F.T. 2020: RMEA: An R package to assess nonverbal synchronization in motion energy analysis time-series. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 2020: 1-14

Shahjaman, M.; Rahman, M.R.; Islam, T.; Auwul, M.R.; Moni, M.A.; Mollah, M.N.H. 2021: RMisbeta: a robust missing value imputation approach in transcriptomics and metabolomics data. Computers in Biology and Medicine 138: 104911

Li, Q.; Ren, J.; Xian, H.; Yin, C.; Yuan, Y.; Li, Y.; Ji, R.; Chu, C.; Qiao, Z.; Jiao, X. 2020: ROmpF and OMVs as efficient subunit vaccines against Salmonella enterica serovar Enteritidis infections in poultry farms. Vaccine 38(45): 7094-7099

Dong, N.; Spencer, D.M.; Quan, Q.; Le Blanc, J.C.Y.; Feng, J.; Li, M.; Siu, K.W.M.; Chu, I.K. 2020: RPTMDetermine: a Fully Automated Methodology for Endogenous Tyrosine Nitration Validation, Site-Localization, and Beyond. Analytical Chemistry 92(15): 10768-10776

Osterman, I.A.; Dontsova, O.A.; Sergiev, P.V. 2020: RRNA Methylation and Antibiotic Resistance. BIOCHEMISTRY. Biokhimiia 85(11): 1335-1349

Görgülü, Öz.; Duyan, M. 2020: RRT-PCR Results of a Covid-19 Diagnosed Geriatric Patient. Sn Comprehensive Clinical Medicine 2(11): 2423-2426

Marks, J.H.; Kunkel, E.; Salem, J.; Martin, C.; Schoonyoung, H.P.; Agarwal, S. 2020: RSILS: initial clinical experience with single-port robotic (SPr) right colectomy. Techniques in Coloproctology 24(8): 817-822

Yuan, Y.; Gao, X.; Guo, N.; Zhang, H.; Xie, Z.; Jin, M.; Li, B.; Yu, L.; Jing, N. 2007: RSac3, a novel Sac domain phosphoinositide phosphatase, promotes neurite outgrowth in PC12 cells. Cell Research 17(11): 919-932

Ciciani, M.; Cantore, T.; Lauria, M. 2020: RScudo: an R package for classification of molecular profiles using rank-based signatures. Bioinformatics 36(13): 4095-4096

Zhu, D.; Lyu, L.; Shen, P.; Wang, J.; Chen, J.; Sun, X.; Chen, L.; Zhang, L.; Zhou, Q.; Duan, Y. 2018: RSjP40 protein promotes PPARγ expression in LX-2 cells through microRNA-27b. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 32(9): 4798-4803

Farias, A.P.F.óe.d.; Rocha Filho, J.é T.R.; Marchioro, S.B.; Moreira, L.S.; Marques, A.S.; Sá, M.d.C.ção.A.d.; Oliveira, A.A.D.S.; Alcântara, M.E.íl.; Mariutti, R.B.; Arni, R.K.; Trindade, S.C.; Meyer, R. 2020: RSodC is a potential antigen to diagnose Corynebacterium pseudotuberculosis by enzyme-linked immunoassay. Amb Express 10(1): 186

Xie, Y.; Guan, M.; Wang, Z.; Ma, Z.; Wang, H.; Fang, P.; Yin, H. 2021: RTMS Induces Brain Functional and Structural Alternations in Schizophrenia Patient with Auditory Verbal Hallucination. Frontiers in Neuroscience 15: 722894

Croce, P.; Spadone, S.; Zappasodi, F.; Baldassarre, A.; Capotosto, P. 2021: RTMS affects EEG microstates dynamic during evoked activity. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior 138: 302-310

Hansbauer, M.; Wagner, E.; Strube, W.; Röh, A.; Padberg, F.; Keeser, D.; Falkai, P.; Hasan, A. 2020: RTMS and tDCS for the treatment of catatonia: a systematic review. Schizophrenia Research 222: 73-78

Malhi, G.S.; Bell, E.; Mannie, Z.; Boyce, P.; Hopwood, M.; Bassett, D.; Mulder, R.; Porter, R.J.; Lyndon, B. 2022: RTMS and treatment-resistant depression: the need to consider class action!. Australian and New Zealand Journal of Psychiatry 56(4): 323-327

Amad, A.; Fovet, T. 2022: RTMS for depression: the difficult transition from research to clinical practice. Australian and New Zealand Journal of Psychiatry 56(1): 14-15

Toledo, R.S.öh.; Stein, D.J.ão.; Sanches, P.R.S.; da Silva, L.S.; Medeiros, H.R.; Fregni, F.; Caumo, W.; Torres, I.L.S. 2021: RTMS induces analgesia and modulates neuroinflammation and neuroplasticity in neuropathic pain model rats. Brain Research 1762: 147427

Nardone, R.; Höller, Y.; Thomschewski, A.; Brigo, F.; Orioli, A.; Höller, P.; Golaszewski, S.; Trinka, E. 2014: RTMS modulates reciprocal inhibition in patients with traumatic spinal cord injury. Spinal Cord 52(11): 831-835

Nardone, R.; Höller, Y.; Langthaler, P.B.; Lochner, P.; Golaszewski, S.; Schwenker, K.; Brigo, F.; Trinka, E. 2017: RTMS of the prefrontal cortex has analgesic effects on neuropathic pain in subjects with spinal cord injury. Spinal Cord 55(1): 20-25

Neri, F.; Romanella, S.M.; Tomai Pitinca, M.L.; Taddei, S.; Monti, L.; Benocci, S.; Santarnecchi, E.; Cappa, S.F.; Rossi, S. 2021: RTMS-induced language improvement and brain connectivity changes in logopenic/phonological variant of Primary progressive Aphasia. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 132(10): 2481-2484

Sousa, S.; Almeida, Aé.; Delgado, L.; Conceição, Aónia.; Marques, Cáudia.; da Costa, Jé.Manuel.Correia.; Castro, Aónio. 2020: RTgOWP1-f, a specific biomarker for Toxoplasma gondii oocysts. Scientific Reports 10(1): 7947

Elferink, L.A.; Anzai, K.; Scheller, R.H. 1992: Rab15, a novel low molecular weight GTP-binding protein specifically expressed in rat brain. Journal of Biological Chemistry 267(31): 22693

Wolter, S.; Löschberger, A.; Holm, T.; Aufmkolk, S.; Dabauvalle, M-Christine.; van de Linde, S.; Sauer, M. 2012: RapidSTORM: accurate, fast open-source software for localization microscopy. Nature Methods 9(11): 1040-1041

Yura, Y.; Azuma, M.; Uchida, K.; Momose, H.; Oyasu, R. 1991: Ras gene alterations in invasive and non-invasive rat bladder carcinomas induced by N-methyl-N-nitrosourea. British Journal of Cancer 64(1): 10-14

DeFeo-Jones, D.; Scolnick, E.M.; Koller, R.; Dhar, R. 1983: Ras-Related gene sequences identified and isolated from Saccharomyces cerevisiae. Nature 306(5944): 707-709

Rocchini, D.; Thouverai, E.; Marcantonio, M.; Iannacito, M.; Da Re, D.; Torresani, M.; Bacaro, G.; Bazzichetto, M.; Bernardi, A.; Foody, G.M.; Furrer, R.; Kleijn, D.; Larsen, S.; Lenoir, J.; Malavasi, M.; Marchetto, E.; Messori, F.; Montaghi, A.; Moudrý, V.ít.ěz.; Naimi, B.; Ricotta, C.; Rossini, M.; Santi, F.; Santos, M.J.; Schaepman, M.E.; Schneider, F.D.; Schuh, L.; Silvestri, S.; Ŝímová, P.; Skidmore, A.K.; Tattoni, C.; Tordoni, E.; Vicario, S.; Zannini, P.; Wegmann, M. 2021: Rasterdiv-An Information Theory tailored R package for measuring ecosystem heterogeneity from space: to the origin and back. Methods in Ecology and Evolution 12(6): 1093-1102

Schwarz, M.; Vohradský, J.ří; Modrák, M.; Pánek, J. 2020: RboAnalyzer: a Software to Improve Characterization of Non-coding RNAs from Sequence Database Search Output. Frontiers in Genetics 11: 675

Caméléna, F.ço.; Poncin, T.; Dudoignon, E.; Salmona, M.; Le Goff, J.ér.ôm.; Donay, J.-L.; Lafaurie, M.; Darmon, M.; Azoulay, E.; Plaud, B.ît.; Mebazaa, A.; Dépret, F.ço.; Jacquier, H.é; Berçot, B.éa. 2021: Rapid identification of bacteria from respiratory samples of patients hospitalized in intensive care units, with FilmArray Pneumonia Panel Plus. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 108: 568-573

Kruger, F.; Stiefl, N.; Landrum, G.A. 2020: RdScaffoldNetwork: the Scaffold Network Implementation in RDKit. Journal of Chemical Information and Modeling 60(7): 3331-3335

Tittes, S. 2020: Rdmc: An Open Source R Package Implementing Convergent Adaptation Models of Lee and Coop (2017). G3 10(9): 3041-3046

Corey, E.J.; Zhang, F.-Y. 1999: Re- and si-Face-Selective Nitroaldol Reactions Catalyzed by a Rigid Chiral Quaternary Ammonium Salt: a Highly Stereoselective Synthesis of the HIV Protease Inhibitor Amprenavir (Vertex 478). Angewandte Chemie 38(13-14): 1931-1934

Karabayev, D.; Molkenov, A.; Yerulanuly, K.; Kabimoldayev, I.; Daniyarov, A.; Sharip, A.; Seisenova, A.; Zhumadilov, Z.; Kairov, U. 2021: Re-Searcher: GUI-based bioinformatics tool for simplified genomics data mining of VCF files. Peerj 9: E11333

Lamothe, G.; Malliavin, Térèse.E. 2018: Re-TAMD: exploring interactions between H3 peptide and YEATS domain using enhanced sampling. Bmc Structural Biology 18(1): 4

Moskalik, A. 2019: ReCAPTCHA all over again. Nature 573(7775): 620

Kinkley, S.; Helmuth, J.; Polansky, J.K.; Dunkel, I.; Gasparoni, G.; Fröhler, S.; Chen, W.; Walter, Jörn.; Hamann, A.; Chung, H-Ryun. 2016: ReChIP-seq reveals widespread bivalency of H3K4me3 and H3K27me3 in CD4(+) memory T cells. Nature Communications 7: 12514

Brun, S.; Rincheval, V.; Gaumer, Sébastien.; Mignotte, B.; Guenal, I. 2002: Reaper and bax initiate two different apoptotic pathways affecting mitochondria and antagonized by bcl-2 in Drosophila. Oncogene 21(42): 6458-6470

Yang, J-Seong.; Garriga-Canut, M.; Link, N.; Carolis, C.; Broadbent, K.; Beltran-Sastre, V.; Serrano, L.; Maurer, S.P. 2018: Rec-YnH enables simultaneous many-by-many detection of direct protein-protein and protein-RNA interactions. Nature Communications 9(1): 3747

Fishel, R.A.; James, A.A.; Kolodner, R. 1981: RecA-independent general genetic recombination of plasmids. Nature 294(5837): 184-186

Moulos, P. 2021: Recoup: flexible and versatile signal visualization from next generation sequencing. Bmc Bioinformatics 22(1): 2

Azab, M.A.; Azzam, A.Y. 2021: Impact of COVID-19 pandemic on the management of glioma patients around the world. An evidence-based review. Brain Disorders 2: 100012

Xu, S.; Feng, W.; Lu, Z.; Yu, C.Y.; Shao, W.; Nakshatri, H.; Reiter, J.L.; Gao, H.; Chu, X.; Wang, Y.; Liu, Y. 2020: RegSNPs-ASB: a Computational Framework for Identifying Allele-Specific Transcription Factor Binding from ATAC-seq Data. Frontiers in Bioengineering and Biotechnology 8: 886

Si, L.; Gu, J.; Wen, M.; Wang, R.; Fleming, J.; Li, J.; Xu, J.; Bi, L.; Deng, J. 2021: RelA Inactivation Converts Sulfonamides into Bactericidal Compounds. Frontiers in Microbiology 12: 698468

Criscuolo, N.G.; Pires, Jão.; Zhao, C.; Van Boeckel, T.P. 2021: Resistancebank.org, an open-access repository for surveys of antimicrobial resistance in animals. Scientific Data 8(1): 189

Morrissey, Z.D.; Zhan, L.; Ajilore, O.; Leow, A.D. 2021: Rest2vec: Vectorizing the resting-state functional connectome using graph embedding. Neuroimage 226: 117538

Landi, I.; Mandelli, V.; Lombardo, M.V. 2021: Reval: a Python package to determine best clustering solutions with stability-based relative clustering validation. Patterns 2(4): 100228

Sellés Vidal, L.; Ayala, R.; Stan, G.-B.; Ledesma-Amaro, R. 2021: RfaRm: An R client-side interface to facilitate the analysis of the Rfam database of RNA families. Plos one 16(1): E0245280

Guo, R.; Wang, X.; Fang, Y.; Chen, X.; Chen, K.; Huang, W.; Chen, J.; Hu, J.; Liang, F.; Du, J.; Dordoe, C.; Tian, X.; Lin, L. 2021: RhFGF20 promotes angiogenesis and vascular repair following traumatic brain injury by regulating Wnt/β-catenin pathway. Biomedicine and PharmacoTherapy 143: 112200

Lassailly, F.; Sielleur, I.; Blaise, D.; Chabannon, C. 2005: RhG-CSF does not affect the phenotype of adult donor peripheral blood NK cells. Bone Marrow Transplantation 35(1): 25-32

Rampling, R.; Steward, W.; Paul, J.; Macham, M.A.; Harvey, E.; Eckley, D. 1994: RhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU. British Journal of Cancer 69(3): 541-545

Legros, M.; Fleury, J.; Bay, J.O.; Choufi, B.; Basile, M.; Condat, P.; Glenat, C.; Communal, Y.; Tavernier, F.; Bons, J.M.; Chollet, P.; Plagne, R.; Chassagne, J. 1997: RhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trial. Bone Marrow Transplantation 19(3): 209-213

Hu, J.; Yan, D.; Gao, J.; Xu, C.; Yuan, Y.; Zhu, R.; Xiang, D.; Weng, S.; Han, W.; Zang, G.; Yu, Y. 2010: RhIL-1Ra reduces hepatocellular apoptosis in mice with acetaminophen-induced acute liver failure. Laboratory Investigation; a Journal of Technical Methods and Pathology 90(12): 1737-1746

Fu, Z.; Jiang, Z.; Guo, G.; Liao, X.; Liu, M.; Xiong, Z. 2021: RhKGF-2 Attenuates Smoke Inhalation Lung Injury of Rats via Activating PI3K/Akt/Nrf2 and Repressing FoxO1-NLRP3 Inflammasome. Frontiers in Pharmacology 12: 641308

Li, H.; Xie, M.; Wang, Y.; Yang, L.; Xie, Z.; Wang, H. 2021: RiboCIRC: a comprehensive database of translatable circRNAs. Genome Biology 22(1): 79

Choi, M.H.; Ravi Kumara, G.S.; Seo, Y.J. 2020: RkDNA-graphene oxide as a simple probe for the rapid detection of miRNA21. Bioorganic and Medicinal Chemistry Letters 30(17): 127398

Nguyen, Y.; Nettleton, D. 2020: RmRNAseq: differential expression analysis for repeated-measures RNA-seq data. Bioinformatics 36(16): 4432-4439

Marusich, L.R.; Bakdash, J.Z. 2021: RmcorrShiny: a web and standalone application for repeated measures correlation. F1000research 10: 697

Silveira, I.H.; Cortes, T.ís.R.; de Oliveira, B.F.át.A.; Junger, W.L. 2021: Projections of excess cardiovascular mortality related to temperature under different climate change scenarios and regionalized climate model simulations in Brazilian cities. Environmental Research 197: 110995

Russo, A.; Saide, A.; Cagliani, R.; Cantile, M.; Botti, G.; Russo, G. 2016: RpL3 promotes the apoptosis of p53 mutated lung cancer cells by down-regulating CBS and NFκB upon 5-FU treatment. Scientific Reports 6: 38369

Li, M.-C.; Lu, J.; Lu, Y.; Xiao, T.-Y.; Liu, H.-C.; Lin, S.-Q.; Xu, D.; Li, G.-L.; Zhao, X.-Q.; Liu, Z.-G.; Zhao, L.-L.; Wan, K.-L. 2021: RpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis. Infection and Drug Resistance 14: 4119-4128

Zeng, M.-C.; Jia, Q.-J.; Tang, L.-M. 2021: RpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates from rural areas of Zhejiang, China. Journal of International Medical Research 49(3): 300060521997596

Tang, M.; Li, A.; Wu, M.; Chen, X.; Xiong, X.; Zhou, Z.; Liu, D. 2020: Rs10490924 surrounding HTRA1/ARMS2 regulates the susceptibility of age-related macular degeneration. Journal of Receptor and Signal Transduction Research 2020: 1-8

Liu, J.; Li, Y.; Chen, X.-Q.; Sun, C.; Sun, X.-L.; Yang, Z.; Kong, Q.-P. 2020: Rs11046147 mutation in the promoter region of lactate dehydrogenase-B as a potential predictor of prognosis in triple-negative breast cancer. Cancer Communications 40(6): 279-282

Xu, J.; Li, G.; Chen, M.; Li, W.; Wu, Y.; Zhang, X.; Cui, Y.; Zhang, B. 2021: Rs12537 Is a Novel Susceptibility SNP Associated with Estrogen Receptor Positive Breast Cancer in Chinese Han Population. Frontiers in Medicine 8: 708644

Zhou, J.; Bao, Q.; Liang, S.; Guo, H.; Meng, X.; Zhang, G.; Li, P. 2021: Rs1344706 polymorphism of zinc finger protein 804a (ZNF804a) gene related to the integrity of white matter fiber bundle in schizophrenics. Experimental and Therapeutic Medicine 22(1): 778

Xiao, X.; Yang, Y.; Ren, Y.; Zou, D.; Zhang, K.; Wu, Y. 2017: Rs1760944 Polymorphism in the APE1 Region is Associated with Risk and Prognosis of Osteosarcoma in the Chinese Han Population. Scientific Reports 7(1): 9331

Zeng, Q.; Tang, T.; Huang, B.; Bu, S.; Xiao, Y.; Dai, Y.; Wei, Z.; Huang, L.; Jiang, S. 2021: Rs1840680 single nucleotide polymorphism in Pentraxin 3: a potential protective biomarker of severe community-acquired pneumonia. Journal of International Medical Research 49(4): 3000605211010621

Hitomi, Y.; Aiba, Y.; Kawai, Y.; Kojima, K.; Ueno, K.; Nishida, N.; Kawashima, M.; Gervais, O.; Khor, S-Soon.; Nagasaki, M.; Tokunaga, K.; Nakamura, M.; Tsuiji, M. 2021: Rs1944919 on chromosome 11q23.1 and its effector genes COLCA1/COLCA2 confer susceptibility to primary biliary cholangitis. Scientific Reports 11(1): 4557

Hu, Y.; Sun, J.-Y.; Zhang, Y.; Zhang, H.; Gao, S.; Wang, T.; Han, Z.; Wang, L.; Sun, B.-L.; Liu, G. 2021: Rs1990622 variant associates with Alzheimer's disease and regulates TMEM106B expression in human brain tissues. Bmc Medicine 19(1): 11

Degtyareva, A.O.; Leberfarb, E.Y.; Efimova, E.G.; Brusentsov, I.I.; Usova, A.V.; Lushnikova, E.L.; Merkulova, T.I. 2020: Rs2072580T>A Polymorphism in the Overlapping Promoter Regions of the SART3 and ISCU Genes Associated with the Risk of Breast Cancer. Bulletin of Experimental Biology and Medicine 169(1): 81-84

Glas, Jürgen.; Seiderer, J.; Pasciuto, G.; Tillack, C.; Diegelmann, J.; Pfennig, S.; Konrad, A.; Schmechel, S.; Wetzke, M.; Török, H-Paula.; Stallhofer, J.; Jürgens, M.; Griga, T.; Klein, W.; Epplen, Jörg.T.; Schiemann, U.; Mussack, T.; Lohse, P.; Göke, B.; Ochsenkühn, T.; Folwaczny, M.; Müller-Myhsok, B.; Brand, S. 2009: Rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population. American Journal of Gastroenterology 104(3): 665-672

Motawi, T.Mohamed.Kamal.; Sadik, N.Abdel.Hamid.; Sabry, D.; Shahin, N.Nabil.; Fahim, S.Atef. 2019: Rs2267531, a promoter SNP within glypican-3 gene in the X chromosome, is associated with hepatocellular carcinoma in Egyptians. Scientific Reports 9(1): 6868

Qi, N.; Chen, Y.; Zeng, Y.; Bao, M.; Long, X.; Guo, Y.; Tan, A.; Gao, Y.; Zhang, H.; Yang, X.; Hu, Y.; Mo, Z.; Jiang, Y. 2020: Rs2274911 polymorphism in GPRC6A associated with serum E2 and PSA in a Southern Chinese male population. Gene 763: 145067

Steck, A.K.; Baschal, E.E.; Jasinski, J.M.; Boehm, B.O.; Bottini, N.; Concannon, P.; Julier, C.; Morahan, G.; Noble, J.A.; Polychronakos, C.; She, J.X.; Eisenbarth, G.S. 2009: Rs2476601 T allele (R620W) defines high-risk PTPN22 type I diabetes-associated haplotypes with preliminary evidence for an additional protective haplotype. Genes and Immunity 10 Suppl. 1: S21-S26

Schulz, S.; Zimmer, P.; Pütz, N.; Jurianz, E.; Schaller, H.-G.ün.; Reichert, S. 2020: Rs2476601 in PTPN22 gene in rheumatoid arthritis and periodontitis-a possible interface?. Journal of Translational Medicine 18(1): 389

Liu, J.; Lončar, I.; Collée, J.Margriet.; Bolla, M.K.; Dennis, J.; Michailidou, K.; Wang, Q.; Andrulis, I.L.; Barile, M.; Beckmann, M.W.; Behrens, S.; Benitez, J.; Blomqvist, C.; Boeckx, B.; Bogdanova, N.V.; Bojesen, S.E.; Brauch, H.; Brennan, P.; Brenner, H.; Broeks, A.; Burwinkel, B.; Chang-Claude, J.; Chen, S-Tung.; Chenevix-Trench, G.; Cheng, C.Y.; Choi, J-Yeob.; Couch, F.J.; Cox, A.; Cross, S.S.; Cuk, K.; Czene, K.; Dörk, T.; Dos-Santos-Silva, I.; Fasching, P.A.; Figueroa, J.; Flyger, H.; García-Closas, M.; Giles, G.G.; Glendon, G.; Goldberg, M.S.; Gon 2016: Rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk. Scientific Reports 6: 36874

Hall, I.F.; Climent, M.; Viviani Anselmi, C.; Papa, L.; Tragante, V.; Lambroia, L.; Farina, F.M.; Kleber, M.E.; März, W.; Biguori, C.; Condorelli, G.; Elia, L. 2021: Rs41291957 controls miR-143 and miR-145 expression and impacts coronary artery disease risk. Embo Molecular Medicine 13(10): E14060

Dong, J.; Zhou, P.; Wu, Y.; Chen, Y.; Xie, H.; Gao, Y.; Lu, J.; Yang, J.; Zhang, X.; Wen, L.; Li, T.; Tang, F. 2022: Integrating single-cell datasets with ambiguous batch information by incorporating molecular network features. Briefings in Bioinformatics 23(1): 211